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Abstract 
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental 
condition characterised by the inability to pay attention, inability to control impulsive 
behaviour and excessive hyperactivity, with prevalence rates in the UK at 
approximately 3 to 8% (National Institute of Clinical Excellence, 2018).  The most 
common and accepted forms of treatment for ADHD are stimulant medication and 
behaviour therapy.  However, stimulant medication only has a positive effect in 
approximately 65% of children (Johnston, Coghill, Matthews, & Steele, 2015) with as 
many as 15% of ADHD patients suffering from side effects including blunting of 
personality, headaches, lack of appetite (Fox, Tharp, & Fox, 2005).  Consequently, a 
need has been identified for a new treatment with improved long-term effects (Arns, 
Heinrich, & Strehl, 2014).  Evidence suggests that neurofeedback, a brainwave training 
programme, can normalise electroencephalogram (EEG) patterns and reduce inattentive 
and impulsive symptoms as a long-term strategy in ADHD (Vernon, Frick, & Gruzelier, 
2004).  There is a growing need for treatment, specifically neurofeedback, to be 
accessible at home (Vernon et al., 2004; Rutterford, Anderson, & Venables, 2008) but 
the effect of this is yet to be investigated.  This was the main purpose of the present 
thesis. 
The aim of this research was to test the feasibility of neurofeedback home 
training in both ADHD and typically developed population as well as stimulant 
medication in combination with neurofeedback home training in an ADHD sample.  It 
was of particular interest to understand the effect of neurofeedback home training on 
personality, EEG measures, and neuropsychometric measures of inattention and 
impulsivity.  The typically developed sample were randomly allocated to: (a) control 
group, sample size 15 participants (b) sensorimotor rhythm uptraining neurofeedback 
home training, sample size 16 participants, or (c) active control group, sample size 16 
participants.  The ADHD sample were randomly allocated to: (a) stimulant medication, 
sample size 19 participants, (b) stimulant medication and neurofeedback home training, 
sample size 8 participants, (c) stimulant medication and neurofeedback in clinic, sample 
size 4 participants, (d) neurofeedback home training, sample size 3 participants.  The 
ADHD sample completed EEG informed neurofeedback.  In both samples, 30 sessions 
of neurofeedback were completed.  Dependent variables, which consisted of personality 
measures, concentration and impulsivity scales and EEG, were conducted pre- and post-
intervention, then compared to assess the affect of the interventions.   
The main results were that: (i) ADHD sample were significantly different to 
typically developed peers when rated by parents and on CPT, differences were found as 
expected on personality and EEG measures, but were not significant, (ii) stimulant 
medication significantly improved executive function, defiance, inattention, hyperactive 
and impulsive traits when rated by parents in an ADHD population, (iii) neurofeedback 
in clinic and home training did not significantly effect concentration, impulsivity, 
personality or EEG in a ADHD or typically developed sample.  The work reported here 
calls into question the use of neurofeedback in the treatment of ADHD in a clinical 
setting.  The present study made an original contribution to the neurofeedback field 
showing neurofeedback home training does not significantly affect concentration, 
personality of EEG, and contributes to existing knowledge about ADHD. 
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1 General Introduction 
Our understanding of mental health difficulties and the impact it has on 
education, social functioning, relationships as well as the cost, has greatly 
expanded over the past few years.  The UK has witnessed a shift in attitude from 
the government with investment taking place in transforming children’s mental 
health services (Department of Education [DoE], 2017).  The current government 
is committed to providing children and their families with the support they require.  
One condition specifically targeted by the Department of Health is Attention 
Deficit Hyperactivity Disorder (ADHD) of which over 132,000 children suffer 
severely in the UK (Department of Health [DoH], 2015).   
As part of this thesis, a literature review was undertaken.  Articles were 
searched for in the City, University of London, library catalogue in addition to 
ScienceDirect Literature search engine.  Specific search terms included searching 
for articles regarding neurofeedback, ADHD, methylphenidate, Conners’, 
personality and EEG.  The criteria for including an article were that it was directly 
relevant to the thesis topic, was peer reviewed and the most recent article was 
discussed. 
1.1 Introduction to Concentration and Impulsivity Difficulties  
   ADHD is a neurodevelopmental condition characterised by the inability to 
pay attention, inability to control impulsive behaviour and excessive hyperactivity.  
ADHD affects individuals of all ages, with prevalence rates as high as 14% among 
the general population, of which 70% of individuals continue to show symptoms 
into adulthood and affecting four times more males than females (Vernon, Frick, & 
Gruzelier, 2004).  ADHD is a condition with a genetic contribution linked to 
abnormal levels of dopamine in the brain’s neurotransmitters, a system involved in 
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the regulation of behavioural responses, which is exacerbated by environmental 
factors (Fuchs, Birbaumer, Lutzenberger, Gruzelier, & Kaiser, 2003).  
Various management strategies are available to combat the deficits faced 
by individuals with ADHD, including psychoeducation for parents and children, 
Cognitive Behavioural Therapy (CBT), medication and neurofeedback (Halperin, 
& Healey, 2011; National Institute for Health and Care Excellence [NICE], 2018; 
Danforth, Harvey, Ulaszek, & McKee, 2006; Feingold, 1975; Barkley, 1998).  
Within this thesis, the most effective combination of treatments to improve 
symptoms of ADHD are investigated. 
1.1.1 Diagnostic and Statistical Manual of Mental Health Disorders (DSM)  
ADHD was first formally recognised in the second edition of the 
Diagnostic and Statistical Manual of Mental Health (American Psychiatric 
Association [APA], 1968), where the condition was described as hyperkinetic 
reaction of childhood.  At this time, the conditions main symptom was excessive 
motor activity (APA, 1968).   
The third edition of the DSM referred to the disorder as Attention Deficit 
Disorder, which consisted of two subtypes: with hyperactivity, and without 
hyperactivity (APA, 1980).  The change in name was due to the belief that 
hyperactivity was not a common symptom of the disorder and to instead focus on 
inattention.  The definition of the condition also expanded to examine the core 
symptoms, inattention and hyperactivity, independently of each other.  
In the DSM-III-R (APA, 1987), the condition changed from Attention 
Deficit Disorder, with or without hyperactivity, to Attention Deficit Hyperactivity 
Disorder (ADHD) with a single diagnostic checklist.  The change in name 
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emphasised the belief that the condition only existed with the presence of 
hyperactivity, reversing back to the original concept in the DSM-II (APA, 1968). 
In 1994, following published research on the presence of ADHD without 
hyperactivity, the DSM-IV explained ADHD as consisting of the three subtypes 
that we know today: predominately inattentive, predominantly hyperactive-
impulsive, and combined subtype (APA, 1994).  
The Diagnostic and Statistical Manual of Mental Disorders, now the DSM-
5, was most recently updated in 2013 where the condition continues to be referred 
to as ADHD (APA, 2013).  Although the name has remained the same as the 
previous DSM-IV, there have been some minor changes in definition of the 
condition.  In regard to the ADHD symptoms, additional examples of how 
symptoms may present themselves in adulthood have been given.  The level of 
impairment that symptoms cause has been lowered to “reduce the quality of 
functioning” rather than being “clinically significant” (Epstein & Loren, 2013).  
The age of onset has been increased to twelve years old instead of seven, in 
addition to symptoms required for adult diagnosis, reflecting the growing 
understanding and acceptance of ADHD in adults (Barkley, 2003; Bresnham & 
Barry, 2002).  These minor changes in the DSM-5 show that the previous DSM-IV 
has lasted well and remains current with the recent research (Epstein & Loren, 
2013). 
Internationally, there are strict criteria for diagnosis and guidance on how 
mental health conditions are managed.  In accordance with the current DSM-5, in 
order for a diagnosis of ADHD to be made, symptoms need to be present for at 
least six months to the point that the severity of the symptoms are disruptive and 
inappropriate to the typical developmental and academic functioning.  Symptoms 
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must be present before the age of twelve and seen in at least two settings, 
commonly home and school (APA, 2013).  
However, some of the changes in the DSM-5 have not been positively 
received.  As the DSM-5 requires fewer symptoms to fulfil a diagnosis, concerns 
have been raised regarding prevalence of ADHD, with an increase in diagnosis.  
Furthermore, suggestions have been made that lowering the age of onset may be 
less significant in diagnosis (Rigler et al., 2016). 
In the DSM-5, the symptoms of ADHD are broken down into the following 
criteria: 
Inattention: 
• Often fails to give close attention to detail or makes careless mistakes 
in schoolwork, at work, or with other activities. 
• Often has trouble holding attention on tasks or play activities. 
• Often does not seem to listen when spoken to directly. 
• Often does not follow through on instructions and fails to finish 
schoolwork, chores, or duties in the workplace (e.g. loses focus, side-
tracked). 
• Often has trouble organising tasks and activities. 
• Often avoids, dislikes, or is reluctant to do tasks that require mental 
effort over a long period of time (such as schoolwork or homework). 
• Often loses things necessary for tasks and activities (e.g. school 
materials, pencils, books, tools, wallets, keys, paperwork, glasses, 
mobile phones). 
• Is often easily distracted. 
• Is often forgetful in daily activities. 
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Hyperactive/impulsive: 
• Often fidgets with or taps hands or feet, or squirms in seat. 
• Often leaves seat in situations when remaining seated is expected. 
• Often runs about or climbs in situations where it is not appropriate 
(adolescents or adults may be limited to feeling restless). 
• Often unable to play or take part in leisure activities quietly. 
• Is often on the go acting as if driven by a motor. 
• Often talks excessively. 
• Often blurts out an answer before a question has been completed. 
• Often has trouble waiting his/her turn. 
• Often interrupts or intrudes on others (e.g. butts into conversations or 
games). 
In any ADHD subtypes, six of the nine criteria must be met for a clinical 
diagnosis to be made (APA, 2013).   
1.1.2 NICE Guidelines 
 In addition to the DSM-5, UK professionals also have the National 
Institute for Health and Care Excellence guidelines to adhere to (NICE, 2018).   
The most recent update of the NICE guidelines was in March 2018.  The regular 
updates are to ensure that research findings are incorporated to provide the best 
care and treatment available for individuals with ADHD.   
 The NICE guidelines state that a diagnostic assessment should include an 
assessment of the individual’s needs, any coexisting conditions considered, social 
and educational circumstances and a physical health examination.  The NICE 
guidelines state that diagnosis should be made only by a specialist psychiatrist, 
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paediatrician, or other healthcare professional with expertise in ADHD.  Rating 
scales can be valuable in contributing towards a clinical assessment, but diagnosis 
should not be made solely on the basis of such tool (NICE, 2018).   
The most recent update of NICE guidelines has emphasised the importance 
of recognising ADHD in females.  It notes that ADHD is thought to be under-
recognised in females and consequently are less likely to be referred, are 
underdiagnosed and more likely to receive an incorrect diagnosis.  Previous 
research has a lack of female presence, showing limited research considering 
gender differences.  A possible reason for this is that historically, females have 
been excluded from research due to low recruitment numbers (Hasson & Fine, 
2012). 
1.2 Theories of Concentration and Impulsivity Difficulties 
 As previously discussed, concentration and impulsivity difficulties have 
been formally recognised in the UK since 1968 (APA, 1968) and there has been 
ongoing research to understand what causes these difficulties.    
There are two main constructs underpinning ADHD: inattention and 
disinhibition.  Inattention difficulties involve the inability to sustain attention while 
responding to tasks, to be able to follow instructions, and to resist distractions.  
Inattention difficulties are typically first seen ranging in age from 5 to 7. 
Disinhibition refers to a multidimensional construct whereby difficulties include 
inhibition to responses and heightened sensitivity to reward or excessive fear. 
Typically, difficulties with inhibition arise at the younger age of 3 to 4 years old  
(Barkley, 2003).  These two constructs will now be discussed in more detail in 
relation to ADHD. 
 21 
1.2.1  Barkley’s Behavioural Response Inhibition Theory of ADHD 
Barkley (1997) theorised that ADHD is a disorder based upon a deficit in 
inhibiting responses, the disinhibition construct.  Specifically, Barkley stated that 
response inhibition consists of three processes.  The first process is the ability to 
inhibit initial prepotent responses to a task.  A prepotent response refers to a 
response with an immediate positive or negative reinforcement, exhibited as a 
reward seeking or avoidance behaviour.  The second process is stopping a 
response that has already commenced.   If someone has commenced a response but 
receives a signal that the response is ineffective, the behaviour needs to be 
interrupted and stopped.  An example of stopping an ongoing response is the 
Wisconsin Card Sorting Task.  The task involves changing responses to a more 
effective response when feedback has been provided.  Children with ADHD often 
repeat the mistake they made, even when corrected.  The third process is self-
directed responses when a previously commenced response has been interrupted, 
also known as interference control.  An example of interference control is the 
Stroop colour word task.  Here, ADHD participants performed poorly when 
responding to the colour rather than reading the words.  Barkley developed the 
theory in an attempt to create a unifying model of ADHD, based upon prior 
theories of neuropsychological brain functions, specifically creating a link between 
inhibition and executive functions (Barkley, 1997). 
In turn, these three response inhibition processes exert control over 4 areas 
of executive functions: working memory, self-regulation, internalisation of speech, 
and reconstitution.  These systems then have a direct downward effect, for 
example, behavioural inhibition effects working memory, which in turn effects 
motor control, fluency and syntax. 
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Figure 1. Behavioural Response Inhibition Theory of ADHD 
Barkley supported that ADHD was caused by structural abnormalities in 
the prefrontal cortex and connections in the brain.  Deficits in executive functions, 
the cognitive management system of the brain, overlap with ADHD symptoms 
(Barkley, 2003) with suggestion being made that ADHD is an impairment on the 
development of executive functions, specifically the ability to inhibit responses 
(Brown, 2006).  In regards to ADHD inattentive subtype, Barkley (1997) stated 
that this is a distinct disorder and is not a subtype of ADHD as, in Barkley’s 
opinion, it is not associated with executive functioning difficulties and has little in 
common with the other subtypes (Brown, 2006).   
1.2.2 Brown’s ADD Syndrome Model 
Another theory to explain ADHD is the ADD Syndrome Model by Thomas 
Brown (2006).  This theory states that ADD is caused by deficits in executive 
functions.  The ADD Syndrome Model explains that there are six areas within 
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executive functions which cause impairment in ADD.  These six clusters are as 
follows: 
1. Activation: organizing, prioritising and activating for tasks. 
• Trouble initiating work, organising tasks, misunderstanding 
instructions. 
2. Focus: focusing, sustaining and shifting attention to tasks. 
• Loses focus, forgets what was read, easily distracted. 
3. Effort: regulating alertness, sustaining effort and processing speed. 
• Difficulty sleeping, loses interest quickly, difficulty completing 
tasks on time. 
4. Emotion: managing frustration and modulating emotions. 
• Overreacts to frustration. 
5. Memory: utilising working memory and accessing recall. 
• Forgets to do planned activities, poor recall. 
6. Action: monitoring and self-regulation action. 
• Difficulty adjusting to situations, does tasks too fast. 
These clusters within executive functions are continuously and 
unconsciously working together to manage daily tasks.  An individual must self-
regulate using attention and memory to move between tasks.  Brown stated that the 
six clusters are dimensional and that we all have impairments within these clusters 
at times particularly when in different situations, but for individuals with ADHD 
the impairments are chronic and severe compared to individuals of the same age 
and developmental level causing impairment in most areas of life.  However, 
impairments of executive function are not unique to ADHD but overlap with many 
other conditions (Brown, 2006). 
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Brown uses an analogy to describe the role of executive functions in ADD. 
“Imagine a symphony orchestra in which each musician plays his or her instrument 
very well.  If there is no conductor to organise the orchestra, to signal the 
introduction of the woodwinds or the fading out of the strings, or to convey an 
overall interpretation of the music to all players, the orchestra will not produce 
good music.  Symptoms of ADD can be compared to impairments, not in the 
musicians but in the conductor” (Brown, 2005, pp. 10).  
The behavioural response inhibition theory and ADD syndrome model are 
based upon deficits in executive functions.  However, the behavioural response 
inhibition theory only examines the combined subtype of ADHD and does not 
involve the impulsive-hyperactive or inattentive subtype.  Additionally, the 
behavioural response inhibition theory states that the main executive functioning 
difficulty is behavioural inhibition, rather than multiple areas of executive 
functions, as the ADD syndrome model states (Brown, 2006).   
In addition to these theories of ADHD based upon executive functions, 
there are other theories which will now be discussed.    
1.2.3 Maturation Lag Model of ADHD 
The Maturation Lag Model is based upon the notion that symptoms of 
ADHD are the result of a delay in typical brain development (Kinsbourne, 1973).  
The theory states that the behaviours of a child with ADHD is abnormal purely for 
their age and that they were eventually catch up with their peers.  Consequently, as 
a child with ADHD matures and catches up with their peers overcoming the 
developmental delay, the symptoms may lessen.  The Maturation Lag Model was 
developed through observations of an ADHD child and a younger child who 
displayed similar levels of hyperactivity, short attention span and lacked impulse 
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control (Burke & Edge, 2013).   The theory predicts that the neurodevelopmental 
factors that inhibit the performance of a child with ADHD is similar to the typical 
limits of a younger child without the disorder.  When examining brain activity, 
children with ADHD show cortical activity similar to children of a younger age 
without difficulties, namely an increase in slow wave theta activity and decrease in 
fast beta waves, evidence that an individual with ADHD is approximately 3 years 
behind a typically developed individual.  A child with ADHD reaches maximum 
brain thickness at 10 years 6 months compared to 7 years 6 months in a healthy 
control.  However, the lag in maturation differs across the brain, with the 
prefrontal cortex lagging by approximately 5 years, but faster maturing in other 
areas, such as the primary motor cortex.  In a sample of ADHD children, 
maturation lag was present when examining brainwaves in 7% of individuals, 
mainly in the posterior regions of the brain (Burke & Edge, 2013).  
One study examining the maturation lag model in ADHD was conducted 
by Berger, Slobodin, Aboud, Melamed, and Cassuto (2013).  Five hundred and 
fifty nine children with ADHD and 365 healthy individuals underwent Continuous 
Performance Tests (CPT).  Results showed improvement with age, but children 
with ADHD demonstrated impairments at all ages compared to the control sample.  
Specifically, ADHD children performed approximately 1 to 3 years younger than 
their age when compared to peers.  This shows brain functions in individuals with 
ADHD develop slower than expected, supporting the maturation lag model. 
1.2.4 Developmental Deviation Model of ADHD 
The Developmental Deviation Model, also known as the Maturational 
Deviation Model, explains ADHD as the result of abnormal functioning in the 
Central Nervous System (CNS).  The model states that the brain of individuals 
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with ADHD are unlikely to develop or mature to the expected level during their 
lifespan.  The developmental deviation model was inspired by 
electroencephalogram (EEG) research which shows that 90% of individuals with 
ADHD have abnormal brainwave activity at all ages and do not mature with 
development, as is expected in a typical individual (Barry, Clarke, & Johnstone, 
2003).   
EEG patterns are created and regulated by our brainstem, thalamic and 
cortical processes, all of which use major neurotransmitters and in turn produce 
electrical activity at both multiple cortical and subcortical levels (Cantor & 
Chabot, 2009).   These can then be recorded on the cortex via an EEG.   
EEG abnormalities typically seem in ADHD include increased theta 
activity in the frontal regions, reduced alpha activity in parietal areas, and 
increased theta/beta and theta/alpha ratios.  One study that supports the 
developmental deviation model was conducted by Burke and Edge (2013).  An 
adult ADHD population with a mean age of 34 years old, underwent clinical 
interview, EEG and rating scales.  Compared to a typically developed control 
group, results showed that ADHD behaviours are due to a neurodevelopmental lag, 
showing cortical activity similar to a younger child, specifically elevated relative 
theta activity as well as increased theta/beta ratio and theta/alpha ratio.  However, 
the symptoms and abnormal EEG patterns were persistent in adulthood, supporting 
the developmental deviation model. 
EEG abnormalities and the role it plays in an ADHD diagnosis will be 
discussed later in this thesis, with one of the research studies focusing on EEG 
differences between ADHD and typically developed individuals. 
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1.3 Causes of ADHD 
The exact cause of ADHD is not known, but research indicates several 
contributing causes including genetic influences and environmental factors.  
Research from genetic and environmental factors suggests that 
neurodevelopmental factors are the major contributors to the cause of ADHD with 
evidence from family, twin, adoption and genetic studies (Faraone et al., 2005).  
However, there are other psychosocial factors that may contribute and will also be 
discussed (Barkley, 2003).  Initially, genetic causes of ADHD will be focused on.   
1.3.1 Genetics 
Evidence suggests that ADHD has a genetic basis, although a single gene 
has not yet been pin-pointed as to the leading cause (Williams et al., 2010; 
Martinez et al., 2016; Rivero et al., 2015).  One study published in the Lancet 
(Williams et al., 2010), examined genome analysis of copy number variants (CNV) 
in 366 children with ADHD and 1047 healthy controls, aged between 5 and 17 
years old.  CNV are associated with chromosomal deletions, with large rare CNVs 
being a risk factor for neurodevelopmental disorders.  Results showed that 57 
children across the 2 samples had large, rare CNV, with a significantly higher rate 
in the ADHD sample.  Consequently, this is evidence that rare genetic variants 
may contribute to ADHD.  
Several specific genes have been identified for their possible causation of 
ADHD, namely ADGRL3 and Cadherin-13.  ADGRL3 encodes protein which 
regulates communication between brain cells; however, if this gene has a genetic 
variation, it can disrupt the regulation of communication (Martinez et al., 2016).   
Martinez et al. (2016) conducted family genetic analysis of 372 individuals with 
ADHD and 466 healthy controls.  Individuals with ADHD showed a reduced 
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amount of ADGRL3 specifically in the thalamus, contributing to the cause of 
ADHD (Martinez et al., 2016).   
Cadherin-13, also known as CDH13, is a cell adhesion molecule which has 
the potential to cause ADHD and other neurodevelopmental conditions.  This gene 
is involved in inhibitory modulation of brain activity, a severe impairment in 
ADHD, and consequently vital for cognitive function and memory formation.  
Deficits in CDH13 can cause behavioural alterations, specifically behaviours 
associated with ADHD, with CDH13 deficits in mice shown to increase motor 
activity and memory deficits (Rivero et al., 2015). 
Dopamine is a key cause of ADHD, both at the genetic level and chemicals 
within the brain.  In regard to a dopamine gene, evidence suggests that a variation 
of the dopamine transporter gene, DAT1, which is responsible for stopping the 
dopamine signal, is involved in the cause of ADHD symptoms. The variation of 
DAT1 causes failure of dopamine cell response, specifically, individuals with 
ADHD are unable to respond to reinforcement in an appropriate way as the 
dopamine cell response does not work correctly (Tripp & Wickens, 2009).  
Another dopamine gene suspected in the cause of ADHD is the DRD4 dopamine 
receptor, although there is little evidence for this (Sharp, McQuillin, & Gurling, 
2009).  
In addition to a possible genetic predisposition to ADHD, neurotransmitters 
are a major contributor to causing impairment.  Individuals with ADHD have 
underactive dopamine levels in the brain as well as the dopamine transporters not 
working efficiently (Sagvolden, Johansen, Aase, & Russell, 2005).  Low levels of 
dopamine create difficultly sustaining attention which in turn leads to clumsiness, 
failure to inhibit responses, hyperactivity and poor executive functions.  Stimulant 
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medication, one treatment option for individuals with ADHD, directly addresses 
underactive dopamine levels (Tripp & Wickens, 2009).  The role of stimulant 
medication in the treatment of ADHD will be discussed in more detail later in this 
thesis. 
1.3.1.1 Family Studies 
ADHD is evident in families and it can be unclear if this is due to genetic 
or environmental factors.  Consequently, studies on families, twins, and adoption, 
aid in separating these issues.  Family studies demonstrate a strong genetic 
contribution to the development of ADHD (Kieling, Goncalves, Tannock, & 
Castellanos, 2008; Faraone et al., 2005).  At least 25% of adults with hyperactive 
symptoms are a biological parent of a child with similar difficulties (Biedermann, 
Newcom, & Sprich, 1991).  One family study conducted by Biedermann, 
Newcom, and Sprich (1991) found that 25% of first-degree relatives of a child 
with ADHD also had the condition compared to 5% in a control group.  
Consequently, if a child has ADHD, it is five times more likely that other members 
in the family are also at risk. 
Twin studies are used in ADHD for various reasons including defining 
phenotype, defining gender differences, and examining the gene-environment 
interaction.  Twin studies show heritability of ADHD at an approximate rate of 0.8 
(Kieling et al., 2008) and heritability estimated at 0.76 from 20 extant twin studies.  
Through numerous studies, findings are clear that ADHD is contributed to by 
genetic factors although shared environment does show to be important (Faraone 
et al., 2005).  One example is a study conducted by Levy, Hay, McStephen, Wood, 
and Walkdman (1997) where 1,938 families with twins and siblings, 4 to 12 years 
old, with one child who had ADHD, were examined.  Findings showed ADHD to 
 30 
have heritability levels of 0.75 to 0.91, a finding across twin, siblings and twin-
siblings.   
Only a few studies have examined the relationship between ADHD and 
adoption (Sprich et al., 2000).   Sprich et al. (2000) found rates of ADHD to be 
significantly higher between biological relatives compared to adoptive relatives.  
Specifically, in an adopted ADHD sample, 6% of adoptive parents and 8% of 
adoptive siblings had symptoms of ADHD compared to 18% of biological parents 
and 31% of biological siblings.  This evidence demonstrates that adoptive parents 
of children with ADHD were unlikely to have created the condition or raised the 
child in an inappropriate manner, but that the child’s genetics predisposed the 
difficulties they experience.  Interestingly, low levels of psychopathological 
difficulties have been observed among adoptive parents suggesting that they have 
the ability to implement behavioural strategies for any child placed in their care 
(Sprich et al., 2000).    
1.3.2 Brain Abnormalities  
 Imaging studies have demonstrated brain abnormalities among individuals 
with ADHD, the most consistent finding being an overall reduction in brain size 
(Castellanos et al., 2002).  A recent meta-analysis of function magnetic resonance 
imaging (fMRI) studies examining ADHD was conducted by Rubia (2018).  
Findings showed that individuals with ADHD have impairments in the right and 
left hemispheric dorsal, ventral and medial fronto-cingulo-striato-thalamic, 
creating widespread dysfunction.  Specifically, individuals with ADHD are late in 
developing specific areas of the brain, including the fronto-striato-parietal and 
fronto-cerebellar networks, areas which are involved in motor response inhibition, 
working memory and sustained attention.  Additionally, impairment has been 
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evident in orbital and ventromedial prefrontal and limbic areas, linked to emotion 
control.  However, the majority of fMRI studies have used male participants with a 
diagnosis of ADHD combined subtype.  Therefore, research needs to be conducted 
in females as well as the other subtypes of ADHD. 
Evidence shows that individuals with ADHD have significantly smaller 
brain volume, specifically in the prefrontal cortex (Mostofsky, Cooper, Kates, 
Denckla, & Kaufmann, 2002).  In individuals with ADHD, the caudate nucleus has 
a smaller volume and asymmetry differences.  The basal ganglia has also been 
shown to be smaller in ADHD subjects compared to healthy controls (Krain & 
Castellanos, 2006).  The basal ganglia is responsible for motor movements, 
procedural learning, routine behaviours, cognition and emotion.  Prior to 
information reaching the basal ganglia, information passes through the caudate 
nucleus.  One study looked specifically at the structure within the basal ganglia to 
find deficits in ADHD, namely the left globus pallidus as well as total globus 
pallidus were smaller in volume in a male ADHD population (Aylward et al., 
1996).  Abnormalities with the cerebellum have also been linked to ADHD; the 
cerebellum is important for cognitive functions such as language, attention and 
regulating a response to fear and pleasure.  In typical individuals, the cerebellum is 
used to produce motor movements but also involved in activities such as attention 
shifting.  Studies of individuals with ADHD have found that the cerebellum is up 
to 6% smaller in volume compared to healthy individuals, although it is unclear 
what effect this has on the functions of the cerebellum (Berquin et al., 1998).    
In conclusion, the evidence suggests that individuals with ADHD have a 
brain which is structurally different to a healthy brain.  Specifically, individuals 
with ADHD have decreased volume in the frontal lobe, particularly to the left side 
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of the lobe, that the basal ganglia, which is involved in the circuits, is smaller and a 
smaller cerebellum, which is involved with co-ordination and non-motor function 
(Krain & Castellanos, 2006).   
1.3.3 Environmental and Psychosocial Factors 
Although there is little evidence to suggest that social-environmental 
factors are the largest contributing factor to the cause of ADHD, they have a role 
to play in the development of the condition (Barkley, 2003).  As we have seen, 
there is a wealth of evidence suggesting that ADHD is a result of our biology, 
however, our biology is further influenced by our environment.  The severity of 
symptoms, type of comorbidities, and outcome of the disorder is related to varying 
degrees of environmental factors (Biedermann et al., 1996).  Environmental risk 
factors include exposure to lead during childhood, prenatal smoking, alcohol, child 
rearing, family conflict, and marital difficulties (Tripp & Wickens, 2009).   
1.3.3.1 Prenatal Risk Factors  
Complications during pregnancy and birth may potentially have a 
detrimental effect on early brain development; there is a higher rate of birth and 
pregnancy complications in individuals with ADHD than healthy individuals.  This 
early trauma can have long term effects, both in terms of cognition and behaviour, 
particularly if they occur during crucial times of development.  In addition to 
pregnancy and birth complications, other risk factors include, if the mother has a 
low education level, if there is a long time between onset of labour and birth, 
presence of delivery complications and young mothers age at delivery.  These 
factors combined account for 42% of the variance in ADHD.  Younger maternal 
age at time of delivery is particularly important; this population are at greater risk 
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of complications during pregnancy and consequently the child is at a higher risk of 
having ADHD symptoms (Claycomb, Ryan, Miller, & Schnakenberg-Ott, 2004).   
Another social-environmental factor that may contribute to ADHD are 
toxins.  Elevated levels of lead in the body has been shown to have a small but 
significant relationship to ADHD symptoms (Needleman, Schell, Bellinger, 
Leviton, & Alfred, 1990).  However, it has been shown that less than 38% of 
children who had high levels of lead exposure also had ADHD symptoms 
(Needleman et al., 1990).  Smoking during pregnancy is a well-studied area in the 
ADHD field (Goodwin, Keyes, & Simuro, 2007).  Approximately 10-20% of 
women smoke during pregnancy due to a variety of reasons (Goodwin et al., 
2007).  A review of previous research on smoking during pregnancy showed an 
association to develop disorders such as depression, addiction and ADHD.  
Maternal smoking shows the strongest association with ADHD whereas maternal 
alcohol consumption is less of a risk factor, but nonetheless a risk (O'Malley & 
Nansom, 2002).   
1.3.3.1 Parenting Style  
It has been previously suggested that a weak parenting style contributes 
towards the development of ADHD.  Specifically, weak parenting can aggravate 
possible symptoms as well as contribute to developing other difficulties.  As 
reported by parents of children with ADHD, there is often more family conflicts in 
the home, disorganisation, and less adherence to rules compared to typical home 
environments (Teixeira, de Freitas Marino, & Carreiro, 2015).  These difficulties 
manifest itself in children showing more impulsivity, inattention and agitation.  
For example, Carlson, Jacobvitz, and Sroufe (1995) suggested that a large 
contributing factor of ADHD is parenting approach.  Observations of mother and 
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son interactions were completed in a sample of 20 typically developed and 20 
hyperactive boys aged 6 to 12 years old.  Mothers of the hyperactive boys had 
more structure and control of the child’s play, and the children were more active 
and less compliant.  It has been noted that parents of hyperactive children tend to 
have overcritical and commanding parenting style, a result of psychological and 
physical overload (Barkley & Cunningham, 1979) which can exacerbate 
hyperactive and oppositional behaviour (Barkley, Fischer, Edelbrock, & Smallish, 
1991).  Keown and Woodward (2002) demonstrated the importance of family 
relations and functioning in the role of ADHD.  Specifically, 33 children with 
pervasive hyperactivity and 33 typical boys were assessed at home with their 
mothers through interview, parental questionnaire and observations.  Results 
showed higher rates of lax discipline, less efficient parental coping and lower rates 
of father-child communication among the ADHD population.  This study 
demonstrated the importance of a father figure in behavioural development as well 
as parental coping.  On the other hand, the challenging behaviour and temperament 
of a child with potential or diagnosed ADHD can affect the type of parenting as 
well as the stress placed on the parents (Cunningham, 2007).  The parents have to 
attempt to manage impulsivity, poor choices, lack of friendships, low self-esteem, 
disruptive behaviour as well as their own social distress and negotiating with the 
health and education systems.  As previously discussed, ADHD has a large genetic 
component (Faraone et al., 2005) and therefore parents may have ADHD 
symptoms, effecting their parenting skills. 
1.4 Management of Concentration and Impulsivity Difficulties 
A comprehensive treatment plan is required to manage individuals with a 
diagnosis of ADHD including psychological, behavioural and educational 
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strategies.  The NICE guidelines recommend methods such as parent-
training/education programmes, behavioural interventions from trained teachers, 
cognitive behavioural therapy, social skills classes, and possible medication 
(NICE, 2018).   Some of these strategies, their strengths, weaknesses and guidance 
on implementing such strategies, will now be discussed.    
1.4.1 NICE Guidelines on Treatment of ADHD 
Recommended treatment by the NICE guidelines for an individual with 
ADHD depends upon the individual’s age and severity of symptoms.  For a pre-
school child, parent training is recommended as the first line of treatment.  For a 
school aged child or young person with moderate ADHD, parent training as well 
as group therapy, such as cognitive behavioural therapy or social skills training, 
are suggested.  For a school aged child or young person with severe ADHD, drug 
treatment is the first line of treatment in conjunction with offering group-based 
parent training.  For adolescents, individual psychological interventions are 
recommended; however, if an adolescent finds psychological treatments to be 
ineffective or the individual refuses to take part, drug treatment can be commenced 
(NICE, 2018).  
1.4.2 Cognitive Training Programmes 
Cognitive training programmes target deficits in cognitive domains that are 
causally linked to ADHD symptoms, such as executive function deficits (Halperin 
& Healey, 2011).  Studies examining cognitive training programmes found 
improvements on working memory, inhibition, inattention, and non-verbal 
reasoning skills, in individuals with ADHD (Klingberg et al., 2005).  One study 
that focused on working memory and attention shifting found little improvement 
on teacher rating scales.  However, on parent rating scales, there was significant 
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improvement on inattentive symptoms and a small improvement on hyperactive 
and impulsive symptoms (Epstein & Tsal, 2010).   
A specific cognitive training programme available for ADHD treatment is 
“Pay Attention!”.  This programme uses visual and auditory tasks to train different 
types of attention including sustained, selective, and divided attention.  Research 
shows that through completing a course of Pay Attention! improvements in 
neurocognitive and academic behaviours are achieved.  However, improvement 
was not noted in behavioural symptoms (Kerns & Thomson, 1999).   
Another form of cognitive training specific for individuals with ADHD is 
the Cogmed Working Memory Training Program, also known as Cogmed.  This 
training program is computer based, with beneficial outcomes after 25 sessions, 
specifically 5 sessions a week for 5 weeks.  Through completing a course of 
Cogmed training, children with ADHD showed improvements in visual and verbal 
working memory in addition to nonverbal complex reasoning and response 
inhibition.  The significant improvements were still evident at a three-month 
review (Klingberg et al., 2005).  This intervention is also effective in adults with 
ADHD (Olesen, Westerberg, & Klingberg, 2004).     
Sonuga-Barke et al. (2013) conducted a meta-analysis examining 
nonpharmacological interventions on ADHD.  Six cognitive training trials were 
included, three focusing on attention and three focusing on working memory.  In 
trials where observers were aware of the research and intervention, significant 
treatment effects were found.  However, the significant treatment effects were lost 
when raters (e.g. teachers) were blinded to the intervention group. 
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1.4.3 Parent-Training Programmes 
As noted in the NICE guidelines (NICE, 2018) parent training is an 
important part of a comprehensive treatment plan for children with ADHD.  Parent 
training programmes teach effective communication with children in a stress-free 
way.  When medical management is in place, parent training should still be 
completed due to medication effects wearing off and behavioural intervention 
consequently being implemented (Willis, 2003).  Danforth, Harvey, Ulaszek, and 
McKee (2006) conducted parent training to parents of 45 children with ADHD.  
The training included an explanation of the features of ADHD and specific 
strategies to implement at home.  Nine or ten families attended per group for 
approximately 90 minutes for 8 weeks.  Upon completing the course, results 
showed reduced hyperactivity, aggression, and oppositional behaviour, and in 
addition it improved parenting behaviour and reduced parental stress.  These 
benefits led to improved social skill abilities in children with ADHD (Hinshaw et 
al., 2002).  In another study by Anastopoulos, Shelton, and DuPaul (1993) 34 
children with ADHD along with their mothers took part in parent training.  Nine 
sessions were completed including an overview of ADHD, general behaviour 
management principles, positive reinforcement, and punishment strategies.  
Results showed that parent training not only improved the child’s behaviour but 
also enhanced family functioning, decreased parent stress and increased parent’s 
self-esteem.  Consequently, this led to an improved overall emotional climate in a 
family and strengthened relationships between parents (Barkley, 2003).  Thus, if 
parent-training is completed and implemented effectively, there are benefits to the 
child and parent.   
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More recently Lange et al. (2018) examined parent training in improving 
core ADHD symptoms, specifically the New Forest Parenting Programme, in 
preschool children aged 3 to 7, with ADHD in a randomised control trial.  Results 
showed positive improvement in ADHD symptoms as rated by parents.  However, 
no effects were evident in direct observations or teacher rating, questioning the 
overall effectiveness of parent training.   
A further type of parent-training programme is based on psychoeducation.  
This intervention has been developed by mental health care professionals and 
focus’ on consumer outcomes as well as family outcomes through teaching on 
symptomology, its treatment, skills development and patient empowerment (Dixon 
et al., 2001).   The intervention is informative using both psychotherapeutic and 
educational components and encourages families to recognise systems as well as 
the patient actively participating in treatment to increase compliance (Bauml, 
Frobose, Kraemer, Rentop, & Pitschel-Walz, 2006).  However, the type of 
information provided can vary between providers (Dixon et al., 2001).  Evidence 
suggests that psychoeducation and other educational programmes play a positive 
role in the intervention of ADHD in children and adolescents with studies showing 
reduced levels of relapse (Dixon et al., 2001).  However, despite a systematic 
review of the evidence there is little research into the use of psychoeducation in the 
treatment of ADHD, an area that requires research (Dixon et al., 2001).       
1.4.4 Teacher Training/Educational Strategies 
Educational strategies also need to form part of a comprehensive treatment 
plan for children with ADHD (NICE, 2018).  Interventions that take place in the 
home rarely translate to classroom situations and therefore, interventions within 
the school setting will be most effective for improving school performance 
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(Abramowitz & O’Leary, 1991).  The most important aspect of educational 
strategies is for teachers to understand and have knowledge about the condition, 
how it affects the child in the classroom and basic strategies that can be put in 
place.  Classroom strategies should be both proactive and reactive to create the 
most improvement.  Specific strategies include seating the student at the front of 
the class next to a buddy and away from distractions, presenting instructions 
visually, chunking tasks into small manageable sections, and allowing the child 
movement breaks (DuPaul & Stoner, 2003).   
Arcia, Frank, Sanchez-LaCay, and Fernand (2000) conducted semi 
structured interviews with 21 primary school teachers.  Strategies implemented 
included: behavioural, use of rewards, positive praise; instructional, one to one 
instruction, peer tutoring; environmental, seating the child close to the teacher at 
the front of the class, with a buddy; and interpersonal strategies, the teacher talking 
with the child discussing appropriate behaviour.  Results from the study showed 
that teachers lack understanding of ADHD and of classroom management and 
tended to employ reactive rather than proactive strategies.  If a teacher lacks basic 
knowledge about ADHD, then classroom strategies generally have little impact on 
a child with ADHD (Arcia et al., 2000).   
1.4.5 Medication 
Drug treatment is the first line of recommended treatment for school aged 
children or young person with severe ADHD (NICE, 2018).   
Stimulant medications are widely used to treat individuals diagnosed with 
ADHD to combat their symptoms.  There are several types of stimulant 
medications including methylphenidate, dexamfetamine, amphetamine, and 
lisdexfetamine.  Other non-stimulant medications used to treat ADHD include 
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atomoxetine, clonidine, and guanfacine, but are less effective and less tolerated 
than stimulant medication (NICE, 2008).         
1.4.5.1 Neurochemistry of Stimulant Medications 
Methylphenidate prevents the re-uptake of dopamine and norepinephrine in 
the brain (Shiels, Hawk, & Reynolds, 2009).  The stimulant medication binds to 
the presynaptic neuron which increases the concentration of catecholamines in the 
extraneuronal space, and consequently improves postsynaptic catecholaminergic 
neurotransmission (Volkow et al., 2012).  This explanation is coherent with the 
causes of ADHD as it is suggested that symptoms occur due to dysfunction in the 
neurotransmitters, specifically with low levels of dopamine (Sagvolden et al., 
2005), which is involved in sending signals to the brain for reward processes as 
well as regulating behavioural processes (Shiels et al., 2009).   
1.4.5.2 History of Stimulant Medication 
The first evidence of the use of stimulant medication was conducted by 
Bradley (1937).  It demonstrated that benzedrine, when administered to children 
aged 5 to 14 who had behavioural difficulties, created academic improvement.  
The most widely used stimulant medication for the treatment of ADHD is 
methylphenidate which is recommended to be the first line of pharmacological 
treatment due to the large response rate and significant improvement in symptoms 
(NICE, 2018).  In the United States, immediate release methylphenidate became 
commonly available in 1995.  Immediate release preparations of methylphenidate 
have a rapid onset and an effect within 20 to 60 minutes.  There is a peak plasma 
of concentration within approximately 1 to 2 hours after taking the tablet with the 
whole duration lasting approximately 4 hours (Hoffman & Lefkowitz, 1996).  
However, multiple doses may be needed which can be inconvenient and can lead 
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to missing of doses.  Additionally, the overlap in doses can cause a fluctuation in 
symptoms.  It was not until the mid 1990s that prescribing methylphenidate 
increased in the UK, along with a better understanding of ADHD and changes in 
regulatory frameworks.  At the same time, once daily methylphenidate 
preparations became available, namely Concerta XL, Equasym XL and Medikinet 
XL.  Once-daily preparations are effective for roughly 8 to 14 hours, depending on 
the preparation, 22-50% of the medication is released immediately and the 
remaining proportion released later, therefore continuing to be effective over a 
longer duration (Joint Formulary Committee, 2018; Loureiro-Vieira, Costa, de 
Lourdes Bastos, Carvalho, & Capela, 2017).   
1.4.5.3 Benefits of Stimulant Medication in ADHD 
It has been found that stimulant medication has a positive effect on ADHD 
symptoms in 65% to 77% of children with ADHD (Barkley, 1997; Johnston et al., 
2015) while approximately 25% to 30% of ADHD children do not respond or 
tolerate stimulant medication (Elia, Borcherding, Rapport, & Keysor, 1991).  
Evidence shows that stimulant medication has positive effects on children of 
various ages including improvement in impulsiveness, disruptiveness, 
noncompliance, talking out of turn, restlessness, and aggression (Whalen, Henker, 
& Granger, 1990).  
One study examined the effect of taking methylphenidate for 4 months in a 
child ADHD population.  Ninety-one children participated, either in a 
methylphenidate or placebo condition.  The methylphenidate condition showed 
improvement in symptoms and behaviour at school but not at home.  Side effects 
of physiological symptoms and lack of weight gain were seen in the 
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methylphenidate condition, which were reported by parents but not teachers 
(Schachar, Tannock, Cunningham, & Corkham, 1997). 
A meta-analysis was conducted reviewing 13 randomised control trials 
examining methylphenidate.  It total, 882 participants with a diagnosis of ADHD, 
up to the age of 18 years old, participated.  On parent ratings, there was a 
preference for long acting methylphenidate, due to improvements on 
hyperactive/impulsive behaviours.  However, teacher ratings favoured short acting 
methylphenidate, specifically for hyperactivity (Punja et al., 2013).   
A further study conducted a meta-analysis of all randomised controlled 
trials comparing methylphenidate to control conditions.  In total, 5,111 child 
participants with a diagnosis of ADHD participated, with an average age of 9.7 
years.  Results showed 29% of participants experienced non-serious adverse 
effects, such as sleep problems and decreased appetite.  When rated by teachers, an 
improvement in general behaviour was seen, although exact details were not 
discussed and parents reported an improvement in quality of life (Storebo et al., 
2015). 
Methylphenidate has been shown to improve performance on Continuous 
Performance Tests.  Specifically, findings showed that the higher dose of 
methylphenidate taken, the fewer errors occurred, showing successful 
concentration.  Additionally, the higher the cognitive ability of an individual, the 
higher the response rate to methylphenidate (Pearson et al., 2004).  Continuous 
Performance Tests will be discussed in more detail later in this thesis, with one of 
the research studies using this as a measure of concentration.     
In a questionnaire of 50 students aged 11 to 18 years old taking 
methylphenidate, they reported improvements in behaviour, social ability with 
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friends, parents and teachers and attention.  However, they felt that 
methylphenidate did not show improvement in academic achievement.  
Additionally, the majority of students experienced some form of side effects, detail 
of which are discussed shortly (Moline & Frankenberger, 2001). 
Cortese et al. (2018) conducted a systematic review on examining 
medication as an intervention for ADHD.  One hundred and thirty-three double-
blind randomised control trials were included.  All medications consumed by 
children were more efficacious than placebo.  It concluded, supporting NICE 
guidelines, that methylphenidate is the first choice of recommended short-term 
treatment for children and adolescents with ADHD.   
1.4.5.4 Short Term Side Effects of Stimulant Medication 
An unknown percentage of families do not wish to trial medication, despite 
the possible benefits, because of potential side effects (Arnold et al., 2013).  
Although stimulant medications are usually well tolerated, there is evidence of side 
effects.  Short term side effects of methylphenidate include appetite suppression, 
sleep difficulties, headaches, stomach aches, blunting of personality, and 
irritability with frequency rates ranging between 5% to 15% (Monastra, 2008).  In 
a study by Moline and Frankenberger (2001) 50 students aged 11 to 18 years old 
completed a questionnaire regarding their experiences of taking methylphenidate.  
Of the 50, 64% of participants reported some form of short-term side effect, 
specifically 48% experienced headaches, 54% experienced sleep difficulties, 57% 
experienced appetite suppression (particularly at lunchtime), and 40% experienced 
tics.  It is very important that tics are closely monitored as it is known that 
methylphenidate can exacerbate these.  Additionally, appetite suppression needs to 
be monitored as can lead to decrease in growth.  However, in many cases the 
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positive effect of stimulant medication outweighs the negative side effects as these 
tend to wear off when the medication is not active within the body (NICE, 2018).   
1.4.5.5 Long Term Side Effects of Stimulant Medication 
Despite an increase in the understanding of mental health conditions and 
improvement in diagnostic criteria (APA, 2013), there are very few studies that 
have examined the long-term effect of stimulant medication, particularly on the 
long term effect of use during childhood and consequently the effect in adulthood 
(Loureiro-Vieira et al., 2017).  Previous research suggests that methylphenidate 
can lead to heart rate difficulties and systolic blood pressure.  One study 
investigated the effect of methylphenidate on blood pressure.  In a sample of 125 
adults with ADHD where methylphenidate was being taken, minor but statistically 
significant changes in heart rate and blood pressure were seen. In 10% of subjects, 
systolic or diastolic hypertension was caused as a result of taking methylphenidate 
(Wilens et al., 2005).  Consequently, NICE supports monitoring on a 6-monthly 
basis (NICE, 2018).   
Various interventions for ADHD have been discussed here including 
cognitive training, parent-training programmes, school strategies, and medication.  
All of these strategies have some benefit in the treatment of children with ADHD 
with stimulant medication having the highest effect rate at 73% to 77% (Barkley & 
Cunningham, 1979).  However, stimulant medication only has an effect while in 
the individual’s system.  Consequently, with the development of new technologies, 
other interventions are becoming available with possible improved long-term 
effects. 
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1.4.6 Neurofeedback 
In regard to ADHD, stimulant medication and behaviour interventions are 
the most widely used and accepted forms of treatment.  However, a need has been 
identified for a new treatment with improved long-term effects (Arns, Heinrich, & 
Strehl, 2014). 
Neurofeedback is a form of biofeedback whereby the person is being 
consciously made aware of their brain wave activity.  “Neurofeedback is a very 
special discipline because it stands right at the landmark of brain and behaviour as 
it deals with all the complexities of brain function”, (Romano-Micha, 2010, pp.80).  
Neurofeedback improves attention and behavioural control by an individual 
learning to regulate levels of cortical arousal in the brain via visual and/or auditory 
reinforcement (Monastra, 2005).  Based upon the operant conditioning paradigm, 
developed by B. F. Skinner (1938) neurofeedback teaches modified behaviour 
through positive reinforcement, rewarding when desired behaviour is produced.  In 
relation to neurofeedback, operant conditioning encourages specific amplitude and 
frequency of particular brain wave activity (Monastra, 2008).  
A typical neurofeedback training session is approximately 45 to 60 minutes 
in duration where several short training periods take place. The average amount of 
sessions required to gain normalization of EEG patterns is 43 sessions, with total 
amount of sessions ranging from 34 to 50.  A neurofeedback session is designed so 
that the patient demonstrates the undesired brainwave for 40% of the time and 
desired brainwave for 60% of the time, enabling the patient to learn what the 
desired brainwave feels like and how to maintain it through positive reinforcement 
(Monastra, Monastra, & George, 2002).  
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There are six different types of brain wave frequencies that form human’s 
overall brain wave activity and therefore can be manipulated via neurofeedback.  
Brainwaves progress from the slow wave of delta, theta, alpha and SMR, to the fast 
wave of beta and gamma, each associated with varying behaviours (Demos, 2004).  
Further detail regarding EEG and specific roles of various brainwaves are discussed 
in a later chapter, where research focuses on the differences between typical and 
ADHD brainwave activity. 
1.4.6.1 Neurofeedback and The Brain 
Neurofeedback manipulates brainwave activity via neuronal plasticity.  
Neuronal plasticity, the ability for the human brain to continuously change 
structure and function, is evident during our childhood development but the brain 
remains malleable throughout a lifetime (Kolb, 1995; Raymont & Grafman, 2006).  
Neuromodulation and long-term potentiation (LTP) are two processes enabling 
brain plasticity to occur (Abarbanel, 1999).  Neuromodulation is a 
neurotransmission whereby metabotropic receptors exert a great influence in 
electrophysiological properties of a cell.  LTP is the increased synaptic 
transmission efficiency as the result of high-frequency synaptic activation 
(Andersen, 2004).  LTP is the process enabling structural and biochemical changes 
to become long term changes (Bliss, Collingridge, & Morris, 2004). During 
neurofeedback, the relevant neural networks are modified through 
neuromodulation (Abarbanel, 1999) and these changes are long lasting through 
LTP (Abarbanel & Evans, 1999; Sterman & Egner, 2006).  
Neurofeedback training exerts control over specific EEG parameters and 
consequently, associated functions.  In the case of clinical applications, 
neurofeedback training aims to normalize electrophysiological imbalances 
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(Monastra et al., 2005).  In healthy individuals, neurofeedback can improve 
performance in specific areas including sport, cognitive and artistic performance 
(Vernon, 2005).  Neurofeedback can be used to treat a variety of disorders such as 
alcoholism and substance abuse, anxiety, ADHD, autism, depressive disorders, 
epilepsy, insomnia, post-traumatic stress disorder, and traumatic brain injury 
(Yucha & Montgomery, 2008).   
1.4.6.2 Approaches to Neurofeedback 
One group of neurofeedback practitioners use standard protocols to treat 
symptoms.  Practitioners obtain a description of symptoms from the patient and 
interpret the symptoms and possible dysregulated brain wave patterns, a subjective 
approach which can lead to incorrect conclusions.  Practitioners develop a 
neurofeedback protocol based upon the individual’s symptoms rather than the 
underlying brain wave abnormalities (Romano-Micha, 2010).   
An alternative approach to neurofeedback involves collecting and 
analysing EEG patterns in conjunction with the patient’s symptoms to develop a 
personalised neurofeedback protocol.  Arns, Drinkebury, and Kenemans (2012) 
investigated the effect of EEG-informed neurofeedback in a pilot study.  Adults 
with ADHD underwent a 26 channel EEG recording, where the participant was 
exposed to a series of high and low-pitched tones. Participants were asked to press 
a button with their left and right index finger in response to the high-pitched tone, 
while keeping their eyes fixed on a red dot presented on a computer screen in front 
of them.  The raw EEG data were then visually inspected to establish a 
neurofeedback protocol.  Participants received at least one established protocol, 
Sensori-Motor Strip (SMR)/theta or theta/beta, and one protocol based on EEG 
findings.  Personalised neurofeedback protocols based upon EEG findings 
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improved clinical outcomes, specifically on attention scales.  Seventy-six percent 
of participants responded to personalised neurofeedback, 14% were non-
responders, and a 10% drop out.   
1.4.6.3 Neurofeedback Protocols in Healthy Participants  
 Evidence has shown that neurofeedback can be successfully applied in a 
healthy population (Egner & Gruzelier, 2001; Vernon et al., 2003; Vernon, 2005; 
Fritson, Wadkins, Gerdes, & Hof, 2007). For example, Egner and Gruzelier (2001) 
employed SMR training (increase of 12-15 Hz) at C4 and beta training (increase of 
15-18 Hz) at C3 in a group of 22 healthy adults while simultaneously inhibiting 
theta (4-7 Hz) and high beta (22-30 Hz).  After ten neurofeedback sessions, a 
significant reduction was seen on Continuous Performance Test commission errors 
but no change on omission errors.  Also, SMR neurofeedback was highly 
positively correlated to commission error reduction.  However, Vernon (2005) 
noted a lack of control group and absence of EEG changes. 
In another healthy population study by Vernon et al. (2003) neurofeedback 
training was employed with two groups, a theta-group, up training theta (4-8 Hz), 
while inhibiting delta (0-4 Hz) and alpha activity (8-12 Hz); and an SMR-group, 
trained to enhance SMR (12-15 Hz) and simultaneously inhibiting theta and beta 
(18-22 Hz).  Eight sessions were completed at the Cz location. Participants in the 
SMR-group showed improvements in the accuracy of attentional processing and 
semantic working memory tasks. It was hypothesized that the improvement 
produced by SMR training on working memory performance could be related to 
the fact that training in this frequency band may help to maintain the memory 
representation used in semantic working memory (Vernon et al., 2003). 
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Fritson, Wadkins, Gerdes, and Hof (2007), explored the effects of 
neurofeedback training on measures of response control and attention. Two groups 
of healthy participants, totalling 32 participants, were randomly assigned to a 
neurofeedback or control condition.  In the neurofeedback condition, participants 
received SMR training (12-15 Hz), while inhibiting theta (4-7 Hz) and high beta 
(22-36 Hz), whereas the control condition received sham neurofeedback training 
(feedback based on a previously recorded EEG from another person). Participants 
attended a total of 20 twice-weekly sessions. No significant changes were found 
for measures of attention in either the control or treatment group.  Although a 
control group was used, EEG measures were not reported. 
1.4.6.4 Neurofeedback and ADHD 
Neurofeedback was first used with individuals diagnosed with ADHD in 
1976 whereby improvements were shown in distractibility and hyperactivity 
(Lubar & Shouse, 1976).  These findings are considered to be the earliest clinical 
effects of neurofeedback on ADHD (Arns et al., 2014).  A meta-analysis was 
conducted examining ADHD and neurofeedback studies with the main conclusions 
showing neurofeedback had a large effect size on improving impulsivity and 
inattention, and a medium effect size on improving hyperactivity (Arns, Ridder, 
Strehl, Breteler, & Ccoenen, 2009).     
One standardised protocol for the treatment of ADHD is uptraining SMR, 
which has been shown to improve impulsivity and attention (Carmody, Radvanski, 
Wadhwani, Sabo, & Vergara, 2001; Fuchs, Birbaumer, Lutzenberger, Gruzelier, & 
Kaiser, 2003; Kaiser & Othmer, 2000; Rossiter, 2004; Rossiter & La Vaque, 
1995), behavioural indices (Shouse & Lubar, 1979), changes in subcortical areas 
associated with response inhibition and selective attention (Beauregard & 
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Lévesque, 2006).  Fuchs, Birbaumer, Lutzenberger, Gruzelier, and Kaiser (2003) 
conducted a study on 34 children with a diagnosis of ADHD, aged 8 to 12 years 
old, of which 22 children completed 3 months of neurofeedback sessions, 3 
sessions a week with the same therapist at the same time of day.  Children 
diagnosed with ADHD hyperactive-impulsive subtype received SMR uptraining at 
C4, whereas children diagnosed with ADHD inattentive subtype received beta 
uptraining at C3.  Children diagnosed with ADHD combined subtype received a 
combination of these protocols.  A further 12 children received stimulant 
medication.  All conditions saw a reduction on ADHD symptoms.  Specifically, all 
conditions had a reduction on Conners' Behaviour Rating Scale, as completed by 
parents and teacher, and on d2 Attention Endurance Test.  Little change was seen 
on intelligence scales.  This demonstrates the efficiency of neurofeedback in 
reducing ADHD symptoms using standard protocols, however, there was a small 
sample size. 
Within the 2009 meta-analysis, several neurofeedback protocols were 
examined in the treatment of ADHD including: SMR increase with theta decrease 
and beta increase with theta decrease.  The core locations that were targeted in 
training were Cz, C3 and C4, across the sensorimotor strip, with a small group of 
research targeting frontal regions.  Analysis showed no difference on outcome 
measures such as parent and teacher ratings regardless of the type of protocol or 
location used (Arns et al., 2009).   
One case study examined the effect of neurofeedback on an 11-year-old 
girl who met the criteria for ADHD combined subtype and ODD.  She completed 
31 neurofeedback sessions whereby theta was downtrained and beta was 
uptrainined at Fz, and coaching was also performed during the sessions.  Upon 
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completing neurofeedback, the participant no longer met the criteria for ADHD, 
her concentration was improved on ADHD questionnaires, she was much calmer 
in her behaviour and was no longer hyperactive when described by her parents and 
teachers; she also no longer met the ODD criteria.  However, it was unclear if the 
improvements were due to neurofeedback or coaching.  The author felt that 
coaching did not take place at every session and it was not used as an intense 
therapy, inferring that neurofeedback created improvement (Winklemolen, 2011). 
1.4.6.5 Control Group Studies 
In neurofeedback studies, a variety of control groups can be used to prevent 
confounding variables from occurring.  Possible confounding variables, if not 
controlled for, include failure to control treatment bias, combining neurofeedback 
with different strategies and accounting for therapist-patient interaction.  
Therefore, the benefit of a control group can ensure that these variables do not 
occur and that the outcomes are valid (Vernon et al., 2004).   
The difficulty with “placebo or sham controlled double blind studies is that 
they violate fundamental ethical principles guiding human research in 
circumstances in which known standard treatments are available” (La Vaque & 
Rossiter, 2001, pp. 24).  It was suggested that instead of comparing a relatively 
new treatment such as neurofeedback to a placebo or sham group, it should be 
compared to an already established treatment strategy, such as stimulant 
medication in the treatment of ADHD.  Demonstrating that neurofeedback is 
statistically superior to a placebo condition is one of the conditions required for 
treatment to be considered “Efficacious and Specific”, according to the guidelines 
for the evaluation of clinical efficacy of psychophysiological interventions (La 
 52 
Vaque et al., 2002).  This is difficult to achieve if research involving placebo 
conditions cannot take place.   
Sham neurofeedback refers to conditions whereby an individual feels they 
are completing neurofeedback but are actually watching someone else’s brain 
wave activity.  A pilot double-blind sham-controlled randomised neurofeedback 
study was conducted by Arnold et al. (2013).  Participants with a diagnosis of 
ADHD aged 6 to 12 years old, were randomly allocated to active neurofeedback 
twice a week, active neurofeedback 3 times a week or sham neurofeedback.  
Active neurofeedback consisted of rewarding a decrease in theta and alpha and an 
increase in beta.  Sham neurofeedback appeared the same as the active group, but 
the feedback provided was random.  Forty, 45-minute sessions were completed.  
Findings showed a large pre-post improvement on parent ratings but no difference 
between active and sham neurofeedback.  Improvement on parent training 
plateaued at session 24.  It was therefore recommended that neurofeedback is 
completed 3 times a week, which parents stated they preferred, for 30 sessions.  
Blinding to conditions did work and sham neurofeedback did not prevent 
recruitment for the study.  
A further sham study was completed by Vollebregt et al. (2014) where 40 
ADHD children completed EEG informed neurofeedback or sham neurofeedback 
for 30 sessions.  Results showed no significant treatment effect on neurocognitive 
variables.  The authors explained that existing literature fails to support any benefit 
of neurofeedback on neurocognitive functions which may be due to small sample 
sizes in this research field.   
As shown here, there are only a few studies using sham neurofeedback in 
an ADHD population.  This may be due to the ethical concerns and therefore other 
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strategies have been used such as comparing to an established treatment (La Vaque 
& Rossiter, 2001).   
1.4.6.6 Randomised Control Trial (RCT) Studies 
The first randomised controlled trial for individuals with ADHD using 
neurofeedback was conducted in 1996 (Linden, Habib, & Radojevic, 1996).  
Eighteen children with ADHD aged 5 to 15 years old were randomly allocated to 
40, 45-minute beta increase neurofeedback while suppressing theta, or control 
condition.  Findings showed improvements in cognitive measures, specifically on 
attention and IQ.  Since then, more randomised control studies have been 
conducted, including a meta-analysis. 
A large-scale study was conducted by Gevensleben et al. (2009) 
investigating the efficacy of neurofeedback as a treatment for ADHD.  One 
hundred and two children diagnosed with ADHD, ranging in age from 8 to 12, 
were randomly assigned to 36 sessions of neurofeedback or computerised attention 
skills training.  Neurofeedback consisted of theta/beta training and slow cortical 
potential training.  Results showed parent and teacher ratings were superior for 
neurofeedback, demonstrating clinical efficacy for children who have a diagnosis 
of ADHD.   
In a meta-analysis by Arns et al. (2009) several randomised control trials 
had been completed by this stage (Gevensleben et al., 2009; Holtmann et al., 2009; 
Leins et al., 2007; Levesque, Beauregard, & Mensour, 2006; Strehl et al., 2006).  
The meta-analysis of 15 studies showed neurofeedback had a large effect size on 
inattention and impulsivity and a medium effect size on hyperactivity in both 
parent and teacher ratings.  Two of these studies (Gevensleben et al., 2009; 
Holtmann et al., 2009) were randomised control trials using computerised attention 
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skills training as a control condition, and improvement was greater in the 
neurofeedback conditions. 
The most recent meta-analysis examining neurofeedback in the use of 
ADHD was conducted in 2016 (Cortese et al., 2016).  Thirteen trials were 
included, with a total of 520 participants.  Significant effects were found when 
rated by individuals who were least blinded to the interventions, compared to 
blinded raters who showed no significant effects.  Consequently, this fails to 
support the use of neurofeedback as a treatment for ADHD.   
1.4.6.7 Neurofeedback Compared to Stimulant Medication 
An alternative way to examine the effectiveness of a new intervention is to 
compare to an already established treatment, such as stimulant medication (Arns et 
al. 2014).  There are several studies which have examined neurofeedback 
compared to stimulant medication (Arns et al., 2009; Fuchs et al., 2003; Monastra 
et al., 2002; Rossiter, 2004; Rossiter & La Vaque, 1995; Duric, Assmus, & Elgen, 
2012; Meisel, Servera, Garcia-Banda, Cardo, & Moreno, 2013).  Here it was 
demonstrated that stimulant medication, namely methylphenidate, was not superior 
to neurofeedback.  These studies will be discussed in more detail.   
A neurofeedback RCT study has been conducted examining the effects of 
neurofeedback and methylphenidate.  One hundred and twelve children with a 
diagnosis of ADHD ranging in age from 7 to 13 were involved.  The three 
conditions consisted of neurofeedback, 30 sessions of theta/beta training at Cz for 
10 weeks, physical activity semi-active control group, and methylphenidate.  Pre to 
post EEG findings showed similar reduction in theta activity for individuals who 
received neurofeedback and methylphenidate.  However, individuals who received 
neurofeedback showed greater overall reductions in ADHD symptoms as 
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measured by rating scales.  Despite this success, improvement was not generalised 
to classroom behaviours (Janssen et al., 2016). 
Meisel et al. (2013) also conducted a randomised control trial to evaluate 
the efficacy of neurofeedback compared to pharmacological intervention for the 
treatment of ADHD.  Twenty three children diagnosed with ADHD aged between 
7 and 14 years old were randomly allocated to 40 theta/beta neurofeedback 
training sessions or methylphenidate.  At a 6 month follow up, similar 
improvements were reported by parents and teachers, but significant academic 
improvements were only shown in the neurofeedback condition.  This is a 
significant finding for the first randomised control trial with a six month follow up 
comparing neurofeedback and methylphenidate in the treatment of ADHD. 
Sonuga-Barke et al. (2013) conducted a meta-analysis examining 
nonpharmacological interventions on ADHD.  Eight neurofeedback trials were 
included.  Three trials implemented theta-beta training, one used slow cortical 
potential training, one used a combination of both of these, and one used 
personalised training.  In trials where observers were aware of the research and 
intervention, significant treatment effects were found.  However, the significant 
treatment effects were lost when raters (e.g. teachers) were blinded to the 
intervention group. 
1.4.6.8 Neurofeedback in combination with medication 
The studies mentioned above did not examine the effect of neurofeedback 
in combination with stimulant medication on EEG.  Information regarding this 
interaction on the brain may aid in understanding the root cause of ADHD, as well 
as the best combination of treatments to normalise abnormal brainwaves seen in 
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ADHD.  This is an area that the research presented in this thesis aims to examine.  
The evidence that is available will now be discussed.  
Arns et al. (2009) conducted a meta-analysis examining neurofeedback in 
ADHD.  Three studies compared neurofeedback to stimulant medication, totalling 
12% of participants on medication.  Findings suggest that the effects of 
neurofeedback are similar for medicated and unmedicated participants, but further 
research is required on the impact of stimulant medication on neurofeedback.  
Furthermore, the studies failed to report or examine any pre to post EEG 
difference, an area that requires further investigation.   
Monastra et al. (2002) conducted neurofeedback on 100 children diagnosed 
with ADHD, with three conditions: neurofeedback only, neurofeedback with 
stimulant medication, and stimulant medication only.  Following a series of 
neurofeedback sessions, all children had EEG patterns within one standard 
deviation of the mean.  Measures were repeated 6, 12 and 24 months after the first 
treatment.  At a one year follow up, when medication was present in the patient’s 
system, there were no differences in EEG or behavioural measures between 
conditions.  However, after a one-week washout of stimulant medication, all 
individuals who did not receive neurofeedback regressed on all measures whereas 
the neurofeedback group showed significant improvement on ADHD symptoms.  
Consequently, stimulant medication caused no enduring change as a standalone 
treatment whereas neurofeedback patients demonstrated long term improvements.  
Specifically, 80% of individuals who received neurofeedback and stimulant 
medication were able to reduce their medication dose by at least 50% (Monastra et 
al., 2002).   
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Looking specifically at randomised control trials, Duric et al. (2012) 
investigated 91 children diagnosed with ADHD ranging in age from 6 to 18.  
Participants were randomly allocated to one of three conditions; 30 participants 
completed neurofeedback focusing on enhancing cortical beta1activity and 
suppressing theta, 31 participants were in a methylphenidate control condition, and 
30 participants received both neurofeedback and methylphenidate.  Parents report 
on the Clinician’s Manual for the Assessment of Disruptive Behaviour Disorders 
showed significant effects of treatment, but no significant difference between the 
treatment conditions.  Consequently, neurofeedback was seen as effective as 
methylphenidate in treating ADHD symptoms (Duric et al., 2012).   
1.4.6.9 Neurofeedback Setting 
The majority of research concerning neurofeedback has taken place in 
clinical settings, however, there is evidence that neurofeedback is effective in other 
situations.  Wadhwani, Radvanski, and Carmody (1998) investigated the effect of 
neurofeedback on a ten-year-old boy completing sessions at school.  At C3, a beta 
protocol was used and at Cz a SMR uptraining protocol was used; the sessions 
lasted up to 30 minutes.  Thirty-seven sessions took place over six months.  The 
training was successful with improvement in national achievement tests and results 
in a school setting were similar to that of a laboratory setting.  However, only one 
participant took part and the study therefore needs to be replicated with a greater 
number of participants.  
More recently, Steiner et al. (2014) also examined the effect of 
neurofeedback at school.  One hundred and four children aged between 7 to 11 
years old with ADHD were allocated to neurofeedback, cognitive training, or a 
control group, while completing the interventions at school.  Forty sessions of 
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neurofeedback were completed.  At a 6 month follow up, neurofeedback 
participants maintained significant gains on Conners’ Parent Rating Scale as well 
as having greater improvements compared to the cognitive training condition. 
There is a current trend for individuals wishing to complete neurofeedback 
at home.  This provides individuals with the flexibility of being able to complete 
neurofeedback when it is most convenient for them, in the comfort of their own 
home and as often as they wish.  Despite this demand, the effectiveness of 
neurofeedback home training has not yet been examined (Vernon et al., 2004; 
Rutterford, Anderson, & Venables, 2008).  This is an area which this thesis aims to 
address. 
1.4.6.10 Side Effects 
There are some potential negative side effects to neurofeedback.  There is a 
very small possibility that neurofeedback could induce seizures, therefore it is 
absolutely vital that patients are closely monitored (Vernon et al., 2004).  Monastra 
et al. (2002) reported transitional side effects when treated with both stimulant 
medication and neurofeedback, including irritability and moodiness.  These side 
effects were overcome when the dose of stimulant medication was reduced.  Other 
reported side effects include headaches and dizziness, both of which were 
overcome by having a rest or something to eat after a neurofeedback session 
(Monastra et al., 2005).    
In conclusion, neurofeedback is a promising new treatment for ADHD.  
Neurofeedback has been shown to be an effective strategy in reducing ADHD 
symptoms, specifically impulsive and inattentive symptoms, particularly for 
patients who are unresponsive to pharmacological treatments such as stimulant 
medication or who have experienced side effects to medication (Monastra, 2005).  
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Protocols typically aim to increase SMR or increase beta waves across Cz, C3 and 
C4 and less often target frontal regions with sessions occurring on average twice a 
week for three to six months.  However, there are still some unknowns about 
neurofeedback, including its effectiveness when used in the home (Vernon et al., 
2004; Rutterford et al., 2008) and its effectiveness when combined with 
medication (Arns et al., 2009; Monastra et al., 2002; Duric et al., 2012) which this 
research aims to address. 
1.5 Aims  
Three research studies have been conducted as part of this thesis.  Each 
study will be presented with a literature review regarding the specific area of focus 
with their own aims and hypothesis.  After conducting the overall literature review, 
several areas have been identified that require further research which aim to be 
addressed in this thesis. 
Neurofeedback has been shown to have a large effect size on inattention 
(0.8) and impulsivity (0.7) and a medium effect size (0.4) on hyperactivity (Arns et 
al., 2009).  However, previous neurofeedback research has been conducted in 
clinical or school settings and not in the home (Vernon et al., 2004; Rutterford et 
al., 2008).  Consequently, we aim to examine the effect of neurofeedback home 
training on a healthy and ADHD population, examining EEG, personality, and 
neuropsychological measures.   
There have been limited previous research which has examined 
neurofeedback and stimulant medication.  There have been several studies which 
have compared the two interventions, showing similar effect on ADHD symptoms 
(Arns et al., 2009; Fuchs et al., 2003; Monastra et al., 2002; Rossiter, 2004; 
Rossiter & La Vaque, 1995).  The present study aims to examine the effect of 
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stimulant medication and neurofeedback combined on ADHD symptoms, 
specifically looking at EEG, personality, and neuropsychological measures.   
Many previous neurofeedback studies have failed to examine the effect of 
treatment on EEG (Fritson, Wadkins, Gerdes, & Hof, 2007; Fuchs et al., 2003; 
Winklemolen, 2011) and therefore we lack understanding of the effect of 
neurofeedback on the brain.  Consequently, in the present study, the aim is to 
examine the effect of neurofeedback home training on EEG in a healthy and 
ADHD sample.   
Additionally, the present study is being conducted as a feasibility study, 
with the aim to examine if successful implementation of neurofeedback home 
training is possible.  Consequently, the study aims to examine participant’s ability 
and acceptability to complete the intervention at home in addition to the viability 
of recruitment.   
The purpose of feasibility studies is to assess possible successful 
implementation of interventions.  As described by the United Kingdom’s National 
Institute for Health Research, Evaluation, Trials and Studies Coordination Centre 
(NETSCC, 2012) “feasibility studies are pieces of research done before a main 
study in order to answer the questions ‘can this study be done?’ used to estimate 
important parameters that need to design the main study” (Research Methods 
section).  A feasibility study tests areas of a possible randomized control trial, 
whereas a pilot study conducts the whole piece of research on a smaller scale.  
Both studies are expected to have small sample sizes, consequently, this results in 
inadequate power statistics.  Both feasibility and pilot studies are required to 
enable successful implementation of randomized control trials (Tickle-Degnen, 
2013).  
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1.6 Significance of the Study 
The proposed studies will focus on the application of neurofeedback home 
training, an area which has not been previously investigated (Vernon et al., 2004; 
Rutterford et al., 2008) 
The outcomes of this research will produce unique, original findings.  
Specifically, it will examine the effect of neurofeedback and stimulant medication 
on personality, to our knowledge, an area that has not been previously 
investigated.  If neurofeedback was deemed to alter personality, it may deter 
individuals from wishing to implement such intervention.  There have been limited 
previous research which has examined neurofeedback and stimulant medication in 
an ADHD sample.  There have been several studies which have compared the two 
interventions, showing similar effect on ADHD symptoms (Arns et al., 2009; 
Fuchs et al., 2003; Monastra et al., 2002; Rossiter, 2004; Rossiter & La Vaque, 
1995) but the present study aims to examine the effect of stimulant medication in 
combination with neurofeedback on ADHD symptoms.  This will examine what 
combination of treatments is the most effective in improving diagnosed inattention 
and impulsive behaviours.  This is significant, as depending on the findings, the 
outcome may influence interventions within the ADHD field.   
The research design and methods will ensure that the aims of the study are 
met in a controlled and rigorous manner, through the inclusion of a control group, 
randomized allocation to groups, and neuropsychological and psychophysiological 
measures (taken before and after neurofeedback training). This controlled 
methodology has often not been achieved in research concerning neurofeedback. 
Therefore, the present study will make an original contribution to the 
neurofeedback field and will add to existing knowledge. 
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2 General Methods 
A quantitative approach was used to measure significant change in 
children’s attention and impulsivity.  Qualitative measures were a possibility; 
however, these scales are subjective and difficult to compare from pre- to post-
measures as well as across parents and teachers.  Consequently, a quantitative 
methodology was determined to be the most effective approach in this research 
design to enable direct comparisons across time points and settings. 
2.1 Overview of Studies 
The research within this thesis focused on the application of neurofeedback 
home training, an area which has not been previously investigated (Vernon et al., 
2004; Rutterford et al., 2008). 
Due to the vast number of dependent variables, the research was split into 
three studies: (1) focusing on personality, (2) focusing on neuropsychological 
measures, (3) focusing on EEG measures.   
In all three studies, a between-participants design was used where pre-
measures were initially taken, including quantitative EEG, Behavioural Inhibition 
System/Behavioural Activation System (BIS/BAS) personality scale, Conners’ 
Parent and Teacher Rating Scale and Conners’ Continuous Performance Test 
(CPT).  Dependent on diagnosis, participants were randomly allocated to an 
intervention which was completed for 15 weeks, and then post-measures 
completed (repeated pre-measures).   
2.2 Ethical Considerations 
Informed consent was gained from the parents/guardians of participants.  
As participants were children and therefore may not have the capacity to provide 
informed consent, it was necessary to gain consent from parents.  However, 
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children were verbally informed about the research and asked to give verbal 
consent and written assent, as, legally, children under 18 years cannot give consent 
for research.  A written debrief was provided for parents and children with this 
verbally given to the participant as well. 
High priority was placed on confidentiality.  A numbering system was used 
to identify participants with only the researcher and supervisor team having access 
to this system.  All information was kept in a locked cabinet and a password 
protected computer.  As agreed with participants, parents and teachers were 
informed regarding involvement in the research, in addition to GPs and the 
Learning Assessment and Neurocare Centre Ltd consultant were advised of those 
in the ADHD sample.  No one else was made aware of any individuals 
participation.  
The questionnaires examined difficulties that the child may be 
experiencing or may have experienced in the past.  This could have been upsetting 
to parents and had to be dealt with in a sensitive manner. If either the child or 
parents were emotionally or physically distressed, they were advised by the 
information sheet to contact the researcher who could arrange for them to receive 
coaching or counselling sessions.  Furthermore, the neurofeedback home training 
group emailed the researcher after each session had taken place, enabling the 
researcher to keep in regular communication with the participant/family and 
monitor any distress.  Ultimately, there were no requests made for coaching or 
counselling. 
Participants were able to withdraw anytime up to 4 weeks after the post 
measures had been collected.  After this point, data were analysed and 
consequently difficult to identify and withdraw from the dataset.  There was no 
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penalty for withdrawing from this research.  No participants withdrew at this stage.  
However, 11 participants withdrew during the intervention stage.   
The ADHD patients Specialist Consultant Paediatrician at the Learning 
Assessment and Neurocare Centre Ltd was medically qualified and responsible for 
diagnosis as well as management of the patients with ADHD.  He was responsible 
for prescribing, monitoring and titrating medication to the most appropriate dose if 
agreed to by the parents/patient.  This was not the role of the researcher, who was 
observing and testing the effects of usual treatment variants.   
For children with severe ADHD, the first line of recommended treatment as 
stated in the NICE guidelines is drug treatment, namely stimulant medication. In 
this research, medication was only recommended and prescribed by the Consultant 
if it was felt that this was within the NICE guidelines.  The Learning Assessment 
and Neurocare Centre Ltd complies with the NICE guidelines for both diagnosis 
and management of individuals with ADHD.     
Participants and/or their parents were charged a fee for the assessment and 
treatment they received at the Learning Assessment and Neurocare Centre Ltd.  
However, participants and/or their parents did not incur any additional fees for 
taking part in this research.   
2.3 Design  
A between participants design was used to ensure unbiased and clear 
results.  Participants were randomly allocated to one of the following conditions, 
dependant on if they had a diagnosis or not: 
• Neurofeedback home training (typically developed sample) 
• No neurofeedback: control group (typically developed sample) 
• Computer based activities: active control group (typically developed sample) 
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• Neurofeedback home training (ADHD sample) 
• Neurofeedback home training and stimulant medication (ADHD sample) 
• Stimulant medication only (ADHD sample) 
• Neurofeedback in clinic and stimulant medication (ADHD sample) 
The dependent variables obtained at the pre-and post-measure time points, before 
and after participating in their allocated condition, were: 
• electrophysiological measures of EEG  
• BIS/BAS personality scale with subscales of BIS, BAS drive, BAS fun 
seeking, and BAS reward responsiveness 
• Conners’ 3 Parent Rating Scale with subscales of learning difficulties, 
executive function, defiance, inattention, and hyperactive/impulsive 
• Conners’ 3 Teacher Rating Scale with subscales of learning difficulties, 
executive function, defiance, inattention, and hyperactive/impulsive 
• Conners’ Continuous Performance Test (CPT) with subscales of 
omissions, commissions, hit response time, hit response time standard 
error, variability, detectability, response style, preservations, response 
time block change, and response time block change standard error 
2.3.1 Design Development 
2.3.1.1 Design Development: Typically Developed Sample 
Initially, the design of this sample was a between participants design, 
whereby the conditions consisted of neurofeedback home training and a control 
group of typically developed children. 
Having undergone ethical review, the study was expanded to include a 
third condition, an active control group, where computer-based activities were 
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completed.  The active control group was introduced to overcome potential 
confounding variables, specifically to see if sitting and watching a computer has an 
effect on brainwaves and behaviour.   
2.3.1.2 Design Development: ADHD Sample 
The design of the ADHD sample evolved considerably from the original 
concept to delivery.  Initially, the study was a 2 x 2 between participants design 
where the conditions consisted of neurofeedback home training, neurofeedback 
home training and stimulant medication, stimulant medication only and a control 
group.   
This research underwent various ethical reviews, including NHS.  Please 
see Appendix A for detail regarding the ethical reviews.  This was a lengthy and 
time-consuming process which took over 2 years to complete.  There were several 
reasons as to why the process was so difficult and lengthy. 
 Firstly, it was advised that the research required NHS ethical review.  
Many questions were raised about the Centre that the research was being 
conducted at, as well as lack of clarity in the information sheets.  However, 2 NHS 
ethical reviews were completed and alterations made, but were unsuccessful.     
Secondly, it was advised by the University that after 2 unsuccessful NHS 
applications, NHS ethical review was not required, due to patients being private 
patients and not NHS patients, but instead be reviewed by the University ethics 
committee.     
Feedback from the University ethics committee criticised the use of a 
waiting list control group in this sample as treatment that could potentially enhance 
the individuals’ quality of life was being withheld.  Consequently, the control 
group was withdrawn.  To develop the design even further and to strengthen the 
 67 
findings, it was suggested by the University ethics committee that two further 
conditions were added to the design: neurofeedback in clinic only and 
neurofeedback in clinic with stimulant medication.  Incorporating these two 
conditions meant that comparisons could be drawn between neurofeedback home 
training and neurofeedback in clinic.  These alterations were incorporated into the 
study and have made a stronger research study. 
Thirdly, part way through the ethic review process, the research team 
(researcher and supervisor) changed University.  The research proposal was 
submitted to the new University ethics committee.  However, there was much 
confusion due to the lengthy process up to this point, why NHS approval was no 
longer required and why approval had not been granted.   
Finally, the application was made explicitly clear that this research was not 
imposing any treatment that the patients were not already being offered as part of 
their care at the Centre.  At this stage, after 2 years and 3 months, and seven ethical 
review applications, ethical approval was granted. 
2.3.2 Participants 
 There were two samples of participants that took part: typically developed 
and ADHD participants. 
2.3.2.1 Typically Developed Participants 
Participants were a self-selected sample of volunteers who did not have any 
clinical diagnosis. Participants were children aged between 7 and 17 years old.   
The reasons for this age group was threefold.  Firstly, normative databases for 
EEGs have been established from the age of 6 to 95 years old and therefore it 
would not be appropriate to use children below this age due to lack of data 
(Butnik, 2005).  Secondly, children experience rapid brain development until the 
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age of 7, a process known as maturation.  After this age, brain development slows, 
becomes less erratic and more consistent (Bresnaham & Barry, 2002).  Thirdly, the 
norms for the Conners’ Rating Scales are up to the age of 17.  Prospective 
participants were approached via advertising the research on social media, local 
newspapers and websites.  Local schools were contacted to distribute information 
leaflets but were not willing to do so.   
Inclusion criteria: 
• Child aged between 7 and 17 years old 
• Child does not have any clinical diagnosis 
• Child has not previously received any neurofeedback treatment 
• Child is not and has not previously taken stimulant medication  
Fifty healthy participants completed the pre-measures, 68% were male, 
32% female, with a mean age of 10.98 years old.  The ADHD sample had a higher 
male-to-female ratio.  This was to be expected as ADHD occurs more in males. 
2.3.2.2 ADHD Participants 
The sample was self-selected and comprised of volunteers who had 
attended the Learning Assessment and Neurocare Centre Ltd for an assessment 
due to concerns regarding concentration.    The Centre was an independent, multi-
disciplinary lifespan clinic that specialised in the multi-professional assessment 
and management of children, adolescents, and adults, with complex 
neurodevelopmental difficulties, especially ADHD. 
Prior to approaching a potential participant, the researcher discussed with 
the participant’s consultant, their diagnosis and appropriate treatment.  Participants 
were only informed of the research if both treatments involved in the present 
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study, neurofeedback and stimulant medication, were offered to them as part of 
their standard treatment at the Learning Assessment and Neurocare Centre Ltd. 
Participants were children aged between 7 and 17 years old who had a 
main clinical diagnosis of ADHD (combined subtype).   Individuals diagnosed 
with other psychiatric conditions were included as long as they had a main 
diagnosis of ADHD (combined subtype). 
Inclusion criteria: 
• Child aged between 7 and 17 years old 
• Child who had a main clinical diagnosis of ADHD 
• Child who had not previously received a course of methylphenidate or 
other stimulant medication 
• Child who had not previously completed a course of neurofeedback 
Forty-one ADHD participants completed the pre-measures; 85% were 
male, 15% were female, with a mean age of 11 years old.  Eighty percent of the 
ADHD participants had pure ADHD with no additional diagnosed complications.  
The other twenty percent of participants had one comorbidity of either Autistic 
Spectrum Disorder (ASD), Developmental Co-ordination Disorder (DCD), 
Oppositional Defiant Disorder (ODD), or Dyslexia.   
2.3.3 Intervention Conditions 
Typically developed participants were randomly allocated to one of three 
conditions:  
• Neurofeedback home training (typically developed sample) 
• No neurofeedback: control group (typically developed sample) 
• Computer based activities: active control group (typically developed 
sample) 
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Participants with a diagnosis of ADHD were allocated to one of the 
following conditions: 
• Neurofeedback home training (ADHD sample) 
• Neurofeedback home training and stimulant medication (ADHD sample) 
• Stimulant medication only (ADHD sample) 
• Neurofeedback in clinic and stimulant medication (ADHD sample) 
Unfortunately, complete randomisation was not possible.  Consideration 
needed to be made for individuals allocated to the neurofeedback in clinic 
condition, ensuring they live in close proximity to the Centre to access 
neurofeedback in clinic twice a week.   
2.3.3.1 Neurofeedback Home Training Condition in Typically Developed Sample 
Sixteen participants were allocated to the neurofeedback home training 
condition.  The mean age was 10.62 years old, 68.8% were male, 31.3% female. 
During the initial meeting, the researcher explained that neurofeedback 
home training needed to be completed in a quiet environment, in the same room 
and same time of day, twice a week for 15 weeks.   
Neurofeedback home training was administered using the PET 
Biofeedback system.  The software used to digitize the signal and to design the 
training protocol was BioExplorer.  A standard improving concentration protocol 
was used; an increase in SMR (12 - 16Hz) activity at a threshold of 70% across the 
sensorimotor strip at locations C3, Cz and C4.    
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Figure 2. Typically developed sample neurofeedback home training placement. 
The written neurofeedback instructions provided for the participant are 
shown in Appendix O.  The scalp and mastoids were cleaned using NuPrep and 
then a conductive paste, namely Ten20 paste, was used on the electrode on the 
scalp.  A referential montage was used, whereby a reference electrode was 
attached to the right mastoid and a ground electrode was attached to the left 
mastoid.  The active electrode was first placed on C3, as per the 10-20 system.  
The 10-20 system is a standard EEG placement system with a minimum of 21 
electrodes on the scalp allowing standardised placements of the electrodes.  Each 
electrode name consists of a number and letter.  The left side of the brain 
electrodes are odd and right sided electrodes are even.  The letter refers to the brain 
region: F frontal, T temporal, C central, P parietal, and O occipital (Chong, 
Sahlem, & Bazil, 2007).  At the C3 location, the participant completed 10 minutes 
of neurofeedback receiving Pacman as a visual and audio reinforcement.  The 
participant then moved the electrode to Cz where the participant completed 10 
minutes of neurofeedback receiving Boxes as a visual reinforcement.  Finally, the 
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electrode was moved to C4 where the participant completed 10 minutes of 
neurofeedback watching Videos with both visual and audio reinforcement. 
After every completed session, the participant sent the researcher the 
neurofeedback session as an attachment to an email for the researcher to review.  
This enabled the researcher to ensure that the neurofeedback home training 
sessions were being completed, being completed accurately, and to monitor the 
participants progress.  After every two neurofeedback home training sessions, the 
researcher emailed the participant regarding their progress.  This email took the 
following format: 
• Telling the participant how the session was overall 
• Quantitative information - rating the session out of 10 depending if the 
session had improved or not 
• Qualitative information – giving information about the individuals   
concentration 
• Signal quality from electrodes 
Good signal 
  OK signal 
            *Press the electrode onto the scalp to ensure good connection 
 Bad signal 
          *Check the electrodes are correctly attached 
• Providing the participant with encouragement 
 In this feedback email, the participant was also reminded to complete the 
neurofeedback sessions in the same room, at the same time of day, under the 
supervision of a parent. 
G 
A 
R 
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2.3.3.2 Active Control Condition in Typically Developed Sample 
Fifteen participants were allocated to the active control condition.  The 
mean age was 10.63 years old, 60% were male, 40% female. 
The active control condition completed 30 online computer game sessions, 
specifically 2 sessions a week for 15 weeks.  When allocated to this condition, the 
participant was provided with written instructions which the researcher discussed 
with them.  The researcher explained that the computer activities were required to 
be completed in a quiet environment, in the same room and same time of day every 
time.  The written active control condition instructions provided for the participant 
are included in Appendix P. 
The instructions explained that they were required to complete 30 minutes 
of BBC bitesize games.  Thirty minutes of computer activities were used to ensure 
that the findings would be comparable to the neurofeedback group (whereby the 
participant was completing 30 minutes of active neurofeedback).  The participant 
was provided with the website address appropriate for the participants age.  The 
participant could then choose which activities they wished to complete. 
After each session had been completed, the participant was required to 
email the researcher to notify them that the session had been completed.   The 
researcher acknowledged this and reminded the participant to complete the 
sessions in the same room, at the same time of day, under the supervision of a 
parent. 
2.3.3.3 Control Condition in Typically Developed Sample 
Fifteen participants were allocated to the control condition.  The mean age 
was 11.26 years old, 66.7% were male, 33.3% female. 
The control group did not complete any additional tasks. 
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2.3.3.4 Neurofeedback Home Training Condition in ADHD Sample 
Three participants were allocated to the neurofeedback home training 
condition.  The mean age was 12.27 years old, and all participants were male 
Neurofeedback home training for the ADHD sample was conducted in the 
same way as the typically developed sample, administered using the PET 
Biofeedback system.  The software used to digitize the signal and to design the 
training protocol was BioExplorer.  However, the ADHD sample used a QEEG 
informed protocol for all neurofeedback training.  Consequently, the location and 
protocol were different for each participant.  To determine the protocol, the raw 
EEG data were fed through a quantitative EEG database.  A database is used to 
compare norms and can show any systematic changes in brainwave frequencies 
(Cantor & Chabot, 2009).  In this research, the Neuroguide database was used, 
developed by Robert Thatcher.  The database contains information from 625 
individuals, with both eyes closed and eyes open conditions, and collects 943 
variables including measures of power, coherence, phase, and power ratios 
(Johnstone & Gunkelman, 2010).  Participants within the database range from two 
months old to 82.6 years old.  In this research, absolute power was used and the 4 
brainwave areas that were the furthest away from the norm (had the most standard 
deviations away from the norm) were used.  The protocol had a reward threshold 
of 70%.  The scalp and mastoids were cleaned using NuPrep and then a conductive 
paste, namely Ten20 paste, was used on the electrode on the scalp.  A referential 
montage was used, whereby a reference electrode was attached to the right mastoid 
and a ground electrode was attached to the left mastoid.  The active electrode was 
placed as per the 10-20 system.  
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2.3.3.5 Neurofeedback Home Training and Stimulant Medication Condition in 
ADHD Sample 
Eight participants were allocated to the neurofeedback home training and 
stimulant medication condition.  The mean age was 8.62 years old, 87.5% were 
male, 12.5% female. 
As described above, neurofeedback home training for the ADHD sample 
was conducted in the same way as the typically developed sample.  However, the 
ADHD sample used a QEEG informed protocol for all neurofeedback training.  
Additionally, participants allocated to this condition were prescribed a 
methylphenidate-based medication: namely Concerta XL, Medikinet XL, Equasym 
XL or Ritalin.  Medication was taken daily at the dose prescribed by their 
consultant at the Learning Assessment and Neurocare Centre Ltd.  
2.3.3.6 Stimulant Medication Condition in ADHD Sample 
Nineteen participants were allocated to the stimulant medication condition.  
The mean age was 11.42 years old, 84.2% were male, 15.8% female. 
Participants allocated to the stimulant medication condition were 
prescribed a methylphenidate-based medication: namely Concerta XL, Medikinet 
XL, Equasym XL or Ritalin.  The Consultant Paediatrician at the Learning 
Assessment and Neurocare Centre Ltd was responsible for overseeing the 
participants on medication, ensuring they were on the most effective dose and 
were not experiencing any negative side effects.  Stimulant medication was taken 
every day.   
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Table 1.   
Detail of participants receiving medication 
 
 
 
 
2.3.3.7 Neurofeedback Clinic Training and Stimulant Medication Condition in 
ADHD Sample 
Four participants were allocated to the neurofeedback clinic training and 
stimulant medication condition.  The mean age was 9.75 years old, all of which 
were male. 
The researcher completed the neurofeedback session with the participant, 
setting up the equipment and providing verbal feedback about the session.  The 
researcher ensured that the neurofeedback in clinic was completed in a quiet 
environment, in the same room and same time of day.  The same equipment was 
used as the neurofeedback home training conditions.  Additionally, participants 
allocated to this condition were prescribed a methylphenidate-based medication: 
namely Concerta XL, Medikinet XL, Equasym XL or Ritalin. 
2.4 General Procedure 
After discussing a potential participant with the Consultant and ensuring 
they fulfilled the inclusion criteria, the researcher approached the family via email 
or phone, providing them with the information sheet to consider.  If the family 
wished to participate, the researcher, parent and child arranged a mutually agreed 
time to discuss the research and their involvement.  This meeting took place at the 
Learning Assessment and Neurocare Centre Ltd who gave consent for this.   
Drug Name Frequency Percent 
No medication 10 25 
Concerta 2 5 
Concerta XL 10 25 
Equasym XL 7 17 
Medikinet XL 12 30 
 77 
During the initial meeting, the study was explained in detail to the parent 
and child by the researcher.  This meeting provided participants with the 
appropriate information sheets, consent and assent forms, information on what to 
do if they wished to withdraw and an opportunity to ask questions.  The researcher 
ensured that the child met the inclusion criteria in terms of age and any clinical 
diagnosis.  If parent and child were happy to proceed, the pre-measures were 
collected.   
If the family consented to participate, the child completed the pre-
measures, consisting of: 
• EEG 
• Conners’ Continuous Performance Test 
• BIS/BAS personality test 
The child’s parents and teachers completed the online version of the 
Conners’ 3 Parent/Teacher Rating Scale which was emailed to them after the 
meeting.   The standardised procedures proposed in the manuals of each test were 
followed to ensure the validity of the results.  The tests were aimed at assessing 
concentration and impulsive abilities.  
Following the pre-measures assessments, participants were randomly 
allocated to one of the conditions by the researcher.  The conditions were 
previously described in Chapter 2.3.3.  
If a participant was allocated to any neurofeedback home training 
condition, the researcher uploaded the appropriate software onto the participants 
laptop and provided them with a box of neurofeedback equipment, including PET 
BioExplorer system, NuPrep, 10-20 Paste, electrodes, batteries and a battery 
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charger.  They were also given an interactive demonstration so that they were 
confident to use the equipment as well as written instructions. 
After 15 consecutive weeks of receiving interventions, the measures were 
completed, namely EEG, Conners' Continuous Performance Test, BIS/BAS 
personality questionnaire and Conners' 3 Parent and Teacher Rating Scales, were 
repeated.  These were again conducted at the Learning Assessment and Neurocare 
Centre Ltd.   The participant was debriefed, provided with information regarding 
withdrawing from the study, who to contact if they had any concerns about the 
research or if they had concerns regarding their child, and were thanked for their 
time and effort.  The child and parent were provided with debrief sheets and an 
opportunity to ask any questions. 
2.5 Statistical Analysis 
All statistical analysis was performed using the software SPSS 18.0.  
Significance level was set to p < 0.05.  When referring to confidence intervals,  all 
tables are set to 95% confidence intervals. 
As many comparisons between variables, conditions and diagnosis were being 
performed, host hoc adjustments were necessary.  The Bonferroni correction was used 
to reduce the chances of gaining type I error results.  Specifically, if a null hypothesis is 
true, a significant difference would still be found at least once in every 20 trials.  A 
Bonferroni correction consists of dividing the p value (0.05) by the number of 
comparisons (Perneger, 1998).   
However, there is an argument that the Bonferroni correction can create more 
problems than solutions.  Although the Bonferroni correction reduces the chance of type 
I error, it increases the likeness of type II errors.  The Bonferroni correction is 
appropriate in some situations including repetition of the same tests in multiple 
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subsamples, when the null hypothesis has importance and when it is imperative to avoid 
a type I error (Armstong, 2014).  Even in this situation, it is argued that describing the 
analysis, its significance and importance is the best way of dealing with multiple 
comparisons (Perneger, 1998).      
In the present research, many comparisons between variables were made.  
Therefore, Bonferroni correction was based upon the amount of comparisons made 
within one specific measure.  For example, the Conners’ Parent Rating Scale 
consisted of 5 variables (learning difficulties, executive functions, defiance, 
inattention and hyperactive/impulsive).  Consequently, with the Bonferroni 
correction, p value is set to 0.01 for the Conners’ Parent Rating Scale.  In the 
subsequent tables, p values will be left uncorrected, however, indication will be 
made as to which ones are significant after Bonferroni correction. 
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3 Study One: Effect of Neurofeedback on Personality  
3.1 Introduction  
Personality is defined as “the sum total of the behavioural and mental 
characteristics that are distinctive of an individual, and the personal qualities that 
make a person socially popular” (Colman, 2006, pp. 564).  In accordance with the 
DSM-5 (APA, 2013) a personality trait is defined as “enduring patterns of 
perceiving, relating to, and thinking about the environment and oneself that are 
exhibited in a wide range of social and personal contexts” (APA, 2013, pp.686).   
3.1.1 Personality and ADHD 
There are many theories that attempt to explain personality including: 
psychodynamic, trait, social learning, and social cognitive theory (Gleitman, 
Fridluind, & Reisberg, 2004).  Some of these theories will now be discussed in 
more detail in relation to ADHD. 
3.1.1.1 Social Cognitive Theory 
One approach to personality is the social-cognitive theory.  Bandura is a 
key figure in the development of the social-cognitive theory which has two 
underlying principles: (1) the person, environment and behaviour influence one 
another and (2) our conscious cognitive capabilities dictate our ability to reflect on 
ourselves.  The theory focuses on our ability to think and reflect on our past, 
present and future experiences as well as the capacity we have to influence our 
own development.  Our thinking develops through interaction with the 
environment and our behaviours are learnt through observation, modelling, and 
positive reinforcement.  Behaviours are likely to be strengthened when others are 
observed exhibiting the behaviour and particularly if the behaviour is rewarded 
(Gleitman et al., 2004).   
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Cailles, Bertot, Motte, Raynaud, and Abely (2014) specifically examined 
ADHD in relation to the social cognitive theory.  In a sample of 30 children, 15 
diagnosed with ADHD, 15 typically developed, aged 7 to 10 years old, assessment 
took place including examining theory of mind and executive function.  Findings 
showed that individuals with ADHD experience problems with theory of mind, as 
well as inhibition control deficits.   
Martin, Burns, and Collie (2017) also examined the social cognitive 
perspective in relation to ADHD. One hundred and sixty-four children with ADHD 
as well as 4658 healthy individuals, aged 11 to 13 years old, underwent a self-
efficacy assessment as well as literacy and numeracy tests.  Children with ADHD 
showed significantly stronger associations between self-efficacy, relational support 
and academic achievement.   
3.1.1.2 The Psychodynamic Theory 
The psychodynamic approach was developed from Freud’s psychoanalytic 
theory.  The theory states that our behaviours are a consequence of our 
unconscious influences.  The theory states that our mind consists of three areas: 
conscious (how aware we are at any given moment), preconscious (what we could 
become aware of if we attended to it), and unconscious (part of the mind we are 
unaware of).  Our personalities are formed in our mind, specifically in the 
unconscious and conscious areas, by conflicts that occurred during childhood.  
These conflicts have an impact on the development on the subsystems of 
personality: the id, ego and superego.  Freud went on to explain that during 
childhood we go through stages of psychosexual development.  How we progress 
through these stages and solve conflicts in each stage determines our personality 
later in life.  Additionally, our personality involves several factors including: 
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instinctual drives, specifically food, sex and aggression, unconscious processes, 
and early childhood influences including our role models.  Personality 
development undergoes rapid change during the first five years of life through the 
interplay of instinct and environment.  Personality abnormalities and mental health 
difficulties are often tracked back to this crucial period of personality development 
(Freud, 1920).  However, there has been much controversy surrounding this theory 
due to the lack of supporting evidence (Gleitman et al., 2004).   
There is little literature available in regard to the psychodynamic approach 
to personality and ADHD.  The approach describes hyperactivity as the result of 
avoiding emotional discomfort, therefore avoiding one’s emotional turmoil.  The 
theory states that the ADHD brain has difficulty balancing mental process as well 
as self-regulation.  Furthermore, many relationships between others and a child 
with ADHD are negative.  Consequently, as underlying emotions are not being 
dealt with, impulsive behaviour is exhibited along with a negative mindset and 
placing blame on others, known as learnt helplessness.  As discussed earlier in this 
thesis, the lack of a father figure can contribute to the development of ADHD.  
From a psychodynamic perspective, lack of a father figure causes the child to 
represent the father and analyse any violence, which is exhibited as impulsive 
behaviour (Salomonsoon, 2017). 
3.1.1.3 The Biological Trait Theory 
The biological trait theory of personality was developed by Eysenck (1967) 
and assumes behaviour is determined by relatively stable traits.  The theory 
explains extroversion as low levels of cortical arousal where individuals are 
impulsive but sociable, whereas introversion is characterised by high levels of 
cortical arousal and caution (Eysenck, 1967).  This theory was further developed to 
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identify five major dimensions of personality, now known as the Big Five.  This 
consists of: extroversion, neuroticism, agreeableness, conscientiousness, and 
openness to experience (Gleitman et al., 2004).   
Shaw and Giambra (1993) examined the Big Five in relation to ADHD.  
Nine male and four female students with a diagnosis of ADHD completed 
questionnaires including the Sensation Seeking Scale and Conners Abbreviated 
Rating Scale.  Results showed ADHD individuals to be hyper aroused and seeking 
high levels of sensation, due to boredom being stressful for them. 
Furthermore, Braaten, and Rosen (1997) examined 68 students with ADHD 
compared to 59 control students.  Several questionnaires were completed including 
Patient’s Behaviour Checklist, Early Childhood Environment Rating Scale and 
Environmental Impact Statement.  The ADHD population were positively 
associated with extraversion as well as neuroticism.  High neurotic traits were 
associated with high emotional intensity and strong emotional reactions.  
Specifically, the ADHD sample were significantly lower on emotional reaction to 
punishment, showing that punishment is a less effective behavioural strategy in 
children with ADHD.  Neuroticism, in the case of ADHD, can express itself 
through emotional liability.  Specifically, neuroticism is a significant predictor of 
inattentive, hyperactive, and impulsive behaviours, unlike extraversion.  The 
understanding behind the connection between ADHD and extraversion is that 
individuals with ADHD lack internal stimulation, and therefore compensate for 
this through disruptive behaviour patterns (Parker, Majeski, & Collin, 2004).  This 
finding was from a sample of 587 students with a mean age of 19 years old who 
completed the Conners’ Adult ADHD Rating Scale and the Personality Inventory.  
However, the other areas of personality as derived from the Big Five Theory, 
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including openness to experience, agreeableness and conscientiousness, has had 
little research conducted in relation to ADHD and are often ignored (Nigg, 2000). 
3.1.1.4 The Biopsychosocial Model  
The biopsychosocial model of personality has also explored ADHD.  This 
model is based upon seven dimensions of personality.  Three dimensions are based 
upon character: self-directed cooperativeness, self-transcendence and persistence, 
with a further four temperament dimensions: novelty-seeking, harm avoidance, 
reward dependence, and self-transcendence.  In this theory novelty-seeking is the 
tendency to approach novel situations for rewards, and to experience relief from 
non-punishment. High novelty-seeking behaviours include impulsivity, quick-
temper, and proneness to breaking rules. Harm avoidance behaviours include the 
tendency to inhibit or avoid responses to aversive cues, such as punishment and 
non-reward. High harm avoidance is associated with high anticipatory anxiety and 
fear. Reward dependence is the tendency to maintain responses that have been 
previously conditioned through rewards. High reward dependence is associated 
with being sociable and sensitive to social cues. Persistence is the tendency to 
maintain responses, despite frustration and fatigue. High persistence is associated 
with persevering and being ambitious. Self-directedness reflects the ability to 
control, regulate and adapt one's behaviour to a situation in order to achieve one's 
goals and values. Cooperation reflects identification with, and acceptance of, 
others. Self-transcendence reflects imaginativeness and spirituality (Gomez, Van 
Doorm, Watson, Gomez, & Stavropoulos, 2017).   
Gomez et al. (2017) conducted a meta-analysis examining the 
biopsychosocial theory of personality in relation to ADHD.  Fifteen studies were 
included, all of which consisted of ADHD samples compared to healthy controls.  
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Novelty-seeking and harm avoidance were positively associated with ADHD 
whereas reward dependence, persistence, self-directedness and cooperativeness 
were significantly negatively associated with ADHD.  The personality dimensions 
were not affected by age.  The significance of novelty-seeking and ADHD shows 
that these individuals tend to approach new situations for reward and for non-
punishment.  This system is associated with dopaminergic activity, of which there 
is a deficit in ADHD, as well as serotonin-transporters.  Consequently, the 
significant result of ADHD and novelty-seeking in the present study suggests that 
ADHD is associated with dopamine and serotonin.  The negative association 
between self-directedness and ADHD show a lack of ability to control, regulate 
and adapt behaviour.   
3.1.1.5 Reinforcement Sensitivity Theory 
Gray’s (1972) personality theory, referred to as the Reinforcement 
Sensitivity Theory (RST) is based upon the biological basis of personality.  The 
aim of the theory was to identify the brain-behavioural systems involved in the 
variation of human behaviour and to relate these systems to a measure of 
personality (Corr, 2008). 
The theory was originally adapted from Eysenck’s early theory of 
personality.  However, Gray argued that the extraversion and introversion 
dimensions should be altered to create punishment sensitivity, presenting as 
anxiety, and reward sensitivity, presenting as impulsivity.  Gray predicted that 
impulsively charged individuals are more sensitive to signals of reward whereas 
anxiously charged individuals are more sensitive to signals of punishment (Corr, 
2004).  Gray’s RST of personality consists of three systems.   
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The first system is the Behavioural Approach System (BAS) which seeks 
reward and is responsible for feeling positive.  This activation/impulsive system 
means that the individual seeks rewards and positive emotions which are sensitive 
to reward (Corr, 2008).  Individuals who experience heightened BAS may have 
sociopathic personality and can be associated with disorders such as bipolar and 
conduct disorder (Carver & White, 1994).  Within the brain, the BAS uses 
dopaminergic pathways particularly within the basal ganglia (Carver & White, 
1994) in addition to the prefrontal cortex, the ventral tegmental area, the nucleus 
acumbens and the ventral striatum (Gomez & Corr, 2014).  
The second system in the RST is the Behavioural Inhibition System (BIS) 
which is the aversive motivational system involved in resolving conflicts.  Within 
the brain, the BIS uses the septohippocampal system, monoaminergic afferents 
from the brainstem, and the neocortical projection in the frontal lobe which 
consequently creates a feeling of anxiety (Carver & White, 1994).  The BIS is 
sensitive to and influenced by punishment, nonreward and novelty and is 
responsible for negative emotions.  Individuals who experience heightened BIS 
may experience difficulties linked to anxiety, particularly childhood anxiety 
disorders, and depressive disorders.  These individuals are sensitive to fear and 
punishment and learn best from punishment (Jackson, 2003).  On the other hand, 
individuals who experience underactive BIS and therefore have impaired 
inhibition to punishment, may experience Attention Deficit Hyperactivity Disorder 
symptoms (Carver & White, 1994).  
The third system in the original RST is the Fight-Flight System (FFS) 
which motivates behaviours to avoid or escape certain stimuli such as fear.  Brain 
areas that are activated and associated with this system include the periaqueductal 
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gray matter, medial hypothalamus, amygdale, anterior cingulated and prefrontal 
ventral stream.  The FFS is sensitive to unconditioned aversive stimuli which 
provokes emotions such as panic (Corr, 2004). 
The RST has largely been examined in an adult population.  For the RST to 
be completely understood, it is important for personality to be examined across 
development as our behaviour changes, particularly during adolescence.  For 
example, an increase in risk taking is seen in adolescence, consequently it is linked 
to an increase in reward responsiveness (Pagliaccio et al., 2016).   Specifically, 
Urosevic, Collins, Muetzel, Lim, and Luciana (2012) examined 83 male and 101 
female healthy individuals, aged 9 to 23 years old, who completed the BIS/BAS 
scale and MRI, which was repeated 2 years later.  BAS reward responsiveness was 
seen to peak in mid to late adolescence and decline in adulthood.  This change on 
BAS reward responsiveness is associated with developmental brain changes, 
specifically structural changes in brain regions and a decrease in brain volume.  
Similarly, a further study found a positive association between early personality 
development with age on the BIS/BAS scale, with a peak of BAS reward 
responsiveness in young adulthood followed by a decline.  This finding is 
consistent with neuroimaging literature regarding brain development (Pagliaccio et 
al., 2016).   
Furthermore, a female male difference was found, with adult females 
having higher BIS scores as well as higher BIS sensitivity with age.  This could be 
due to females internalizing psychopathology, particularly during adolescence, and 
consequently altering personality in adulthood.  Furthermore, females on average 
showed higher BAS reward responsiveness scores and males showed higher BAS 
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drive scores (Pagliaccio et al., 2016).  However, this needs to be examined further 
in a child population. 
There are limited studies that have examined the relationship between the 
RST and individuals with ADHD, but the findings that do exist are inconclusive 
(Barkley, DuPaul, & McMurray, 1990; Hundt, Kimbrel, Mitchell, & Nelson-Gray, 
2008; Mitchell & Nelson-Gray, 2006; Gomez & Corr, 2010).    
Overactive BAS is often seen in ADHD combined subtype and ADHD 
hyperactive impulsive subtype, giving more impulsive responses and an inability 
to switch attention.  An overactive BAS system means that the individual is unable 
to resolve goal conflicts, is unable to sustain attention, and is engaged in task-
irrelevant activities.  In individuals with ADHD, this is consequently displayed as 
inattention and distractibility.  The inattentive subtype of ADHD has a different 
association with the RST, specifically a negative relation to BAS resulting in low 
levels of anger and frustration but have higher anxiety levels (Barkley et al., 1990).    
Hundt, Kimbrel, Mitchell, and Nelson-Gray (2008) examined 273 adults 
using the Sensitivity to Punishment and Sensitivity to Reward Questionnaires and 
ADHD Rating Scale.  Results showed that high BAS was associated with 
hyperactive-impulsive symptoms of ADHD as well as alcohol abuse and 
psychopathy.  Consequently, high BAS may be a factor towards externalising 
difficulties.  Low BIS was also associated with hyperactive-impulsive symptoms, 
particularly when inattentive symptoms are not present.  This shows that high BAS 
is a trait associated with external difficulties.  In regard to inattentive ADHD, high 
BIS and low BAS are associated with these symptoms, with the possibility of 
being linked to anxiety and depression. 
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Mitchell and Nelson-Gray (2006) found all subtypes of ADHD to be 
associated with both BIS and BAS tendencies.  Specifically, they examined 209 
undergraduate psychology students, with a mean age of 18 years old.  ADHD 
rating scale and Sensitivity to Punishment and Sensitivity to Reward 
Questionnaires were completed.  BAS was significantly correlated with 
hyperactive-impulsive symptoms, whereas BIS was only moderate in comparison.  
Specifically, BAS scores were a predictor of hyperactive-impulsive symptoms 
whereas BIS scores were not.  This finding supports that overactive BAS and 
behavioural control deficits are due to disinhibition in ADHD, although this is not 
supported for ADHD inattentive subtype. 
In a study by Gomez and Corr (2010) the inattentive subtype of ADHD 
was examined.  Two hundred and fourteen adults completed the BIS/BAS scale, 
the Sensitivity to Punishment and Sensitivity to Reward Questionnaire and ADHD 
ratings.  Inattentive ADHD was positively associated with BIS and sensitivity to 
punishment, specifically BIS anxiety and BIS fear.  ADHD combined subtype was 
positively associated with BAS reward responsiveness, BAS drive, positive 
emotionality, and high reward sensitivity. 
In conclusion, these studies show that adult ADHD is positively associated 
with high BAS, which appear to lead to hyperactive-impulsive symptoms 
(Mitchell & Nelson-Gray, 2006; Barkley, DuPaul, & McMurray, 1990; Hundt et 
al., 2008).  However, findings regarding ADHD inattentive subtype are less 
conclusive, but research suggests it is associated with BIS (Gomez & Corr, 2010).  
The research presented here regarding RST and ADHD have been conducted in 
adult populations.  Consequently, this needs to be replicated in a child population 
to fully understand the development of personality in an ADHD sample.    
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3.1.2 Personality and EEG Patterns 
Specific EEG patterns have been shown to be associated with personality 
traits.  It has been suggested that, as a broad trend, extroverts show more low-
arousal EEG activity such as alpha waves, when compared to introverts (Stenberg, 
1992).   
In a study of 41 students, aged 18 to 46, participants underwent 19 
electrode EEG while exposure to pleasant, neutral and unpleasant images.  
Findings showed highly impulsive individuals to have higher levels of low arousal, 
specifically higher levels of slow theta activity (Stenberg, 1992). 
In the biological theory of personality from which the RST is derived, 
Eysenck explained that differences in extroversion and neuroticism was due to 
differences in cortical arousal detected by EEG.  However, little research has 
investigated this area.  Of the research that is available, there are two key findings 
on the relationship between RST and EEG patterns.  Firstly, higher levels of left 
frontal activity are related to high BAS scores.  Secondly, high levels of activity in 
the right frontal areas of the brain are related to high BIS scores.  Looking 
specifically at the BAS scale, EEG patterns include frontal asymmetry in alpha 
activity and posterior versus frontal theta activity which in turn is linked to 
extraversion (Wacker, Chavanon, & Stemmler, 2010).  Furthermore, Gray and 
McNaughton (2000) understood that activation of BIS produces the theta rhythm.   
To our knowledge, no previous research has examined the RST in relation 
to EEG in an ADHD sample.  Although we know that ADHD presents with higher 
levels of BAS compared to typically developed peers (Mitchell & Nelson-Gray, 
2006; Barkley et al., 1990; Hundt et al., 2008), it is not known how high levels of 
BAS affects the ADHD brain.  Comparisons between a typically developed sample 
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and an ADHD sample will enable us to understand the effect ADHD has on the 
brain as well as on personality.   
3.1.3 Personality and Neurofeedback 
There is evidence to suggest that there are some treatments that can 
influence our personality, specifically neurofeedback (Peniston & Kulkosky, 
1990), although how it affects personality is unclear.   
Peniston and Kulkosky (1990) examined 20 people with alcohol 
dependency with 20 controls, using the Millon Clinical Multiaxial Inventory and 
Sixteen Personality Factor Questionnaire.   Participants underwent medical 
treatment or alpha-beta neurofeedback.  The neurofeedback condition saw a 
significant increase in personality warmth, abstract thinking, stability, 
conscientiousness, boldness, imaginativeness, and self-control, compared to the 
medical treatment who only saw am increase in concrete-thinking.   
However, Raymond, Varney, Parkinson, and Gruzelier (2005) did not 
support Peniston and Kulkosky (1990) results.  Raymond et al. (2005) allocated 12 
medical students to active or sham neurofeedback.  The neurofeedback consisted 
of eyes closed alpha frequency at Pz.  When high levels of alpha were produced, a 
babbling brook sound was heard.  Two sessions a week for 5 weeks were 
completed.  Prior and post neurofeedback, the Personality Syndrome 
Questionnaire was completed.  Results showed no significant difference on results 
between the active or sham neurofeedback.  This could be due to a small number 
of neurofeedback sessions or that personality is too robust to change. 
As seen here, there is very limited research examining the effect of 
neurofeedback on personality, with no research available in an ADHD or child 
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sample.  Further research is required to understand the implications of 
neurofeedback on personality.   
3.1.4 Personality and Stimulant Medication 
An individual’s response to particular medications can be affected by their 
personality.  Response to stimulant medication, namely d-amphetamine, has been 
found to depend on the individual's personality traits.  Corr and Kumari (2000) 
found that individuals low in psychoticism traits were more energetically aroused 
with reduced tense arousal when taking d-amphetamine.  This is compared to 
individuals high in psychoticism who became lowered in energetic arousal and 
increased in tense arousal.  In their study, it was found that other personality traits 
including novelty seeking and extraversion were not modified by d-amphetamine 
(Corr & Kumari, 2000).      
There is limited knowledge and research about the relationship between 
ADHD and personality, specifically EEG measures and the effect of treatment on 
this relationship. Although there is research showing the benefits of treatment on 
ADHD symptoms, it is unclear as to if and how it affects an individual’s 
personality.  This gap in previous literature hopes to be addressed through the 
research conducted here, enabling effective management of the condition without 
altering the person’s underlying personality.   
3.2 Aims of the Study 
 The present study aimed to examine the effect of neurofeedback and 
stimulant medication on personality in a typically developed and ADHD sample.  
As discussed in the literature review, little is known about the effect of these 
treatments on personality, in a child population and in an ADHD population.  If 
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neurofeedback was deemed to alter personality, it may deter individuals from 
wanting to implement such intervention. 
3.3 Hypothesis 
Based upon the previous research and the aims of the present study, the 
hypotheses for the pre-measures were as follows: 
• The ADHD sample would score more highly on the BAS and lower on the 
BIS personality scale than the typically developed sample. 
Based upon the previous research and the aims of the present study, the 
hypotheses for the post-measures were as follows: 
• The ADHD sample who received neurofeedback home training and 
medication would have the most changed personality, with lowered BAS 
and increased BIS results across all samples. 
• The typically developed sample, specifically the control and active control 
conditions, will notice no change on the BIS/BAS scale across time. 
3.4 Method 
For detail regarding participants and interventions, please see Chapter 2: 
General Methods.  
3.4.1 Personality Measures 
The present study used the BIS/BAS Personality Scale.  The measures were 
conducted on two occasions, once during the initial meeting prior to any 
intervention, and 15 weeks later once the interventions had been completed. 
The BIS/BAS Personality Scale consists of two scales, the Behavioural 
Inhibition Scale (BIS) and the Behavioural Activation Scale (BAS) and was 
devised by Carver and White (1994) based upon American undergraduate students.  
The BIS measures actions such as “I worry about making mistakes.”  The BAS 
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scale measures reward responsiveness, for example, “When I get something I 
want, I feel excited and energised”, as well as drive, for example “I go out of my 
way to get things I want”, and fun seeking behaviours, for example “I crave 
excitement and new sensations”.  The scale had been devised to be used in 
conjunction with the original RST.  The BIS/BAS scale is presented as a 
questionnaire with 24 statements.   
Participants were asked to rate how much they agree or disagree with each 
statement using a four-point scale and were told that there were no right or wrong 
answers.  Participants took as long as they needed to complete the questionnaire. 
3.5 Results 
 As the BIS/BAS scale was completed at 2 time points, pre-measures before 
any intervention and post-measures after any intervention, the results have been 
presented in this way. 
3.5.1 Results from BIS/BAS Pre-measures 
A multivariate analysis of variance (MANOVA) was conducted to examine 
the overall effect of diagnosis and gender on the BIS/BAS scale.  A MANOVA is 
an extension of an ANOVA, examining the statistical differences of two or more 
dependent variables.  Overall, there was no significant effect for gender F (5, 80) = 
0.056, p<0.72; Wilk’s = 0.96, or diagnosis, F (5, 80) = 0.806, p<0.54; Wilk’s = 
0.95.   
T-tests were conducted to assess any statistical differences between the 
typically developed sample and ADHD sample (Table 2). 
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Table 2. 
Descriptive statistics and T-test results of pre-measure dependent variables on 
independent variable, diagnosis 
 
On the BIS/BAS scale, the scores between the ADHD and typically developed 
sample were not too dissimilar, specifically not significantly different.   
A Pearson correlation coefficient was then computed to assess the relationship 
between the independent variables and age across the two samples.  
Table 3. 
Pearson Product Moment correlations for dependent variables and age on the typically 
developed sample 
  N Pearson Correlation 
Strength of 
relationship Sig 
BIS 48 0.19 Weak positive 0.18 
BAS Drive 48 0.15 Weak positive 0.29 
BAS Fun Seeking 48 0.39 Moderate positive 0.006 
BAS Reward Responsiveness 48 0.22 Weak positive 0.13 
 
 As shown above, age had a significantly positive correlation on BAS fun 
seeking in the typically developed sample.   
 
 
  Typically Developed Sample ADHD Sample       
  N Mean SD N Mean SD t df 
Sig. 
(2-
tailed) 
BIS 48 14.92 3.19 39 14.87 2.86 0.74 85 0.94 
BAS Drive 48 7.97 2.59 39 8.89 2.92 -1.53 85 0.12 
BAS Fun Seeking 48 6.97 2.00 39 7.27 1.72 -0.74 85 0.46 
BAS Reward 
Responsiveness 48 7.53 2.47 39 7.35 1.8 0.39 85 0.69 
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Table 4. 
Pearson Product Moment correlations for dependent variables and age on the ADHD 
sample 
  N Pearson Correlation 
Strength of 
Relationship Sig 
BIS 39 0.28 Weak positive 0.07 
BAS Drive 39 0.32 Moderate positive 0.04 
BAS Fun Seeking 39 0.19 Weak positive 0.23 
BAS Reward Responsiveness 39 0.43 Moderate positive 0.006 
 
As shown above, age had a significantly positive correlation on BAS drive and 
BAS reward responsiveness in the ADHD sample.   
3.5.2 Results from BIS/BAS Post-measures 
A MANOVA was conducted to assess how diagnosis and gender combined 
affect the overall post measures.  Overall, there was no significant effect of the 
BIS/BAS scale on post measures (gender F (4, 68) = 0.73, p<0.57; Wilk’s = 0.95; 
diagnosis F (4, 68) = 1.24, p<0.31; Wilk’s = 0.93).   
T-tests were then conducted to assess any statistical differences between the 
typically developed sample and the ADHD sample across all of the dependent variables 
at the second-time point, post measures (Table 5). 
Table 5. 
T-test results of post measure dependent variables on independent variable, diagnosis  
  
 
Typically 
Developed Sample 
ADHD Sample 
  
  N Mean SD  N Mean SD t  df  Sig. (2-
tailed) 
BIS 41 15.83 3.43 34 16.5 4.14 0.73 73 0.46 
BAS Drive 41 9.24 2.89 34 8.11 3.03 -1.64 73 0.11 
BAS Fun Seeking 41 9.58 12.13 34 7.02 1.6 -1.21 74 0.22 
BAS Reward Responsiveness 41 8.31 5.02 34 7.67 2.39 -0.67 74 0.51 
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A Pearson correlation coefficient was then computed to assess the relationship 
between the independent variables and age at the post measures time point (Table 6 and  
7).  
Table 6. 
Pearson - product moment correlations for dependent variables and age on the 
typically developed sample for post measures 
  N Pearson Correlation 
Strength of 
correlation Sig 
BIS 42 0.005 No relationship 0.97 
BAS Drive 42 0.05 No relationship 0.72 
BAS Fun Seeking 42 -0.03 No relationship 0.81 
BAS Reward Responsiveness 42 -0.06 No relationship 0.69 
 
Table 7. 
Pearson - product moment correlations for dependent variables and age on the ADHD 
sample for post measures 
  N Pearson Correlation 
Strength of 
correlation Sig 
BIS 34 -0.06 No relationship 0.71 
BAS Drive 34 0.26 No relationship 0.12 
BAS Fun Seeking 34 0.32 Weak positive 0.06 
BAS Reward Responsiveness 34 0.52 Moderate positive 0.001 
 
As Table 6 and 7 show, age had no correlation on the post measures in the 
typically developed sample, but had a significantly positive correlation on BAS reward 
responsiveness in the ADHD sample.   
3.5.3 Results Comparing Pre to Post BIS/BAS Measures 
A repeated MANOVA was then conducted to examine the overall effect of pre-
to post BIS/BAS across all measures (Table 8).  This indicated if there were any overall 
significant effects that therefore needed examining in more detail. 
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Table 8. 
Repeated MANOVA, pre-to post across typically developed and ADHD sample 
 
Table 8 shows across the two time points, there was no significant effect of 
gender and diagnosis on the ADHD sample.  Furthermore, a repeated measures 
multivariate ANOVA with a Bonferroni correction was conducted to examine the 
significant difference between the BIS/BAS Scale and the study conditions.  No 
significant differences were found. 
A paired t-test was then conducted to compare the independent variables from 
the first time point, pre measures, to after any intervention, post measures. 
Table 9. 
Paired T-test results of pre-to post measure dependent variables  
  Mean Difference SD t  df  
Sig. (2-
tailed) 
BIS -1.22 3.87 -2.74 75 0.009a 
BAS Drive -0.09 2.62 -0.31 75 0.75 
BAS Fun Seeking -1.21 9.28 -1.13 75 0.26 
BAS Reward Responsiveness -0.99 9.48 -0.92 75 0.35 
a Significant after Bonferroni correction.  Calculation of 0.05/4=0.012 
 
As Table 9 shows, there was a significant main effect of diagnosis on the 
dependent variables on the BIS scale.  This was examined further by looking at the two 
samples independently (Table 10 and 11). 
 
 
  Pre to Post Gender Diagnosis 
  Mean F Sig. Mean F Sig. Mean F Sig. 
BIS 42.76 5.84 0.02 0.91 0.12 0.72 3.53 0.48 0.49 
BAS Drive 0.201 0.06 0.81 3.48 0.99 0.32 0.22 0.06 0.79 
BAS Fun Seeking 0.43 0.01 0.92 69.05 1.58 0.21 23.2 0.53 0.47 
BAS Reward Responsiveness 111.42 0.11 0.76 2858 2.46 0.12 283.5 0.24 0.62 
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Table 10. 
Paired T-test results of pre-to post measure dependent variables on typically developed 
sample  
  Mean Difference SD t  df  
Sig. (2-
tailed) 
BIS -0.85 3.28 -1.66 41 0.103 
BAS Drive -0.09 2.46 -0.25 41 0.79 
BAS Fun Seeking -2.27 12.35 -1.19 41 0.24 
BAS Reward Responsiveness -0.92 5.22 -1.15 41 0.25 
 
Table 11. 
Paired T-test results of pre to post measure dependent variables on ADHD sample 
  Mean Difference SD t  df  
Sig. (2-
tailed) 
BIS -1.67 4.49 -2.17 33 0.03 
BAS Drive -0.08 2.84 -0.18 33 0.85 
BAS Fun Seeking 0.11 1.68 0.407 33 0.68 
BAS Reward Responsiveness -0.17 1.86 -0.55 33 0.58 
a Significant after Bonferroni correction.  Calculation of 0.05/4=0.012 
 
There were no significant differences from pre-to post on the typically 
developed BIS/BAS scale.  However, there was a significant difference on pre-to post 
on BIS in ADHD conditions, although this was not significant once Bonferroni 
correction was applied. 
 Table 12 demonstrates the absolute mean change scores across several measures 
from pre to post intervention.   
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Table 12. 
Descriptive statistics Absolute Mean Change Scores from pre to post measures 
 
T-test of dependent 
variables on diagnosis 
Pearson Product 
correlation of age 
  
Typically 
developed 
sample 
ADHD 
sample 
Typically 
developed 
sample 
ADHD 
sample 
BIS 0.91 1.63 -0.185 -0.34 
BAS Drive 1.27 -0.78 -0.1 -0.06 
BAS Fun Seeking 2.61 -0.25 -0.42 0.13 
BAS Reward Responsiveness 0.78 0.32 -0.28 0.09 
 
Paired t-tests were then conducted on each condition, comparing pre-to post 
measures on all the dependent variables (Table 13 to Table 19).  This examined the 
main effect of intervention on the dependent variables.   
Table 13. 
Repeated measures t-test from pre-to-post-test differences in the various measures for 
the typically developed sample neurofeedback condition 
  Neurofeedback 
  Mean SD t d 
Sig. 
(2-
tailed) 
Cohen's 
d 
95% 
Confidence 
Interval 
Lower 
95% 
Confidence 
Interval 
Upper 
BIS -0.77 3.75 -0.74 12 0.47 -0.21 -1.94 1.78 
BAS Drive 0.54 2.11 0.92 12 0.37 0.26 -0.14 1.98 
BAS Fun Seeking -0.69 1.71 -1.47 12 0.17 0.17 -1.68 0.51 
BAS Reward Responsiveness -1.15 2.38 -1.75 12 0.11 0.11 -1.32 0.65 
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Table 14. 
Repeated measures t-test from pre-to-post-test differences in the various measures for 
the typically developed sample control condition 
  Control 
  Mean SD t d 
Sig. 
(2-
tailed) 
Cohen's 
d 
95% 
Confidence 
Interval 
Lower 
95% 
Confidence 
Interval 
Upper 
BIS -1 3.38 -1.15 14 0.27 -0.31 -2.9 0.87 
BAS Drive -0.93 3.13 -1.16 14 0.27 -0.31 -2.7 0.79 
BAS Fun Seeking 0.13 2.03 0.25 14 0.79 0.06 -1.11 1.25 
BAS Reward Responsiveness 0.6 2.69 0.86 14 0.39 0.22 -0.9 1.58 
 
Table 15. 
Repeated measures t-test from pre-post-test differences in the various measures for the 
typically developed sample active control condition 
 
Table 16. 
Repeated measures t-test from pre-post-test differences in the various measures for the 
ADHD sample medication condition 
  Medication 
  Mean SD t d 
Sig. 
(2-
tailed) 
Cohen's 
d 
95% 
Confidence 
Interval 
Lower 
95% 
Confidence 
Interval 
Upper 
BIS -1.58 5.24 -1.31 18 0.21 -0.3 -4.11 0.94 
BAS Drive 0.11 3.09 0.15 18 0.88 0.04 -1.38 1.59 
BAS Fun Seeking 0.05 1.43 0.16 18 0.87 0.03 -0.63 74 
BAS Reward Responsiveness 0.26 1.56 0.74 18 0.47 0.17 -1.02 0.71 
 
 
 
  Active Control 
  Mean SD t d 
Sig. 
(2-
tailed) 
Cohen's 
d 
95% 
Confidence 
Interval 
Lower 
95% 
Confidence 
Interval 
Upper 
BIS -1.37 3.58 -1.43 13 0.18 -0.38 -3.43 0.69 
BAS Drive -0.08 2.01 -0.14 13 0.89 -0.04 -1.23 1.08 
BAS Fun Seeking -6.04 20.4 -1.15 14 0.27 -0.29 -17.3 5.27 
BAS Reward Responsiveness -6.17 20.5 -1.17 14 0.26 -0.29 -7.23 1.89 
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Table 17. 
 Repeated measures t-test from pre-post-test differences in the various measures for the 
ADHD sample medication and neurofeedback home training condition 
Table 18. 
 Repeated measures t-test from pre-post-test differences in the various measures for the 
ADHD sample medication and neurofeedback clinic training condition 
 
Table 19. 
Repeated measures t-test from pre-post-test differences in the various measures for the 
ADHD sample medication and neurofeedback home training condition 
  Neurofeedback Home Training 
  Mean SD t d 
Sig. 
(2-
tailed) 
Cohen's 
d 
95% 
Confidence 
Interval 
Lower 
95% 
Confidence 
Interval 
Upper 
BIS -4.11 4.36 -1.59 2 0.25 -0.9 -14.8 6.82 
BAS Drive 0.33 2.31 0.25 2 0.83 0.14 -5.41 6.07 
BAS Fun Seeking 0.67 2.08 0.55 2 0.63 0.32 -4.51 5.83 
BAS Reward Responsiveness 3.12 6.08 0.85 2 0.48 0.49 0.88 3.46 
 
As Table 13 to 19 show, there was no significant difference between conditions from 
pre to post measures.  Although there were no significant changes, there were 
differences in absolute change scores.
  Medication and Neurofeedback Home Training 
  Mean SD t d 
Sig. 
(2-
tailed) 
Cohen's 
d 
95% 
Confidence 
Interval 
Lower 
95% 
Confidence 
Interval 
Upper 
BIS -0.86 2.12 -1.07 6 0.32 -0.4 -2.81 1.09 
BAS Drive -0.43 2.37 -0.48 6 0.65 -0.2 -2.62 1.76 
BAS Fun Seeking -0.57 1.81 -0.83 6 0.44 -0.3 -2.24 1.11 
BAS Reward Responsiveness -0.29 2.29 -0.33 6 0.75 -0.1 -2.02 2.31 
  Medication and Neurofeedback Clinic Training 
  Mean SD t d 
Sig. 
(2-
tailed) 
Cohen's 
d 
95% 
Confidence 
Interval 
Lower 
95% 
Confidence 
Interval 
Upper 
BIS 0 2.71 0 3 1 0 -0.129 4.31 
BAS Drive 0.25 3.33 0.15 3 0.89 0.01 -5.09 5.51 
BAS Fun Seeking 1.75 1.71 2.05 3 0.13 1.02 -0.96 4.46 
BAS Reward Responsiveness 0.25 0.95 0.52 3 0.63 0.26 1.27 1.77 
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Table 20. 
Descriptive statistics absolute mean change scores and t-test from pre-post-test differences in the various measures for the typically developed 
sample under the difference conditions 
 
 Table 20 shows that the largest and most amount of absolute change scores were in the active control condition, apart from the BAS drive 
which had the largest absolute change score in the control condition.  
 
 
 
 
 
  Neurofeedback Control Active Control 
  Pre Mean 
Post 
Mean 
Absolute 
Change 
Score 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
BIS 13.81 14.85 1.03 15.13 16.13 1.00 15.27 16.81 1.53 
BAS Drive 8.38 8.15 -0.22 8.81 9.73 0.93 9.73 10.01 0.27 
BAS Fun Seeking 6.75 7.62 0.87 7.87 7.73 -0.13 7.21 13.24 6.04 
BAS Reward Responsiveness 6.44 7.08 0.64 8.33 8.01 -0.33 7.07 9.74 2.67 
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Table 21. 
Descriptive statistics absolute mean change scores and t-test from pre-post-test differences in the various measures for the ADHD sample under 
the difference conditions 
 
Table 21 shows the largest increase in absolute change was in the BIS scale.  As expected, BAS drive decreased in the ADHD 
medication condition, medication and neurofeedback in clinic, and neurofeedback home training.  On the other hand, in the neurofeedback home 
training and medication condition, there was a slight increase on the BAS drive scale.
  Medication Medication and 
Neurofeedback Home 
Training 
Medication and 
Neurofeedback Clinic 
Neurofeedback Home 
Training 
 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
  
BIS 14.84 16.42 1.58 14.88 15.71 0.84 16.25 16.25 0.00 14.00 18.00 4.00 
BAS Drive 7.79 7.68 -0.11 8.50 8.57 0.07 8.50 8.25 -0.25 8.33 8.00 -0.33 
BAS Fun Seeking 7.00 6.95 -0.05 7.00 7.71 0.71 7.50 5.75 -1.75 7.00 6.33 -0.67 
BAS Reward Responsiveness 7.21 7.37 0.16 7.50 7.29 -0.21 8.25 8.00 -0.25 9.33 9.67 0.33 
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3.6 Discussion 
The present study investigated the difference in personality profiles between 
typically developed children and children with a diagnosis of ADHD.  
Comparisons took place between the two samples both pre and post interventions 
to examine the most effective strategy to improve inattention and impulsive 
behaviours.  We shall look at the main findings from both prior and post 
intervention in turn in relation to previous literature. 
3.6.1 Discussion Regarding Pre Measures 
Based upon previous literature, it was hypothesized that the ADHD sample 
would show higher levels of the Behavioural Activation System and lower levels 
of the Behavioural Inhibition System (Barkley et al., 1990; Hundt, 2008).  There 
was no significant difference on the BIS/BAS scales between the ADHD and 
typically developed sample.  The research presented in this thesis showed the 
ADHD sample having higher levels of BAS drive and BAS fun seeking behaviours 
and less BIS than the typically developed sample, although this was not 
significantly different.   
One possible explanation for the lack of significant difference between the 
samples is that the BIS/BAS questionnaire was not child friendly, particularly for 
younger individuals in the samples.  For example, the wording of the BIS question 
“criticism or scolding hurts me quite a bit” may not be understood by a seven-year-
old.  The fact that there was a significant effect of age on the BIS/BAS scale may 
explain that the older children understood the questions and answered more 
appropriately.  
Based upon the researcher’s clinical experience, it is suggested that the 
ADHD population may not have been a typical sample due to recruitment taking 
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place from a private clinic setting.  The clinic was based in an affluent area and 
participants had to pay to access the Centre, consequently being in a financial 
position to afford assessment.  Furthermore, individuals accessing the Centre were 
typically previously turned away from the National Health Service due to not 
meeting their criteria level.  This may account for there not being a significant 
difference between the two samples as expected.    
The research in this thesis found a significant effect of age, specifically a 
moderate positive correlation between BAS fun seeking and age in the typically 
developed sample, and a moderate positive correlation between BAS drive, BAS 
reward responsiveness and age in the ADHD sample.  This therefore supports that 
personality changes with age and supports Pagliaccio et al. (2016) who showed 
positive associations of BIS/BAS across early development, peaking in young 
adulthood and declining in later adulthood (Pagliaccio et al., 2016).   
3.6.2 Discussion Regarding Post Measures 
Based upon the previous research and the aims of the present study, the 
hypotheses for the post-measures were as follows: 
• The ADHD sample who received neurofeedback home training and 
medication would have the most changed personality, with lowered BAS 
and increased BIS results across all samples. 
• The typically developed sample, specifically the control and active control 
conditions, will notice no change on the BIS/BAS scale across time. 
In the typically developed sample, the BIS/BAS scores increased, although 
not significantly, across time and interventions.  This trend towards higher 
BIS/BAS scores over time albeit not statistically significant is in the same 
direction as findings by Urosevic et al. (2012).  As the sample in the present study 
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was only to the age of 17, it did not find a decline in any scales which would have 
been expected when entering adulthood.   
However, the finding of BIS/BAS scores increasing with age was not 
replicated in the ADHD sample.  This could suggest that personality in an ADHD 
sample may not develop in the same way as a typically developed population.  The 
developmental deviation and maturation lag theory would support this, showing 
that the ADHD brain is abnormal at all developmental stages (Kinsbourne, 1973; 
Barry, Clarke, & Johnstone, 2003).   
As found in the pre measure results, the post measures also saw a 
significant effect of age on the ADHD sample on the BAS reward responsiveness 
scale.  These findings support previous research where it is suggested that an 
increase in risk taking is seen in adolescence, consequently linked to an increase in 
reward responsiveness (Pagliaccio et al., 2016).    
Somewhat of an unexpected finding was that the most changes in the 
typically developed sample was seen in the active control condition.  Specifically, 
the active control condition in the typically developed sample saw a rise in BIS, 
BAS fun seeking and BAS reward responsiveness, although this was not a 
significant difference.  It has been suggested that video gaming can alter neural 
plasticity as gaming requires an individual to process complex events in a specific 
sequence as well as to respond quickly and rapidly (Gong et al., 2015).   This trend 
which though not significant may suggest that sitting and focusing on a computer-
based programme could influence a child’s personality, specifically seeking 
reward and positive feeling through a heightened BAS, but also a heightened BIS 
which can cause anxiety disorders (Carver & White, 1994).  The research area of 
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computer use is growing due to the vast development of technology and its use in 
our everyday lives.   
Whereas the active control condition in the typically developed sample saw 
an increase in many of the BIS/BAS subscales, the ADHD sample mainly saw a 
decrease.  Based upon previous research, it was hypothesised that the ADHD 
sample who received neurofeedback home training and medication will have the 
most changes in personality by lowered BAS and increased BIS results across all 
samples compared pre to post measures.  Results from the present study showed 
that the medication and neurofeedback clinic condition in the ADHD sample saw 
the largest change in absolute mean scores, with a decrease in BAS fun seeking 
and BAS reward responsiveness.   
There have been very few studies which have examined the effect of 
stimulant medication on personality, with one study showing that individuals 
taking d-amphetamine became more energetic and aroused (Corr & Kumari, 
2000).  However, it is known that stimulant medication in an ADHD population 
can reduce impulsivity, disruptiveness, talking out of turn and restlessness 
(Whalen, Henker, & Granger, 1990).  Similarly, there are few studies examining 
neurofeedback and personality.  The evidence that is available showed an increase 
in conscientiousness, boldness and imaginativeness (Peniston & Kulkosky, 1990).  
When neurofeedback in clinic and stimulant medication were combined, a non-
statistically significant trend was found showing a decrease in BAS fun seeking 
and BAS reward responsiveness.  This was an expected finding in the 
neurofeedback home training and medication condition, but was discovered in the 
neurofeedback clinic training and medication condition.  This suggests that the role 
of the clinician is more important than previously anticipated.  This could be due 
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to several reasons.  Firstly, the clinician can ensure that the equipment is set up and 
being used correctly.  Secondly, the clinician is able to provide immediate verbal 
feedback and reinforcement to continue participation.   
However, the expectation of increased BIS post intervention was not found 
in the neurofeedback home training and medication condition.  Instead, this was 
found in the neurofeedback home training condition, in addition to a decrease in 
BAS drive.   
Although there were no significant results within the present research, null 
results are important findings.  Null findings can inform researchers of what 
should be examined differently in future research.  Furthermore, the null results 
can inform policy and practice for implementing strategies (Miller-Halegoua, 
2017).  For example, the null results within this research would suggest that 
neurofeedback home training is not an effective strategy for treating the 
personality aspect of impulsivity in childhood ADHD. 
This research suggests that neurofeedback may (or could) influence 
personality, although not significantly.  In a typically developed child population, 
neurofeedback home training had very little effect on personality, with a slight 
increase in BIS, BAS fun seeking and BAS reward responsiveness.  However, 
these changes were less than the other conditions in this sample.  Participating in a 
computer-based learning activity saw the largest change in personality in a 
typically developed sample.    
In the ADHD sample, the neurofeedback home training condition saw the 
largest changes in personality, specifically an increase in BIS and decrease in BAS 
drive.  Although the findings were not significant, this is the first research to 
examine the effect of neurofeedback in a child population on personality.  This 
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therefore supports Peniston and Kulkosky (1990) that neurofeedback can influence 
personality. 
The lack of significant findings could be Type II error due to small sample 
sizes.  Additionally, as the present study is a feasibility study with small samples, 
findings are treated as tentative for implications, and need to be replicated in a 
larger sample. 
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4 Study Two: Effects of Neurofeedback on Neuropsychometric Measures  
4.1 Introduction  
Currently, there is no single medical laboratory test to assess for ADHD 
(Hamed, Kauer, & Stevens 2015).  There are several tools available, including 
rating scales, Continuous Performance Tests (CPT), and neuroimaging, that can be 
used to aid the diagnostic process for ADHD as well as evaluate the effectiveness 
of any treatment that has been implemented.  Methods such as the CPT are 
important tools to overcome rater bias and ensure thorough and reliable 
assessments (Edwards et al., 2007).   The role of CPTs and rating scales within the 
assessment and management of ADHD will be discussed in this chapter. 
4.1.1 Continuous Performance Tests 
The term CPT is used in conjunction with any performance test that 
measures sustained attention (Reynolds, Lowe, Moore, & Riccio, 1999).  
Typically, CPTs are a vigilance task of stimuli in quick succession on a computer 
screen for a fixed period of time, requiring the participant to be attentive and 
respond to specific stimuli (Edwards et al., 2007).  CPTs measure the amount of 
omission errors (failure to identify a target stimuli), commission errors (identifying 
a non-target), and response time.  CPTs are simple, fairly long and produce low 
levels of interest to measure the extent of the individual’s ability to sustain 
attention (Preston et al., 2005) and are cognitively demanding (Ballard, 1996).  
CPTs are computer based tests ensuring a standardised procedure, reducing bias 
opinions from experimenters and professionals (McGee et al., 2000).  Overall, 
literature suggests that CPTs are a useful tool and can screen individuals with 
various difficulties (Epstein, Conners, Sitarenios, & Erhardt, 2010; Conners, 
2004).  However, the underlying processes and what exactly CPTs measure is still 
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up for debate (Edwards et al., 2007, McGee et al., 2000).  The role of CPTs and its 
use in an ADHD population will now be discussed in more detail. 
4.1.2 Continuous Performance Tests and ADHD 
CPTs are particularly useful in examining the main symptoms associated 
with ADHD and to measure improvement (Epstein et al., 2010).  The key 
measures of CPTs, omission errors and commission errors, are direct measures of 
the key symptoms of ADHD.  For example, high levels of omission errors in CPTs 
suggest that the individual is not responding to the stimuli or that they have a slow 
response.  Usually, slow response time occurring with many errors reflects 
inattention whereas fast response time with lots of commission errors reflects 
impulsivity, both of which are the main symptoms of ADHD (Conners, 2004).   
There are three CPTs available which are marketed for clinical use, namely 
Conners’ Continuous Performance Test (CPT; Conners, 1995), Gordon Diagnostic 
System Vigilance Task (GDS: Gordon, 1988) and the Test of Variables of 
Attention (TOVA; Dupuy & Greenberg, 1993).  These will be discussed in turn, in 
relation to their use in ADHD as well as the theory behind the tool. 
4.1.2.1 Conners’ CPT 
The Conners’ CPT is a computerised visual-motor task whereby 
participants hit the space bar when presented with any letter except for the letter 
“X” and therefore respond to both targets and non-targets (Conners, 2004).  The 
task requires rapid letter identification skills, a potential confounding variable if 
the participant has a specific learning difficulty, and consequently makes it 
difficult to ascertain if results are due to inhibition deficits (McGee et al., 2000).  
Stimuli is presented every 2 or 4 seconds, taking approximately 14 minutes to 
complete and suitable for individuals over the age of 6 years old.  The programme 
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contains a large database, consisting of 2,686 clinical and non-clinical individual’s 
performances, 446 of which were school aged; approximately 50% of the 
population were male and 50% female.  Forty-seven percent of the normative 
sample consisted of white ethnicity, 27% of black ethnicity, 4.6% Asian and 
21.4% other.  This specific programme, which is accessible to most clinicians, is 
standardised with norms for children up to the age of 17 (Conners, 1995).  
Research suggests that the Conners’ CPT can successfully identify children with 
ADHD 52% of the time (Epstein et al., 2010).   
The Conners’ CPT is based upon Barkley’s (1997) Behavioural Response 
Inhibition Theory of ADHD.  Specifically, it assesses concentration for a duration 
of time but also the ability to inhibit responses to stimuli.  Commission errors 
reflects impulsivity and omission errors reflects inattention, both of which are 
linked to abilities in executive functions (Barkley, 1997).  Barkley (1997) stated 
that ADHD inattentive subtype is a distinct disorder rather than a subtype of 
ADHD.  Consequently, the Conners’ CPT may not be able to differentiate between 
subtypes, due to the differing presentation (Edwards et al., 2007).  Commission 
errors were significantly related to 13 of the 18 diagnostic ADHD symptoms.  A 
slowed response time over the duration of the CPT is related to four of the 
hyperactive-impulsive ADHD symptoms (Epstein et al., 2003).  Usually, slow 
response time occurring with many errors reflects inattention whereas fast 
response time with lots of commission errors reflects impulsivity, both of which 
are the main symptoms of ADHD. 
It has been suggested by McGee et al. (2000) that the Conners’ CPT is able 
to identify individuals with ADHD, although is unable to distinguish between 
subtypes.  McGee et al. (2000) came to this conclusion after conducting the 
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Conners’ CPT, Auditory CPT and Conners’ Rating Scale in 100 children aged 6 to 
11 years old.  Forty of the children had a diagnosis of ADHD, fourteen had reading 
disorders, a further 14 had ADHD and reading disorders, and 32 were controls.  
Conners’ CPT was not correlated with age, showing appropriate age relative 
normalising. The only gender difference was that boys made more commission 
errors, but this was not a robust finding.  There was no association found between 
Conners’ CPT and parent teacher rating.  However, Conners’ CPT omission errors 
were moderately associated with teacher rating of hyperactivity.  This 
demonstrates that Conners’ CPT is sensitive to teachers rating of behaviour but 
only when there are high levels of behaviour disturbance.   
No gender difference has been found in Conners’ CPT results (Gianarris, 
Golden & Greene, 2001).  Epstein et al. (2003) administered the Conners’ CPT to 
817 children, 21 of which met the diagnostic criteria for ADHD as well as 
interviewing the parents using the Child and Adolescent Psychiatric Assessment.  
The study found a relationship between neuropsychological task and ADHD.  
Specifically, CPT scales showed relationships with ADHD symptom clusters.  
However, CPT subscale mean hit response time related to ADHD as a whole, 
rather than symptom clusters.  Overall, it showed that omission errors measured 
inattention and commission errors measured impulsivity.   
There is now growing acceptance that ADHD is a disorder seen in 
adulthood and consequently the use of CPTs in an ADHD adult population needs 
to be understood (Epstein et al., 2010).  One study examined the Conners’ CPT in 
95 adults.  Thirty adults without a diagnosis, 26 with ADHD, 17 with a psychiatric 
disorder and 22 with various cognitive deficits completed the CPT.  The ADHD 
group made more omission errors, had longer response times and greater 
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variability in responses.  However, these differences were not significantly 
different to the other conditions (Advokat, Martino, Hill & Gouvier, 2007).  
In another adult population, Epstein et al. (2010) examined sixty adults 
who were referred for an ADHD assessment using a semi-structured interview and 
underwent Conners’ CPT.  Thirty-nine participants fulfilled the diagnosis of 
ADHD inattentive subtype, 7 for ADHD hyperactive-impulsive subtype and 14 
ADHD combined subtype.  They were compared to 72 healthy controls.  Findings 
showed that adults with ADHD showed significant impairment on Conners’ CPT, 
consistent with findings among children with ADHD.  Specifically, the ADHD 
adult sample showed increased omission and commission errors and decreased 
reaction times, supporting an impulsive presentation. 
4.1.2.2 Test of Variable Attention 
The Test of Variable Attention (TOVA) is a computer test that assesses 
attention and impulse control.  It specifically measures four areas: response time 
variability, response time, impulse control (commission errors) and inattention 
(omission errors).  The test comprises of a blank square with a smaller square 
placed inside, either at the top or bottom of the outer square.  The inner square at 
the top of the outer square is the target.  The TOVA presents 22.5% targets and 
77.5% non-targets for half the test, and vice-versa for the remaining half of the test 
(Dupuy & Greenberg, 1993).  The TOVA has standardised norms for 4 to 80 years 
old and takes 21 minutes to complete.  The TOVA had mixed results in 
successfully identifying ADHD.  It has found to misidentify as many as 35% of 
individuals without ADHD (Edwards et al., 2007).  A study by Preston et al. 
(2005) used the TOVA to examine the ability of individuals with ADHD and 
possible subclinical levels of behaviour.  One hundred and sixteen children with 
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ADHD and 51 children in a subclinical control group completed the SNAP parent 
and teacher questionnaires, TOVA CPT and a structured interview.  It was 
concluded that the TOVA scores were unable to determine severity of symptoms 
and therefore its use was questioned.  Consequently, a diagnosis should not be 
made primarily on the results of a CPT performance and this particular study felt 
that this CPT tool did little to aid a diagnosis.  However, this tool may still be 
effective in a research capacity, but less accurate in identifying those at high risk 
with subclinical levels of symptoms of ADHD.  Furthermore, it was noted that the 
TOVA is a difficult task for young children who are sometimes unable to complete 
the task (Preston et al., 2005).      
4.1.2.3 Gordon Diagnostic System Vigilance Task 
The final tool available marketed as a clinical tool to assess for ADHD is 
the Gordon Diagnostic System Vigilance Task (GDS; Gordon, 1986).  This CPT 
consists of 10% targets and 90% non-targets.  This is known as the rare target 
paradigm.  The CPT is presented as two tasks.  Initially, vigilance, where the 
participant presses when they see a specific sequence of numbers, and secondly, 
distractibility, where the same task is presented but with other numbers appearing 
elsewhere on the screen.  Here, participants need the ability to accurately attend to 
changing stimuli and respond to targets which are infrequent.  The GDS is 
understood to assess sustained attention.  However, this tool lacks evidence in 
consistently identifying individuals with ADHD (Edwards et al., 2007). 
Carlozzi and Horner (2007) investigated the use of the Gordon Diagnostic 
System Vigilance Task in an adult population and its use of measuring attention.  
The study failed to find any differences on the test of attention and non-attention, 
therefore questioning the use of this tool.   
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As previously discussed, ADHD is a condition which affects more males 
than females (Vernon et al., 2004).  Therefore, gender is a variable that needs to be 
considered.  In a meta-analysis by Hasson et al. (2012) a small but significant 
difference was found between genders on CPT commission errors but was not 
replicated in omission errors.  Specifically, boys made more commission errors 
and females made more omission errors, although this latter result was not 
significant.  This suggests that gender may influence inhibitory control, but also 
low numbers of girls are referred for assessment, and those that are, are typically 
due to inattentive rather than hyperactive concerns.  Similarly, the difference 
between the male and female populations was also replicated in a typically 
developed child sample (Hasson & Fine, 2012).   
Despite its use, CPTs do have limitations.  For example, there are low 
correlations between CPT results and direct classroom observations, omission 
scores only moderately correlated to rating scales (Gordon, 1988), failure to find 
group differences (Schachar, Logan, Wachsmuth, & Chajczyk, 1988), lack of 
ecological validity (Barkley, 1991), and lacks the ability to differentiate between 
comorbidities and the subtypes of ADHD (Reynolds et al., 1999). 
4.1.3 Rating Scales for ADHD 
Another tool available to assist an assessment of ADHD are rating scales.  
Rating scales are often used in conjunction with parents and teachers to assess the 
extent of the individual’s difficulties in various situations.  Rating scales can be 
useful during an assessment for ADHD but are not diagnostic when used on their 
own (Fonseca et al., 2006).  There are many rating scales available, a few of which 
will be discussed here. 
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4.1.3.1 Child Behaviour Checklist 
One scale is the Child Behaviour Checklist (CBCL).  This scale is for 
children aged 6 to 18 years old and comprises of a 3-point Likert rating scale, 
namely: not true, somewhat or sometimes true, or very true.  The form is 
completed by parents and consists of 113 items.  There are two overarching scales: 
internalizing problems and externalising problems.  These scales are further 
broken down into the following eight areas: aggressive behaviour, 
anxious/depressed, attention problems, rule-breaking behaviour, somatic 
complaints, social problems, thought problems, withdrawn/depressed.  The 
questionnaire scores a wide range of childhood behaviour difficulties including 
hyperactivity.  Additionally, there is a version for teachers (CBCL-TRF), (Miller, 
Fee, & Netterville, 2004).   Biedermann et al. (2001) examined the Child 
Behaviour Checklist in a longitudinal study in an ADHD population.  One hundred 
and forty males with ADHD and a further one hundred and twenty healthy males, 
aged 6 to 17 years old, completed the CBCL and a clinical interview.  This was 
completed again 4 years later.  Results showed high levels of emotional 
functioning in the ADHD population, with stability of scores over time.  Results 
support the use of the CBCL as a longitudinal measure in an ADHD sample as 
well as an effective instrument in the assessment of ADHD (Biedermann et al., 
2001). 
4.1.3.2 Conners’ 3 Parent Rating Scale 
An alternative rating scale is the Conners’ 3 Parent Rating Scale.  This tool 
comprises of 101 items on a 4-point scale: not true at all, just a little true, pretty 
much true, and very much true.  It measures inattention, hyperactive/impulsivity, 
learning difficulties, executive function, defiance, and peer relations; each measure 
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has several statements for the parents to answer.  The primary aim of the form is to 
gather information about the behaviours and feelings of the child.  The Conners’ 
Parent Rating Scale is designed to be brief, easy to score, and to administer 
(Conners, 2004) and said to be a reliable and valid tool in assessing 
neurobiological disorders but is unable to clearly define different disorders.  The 
Conners’ Parent Rating Scale is said to be a reliable and valid tool in assessing 
neurobiological disorders but is unable to clearly define different disorders 
(Gianarris, Golden, & Greene, 2001).   
One study by Snyder et al. (2008) used the Conners’ Parent Rating Scale 
(CPRS) in combination with EEGs to identify ADHD.  One hundred and one 
males and fifty eight females, of which 97 were diagnosed with ADHD, aged 6 to 
18 years old with attention and behaviour difficulties took part.  Semi-structured 
interview, theta/beta ratio using a 19 lead electrode cap and Conners’ Rating 
Scales were completed.  Results showed that CPRS had between 47 – 58% 
accuracy at identifying ADHD compared to EEG that had an accuracy rate of 89%.  
The cause for the lower accuracy in CPRS was likely due to informant bias.  There 
was low agreement between parent and teacher ratings, with a 64% agreement on 
the Conners’ Rating Scale.  Other studies found CPRS accuracy as high as 93% 
and 85% for teachers; however, other comorbidities were not correctly identified 
(Snyder et al., 2008; Conners 2008; Gianarris et al., 2001).    
In addition to the Conners’ 3 Parent Rating Scale, the Conners’ 3 Teacher 
Rating Scale is also available; this is of similar format and purpose to the Parent 
Rating Scale.  The Conners’ 3 Teacher Rating Scale consists of 115 items rated on 
a 4-point scale measuring inattention, hyperactive/impulsivity, learning 
difficulties, executive function, defiance, and peer relations.  The teacher’s 
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perspective is important as difficulties need to be present in two settings in order 
for a diagnosis of ADHD to be made. (APA, 2013).  Teachers are able to monitor 
behaviours during academic learning as well as unstructured peer interactions on 
the playground (Conners, 2008).  In one study, one hundred and eighty four 
children aged 5 to 12 years old had parents complete the Conners’ Parent Rating 
Scale and teachers complete the Conners’ Teacher Rating Scale.  Results showed 
that teachers report children with ADHD to have higher levels of behavioural 
difficulties compared to parent rating.  Furthermore, the Conners’ Teacher Rating 
Scale had higher levels of sensitivity, specificity and accuracy.  Consequently, it 
was recommended that teacher and parent ratings were combined and used in 
conjunction with each other in an ADHD assessment (Tripp, Schaughency, & 
Clarke, 2006). 
Sonuga-Barke et al. (2013) conducted a meta-analysis examining 
nonpharmacological interventions on ADHD.  In both cognitive training and 
neurofeedback trials, where observers were aware of the research and intervention, 
significant treatment effects were found.  However, the significant treatment 
effects were lost when raters were blinded to intervention.  Here it was found that 
teacher completed measures were sensitive to change.  Results suggested that 
individuals aware of the intervention may have inflated significance due to raters 
having an investment in implementing the strategy and therefore its success.  For 
example, behavioural interventions are prone to rater bias, as the rater, the parents 
are implementing the intervention.  On the other hand, the parents may be seeing 
improvements, but these results are not being generalised into other settings, such 
as school. 
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Interpreting observer results via rating scales needs to be done with 
caution.  For example, in a less restrictive and demanding environment such as at 
home, symptoms may not be as evident or troublesome (Barkley, 2003).  With 
CPRS, there is the possibility of informant bias which can significantly affect 
rating scale outcomes.  This therefore implies that rating scales are useful within a 
clinical setting to help determine if ADHD is present or not, but needs to involve 
other elements, such as clinical interview, school observations or EEG (where 
available).  However, having two individuals complete the scales, such as the 
Conners 3 Teacher Rating Scale, can help improve validity (Snyder et al., 2008).     
4.1.4 Rating Scales, Continuous Performance Tests and Neurofeedback 
So far, the presentation of individuals with ADHD on several CPTs and 
rating scales have been discussed.  Another use of these tools is to evaluate the 
effectiveness of any treatment that has been implemented (Edwards et al., 2007).  
Evidence will be discussed here in regard to the effect that neurofeedback has on 
rating scales and continuous performance tests in both a healthy and ADHD 
sample. 
In a healthy sample, Egner and Gruzelier (2001) employed SMR training 
(increase of 12-15 Hz) at C4 and beta training (increase of 15-18 Hz) at C3 in a 
group of 22 adults while simultaneously inhibiting theta (4-7 Hz) and high beta 
(22-30 Hz).  After ten neurofeedback sessions, a significant reduction was seen on 
CPT commission errors but no change on omission errors.  Also, SMR 
neurofeedback was highly positively correlated to commission error reduction.   
In a further healthy sample, Vernon et al. (2003) examined 30 medical 
students aged 20 to 28 years old who completed neurofeedback, twice a week for 4 
weeks. Two neurofeedback protocols were used, enhancing theta condition and 
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enhancing SMR condition.  CPT and conceptual span task was completed before 
and after the neurofeedback training. Results showed that eight sessions of 
neurofeedback was able to change EEG activity in healthy individuals.  
Specifically, SMR activity showed greater improvement on CPT, showing an 
improvement in accuracy of attention.  These two studies have demonstrated the 
use of CPT measuring improvement as a consequence of neurofeedback in an adult 
population and needs to be replicated in a child sample. 
Fuchs et al. (2003) conducted a study of 34 children with a diagnosis of 
ADHD, aged 8 to 12 years old, of which 22 children completed 3 months of 
neurofeedback sessions, 3 sessions a week with the same therapist at the same time 
of day.  Children diagnosed with ADHD hyperactive-impulsive subtype received 
SMR uptraining at C4 whereas children diagnosed with ADHD inattentive subtype 
received beta uptraining at C3.  Children diagnosed with ADHD combined subtype 
received a combination of these protocols.  A further 12 children received 
stimulant medication only.  All conditions saw a reduction on ADHD symptoms.  
Specifically, all conditions had a reduction on Conners’ Behaviour Rating Scale, 
as completed by parents and teachers, as well as a moderate effect size.  This 
demonstrates the efficiency of neurofeedback in reducing ADHD symptoms as 
rated by parents and teachers, using standard protocols.  However, this study had a 
small sample size and consequently needs replicating on a larger scale. 
When CPT is used as an assessment tool, it needs to be used with caution.  
The Federal Drug Administration (FDA) promotes the use of new tools to aid the 
diagnosis of ADHD, clearly stating the tools are aids and are not diagnostic.  FDA 
promotes approval for marketing of a tool, not promotion of best clinical practice 
(Arns et al., 2016).     
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4.1.5 Rating Scales, Continuous Performance Tests and Stimulant Medication 
Methylphenidate has been shown to improve performance on Continuous 
Performance Tests.  Specifically, findings showed that the higher dose of 
methylphenidate taken, the fewer errors occurred, showing successful 
concentration.  Additionally, the higher the cognitive ability of an individual, the 
higher the response rate to methylphenidate (Pearson et al., 2004).     
A meta-analysis was conducted reviewing 13 randomised control trials 
examining methylphenidate.  It total, 882 participants with a diagnosis of ADHD, 
up to the age of 18 years old, were included.  On parent ratings, there was a 
preference for long acting methylphenidate, due to improvements on 
hyperactive/impulsive behaviours.  However, teacher ratings favoured short acting 
methylphenidate, specifically for hyperactivity (Punja et al., 2013).   
4.2 Aims of the Study  
The present study aimed to examine the differences between a healthy and 
ADHD child population when rated by teacher, parent and on a child concentration 
test.  Furthermore, the aim is to determine the most successful intervention or 
combination of interventions that improves concentration in both a healthy and 
ADHD sample as rated by parents and teachers. 
Specifically, there have been limited previous research which has examined 
neurofeedback and stimulant medication in an ADHD sample.  There have been 
several studies which have compared the two interventions, showing similar effect 
on ADHD symptoms (Fuchs et al., 2003; Monastra et al., 2002; Rossiter, 2004; 
Rossiter & La Vaque, 1995).  The present study aims to examine the effect of 
stimulant medication and neurofeedback on ADHD symptoms from a parent and 
teacher perspective.  
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Neurofeedback has been shown to have a large effect size on inattention 
and hyperactivity and a medium effect size on impulsivity in an ADHD sample 
(Arns et al., 2009).  However, previous neurofeedback research has been 
conducted in clinic or school settings and not in the home (Vernon et al., 2004; 
Rutterford et al., 2008).  Consequently, one aim of this thesis was to examine the 
effect of neurofeedback home training on a healthy and ADHD population, 
specifically in regard to parent and teachers’ views.  
4.3 Hypothesis 
Based upon the previous research and the aims of the present study, the 
hypotheses for the pre-measures are as follows: 
• The ADHD sample will have higher scores on omission and commission 
error subscales on the Continuous Performance Test than the typically 
developed sample. 
• The ADHD sample will have a higher score on the inattention, 
hyperactive/impulsive and executive function subscales of the Conners’ 3 
Parent and Teacher Rating Scale than the typically developed sample. 
Based upon previous research and the aims of the present study, the hypotheses 
for the post-measures are as follows: 
• The ADHD neurofeedback home training condition will show greater 
improvement on Conners’ CPT omission and commission subscales, as 
well as Conners’ Parent/Teacher Rating Scales, specifically on the 
subscales of inattention, hyperactive/impulsive, and executive function, 
compared to the typically developed neurofeedback home training 
condition. 
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• The ADHD neurofeedback home training and medication condition will 
show greatest improvement across all conditions on Conners’ CPT 
omission and commission subscales, as well as Conners’ Parent/Teacher 
Rating Scales, specifically on the subscales of inattention, 
hyperactive/impulsive, and executive function. 
• The typically developed sample who received neurofeedback home training 
will show greater improvement on Conners’ CPT omission and 
commission subscales, as well as Conners’ Parent/Teacher Rating Scales, 
specifically on the subscales of inattention, hyperactive/impulsive and 
executive function, compared to the typically developed sample control and 
active control group. 
• No difference will be found between the typically developed sample 
control and active control group on Conners’ CPT omission and 
commission subscales, as well as Conners’ Parent/Teacher Rating Scales, 
specifically on the subscales of inattention, hyperactive/impulsive, and 
executive function, across time. 
4.4 Method 
For details regarding participants and interventions, please see Chapter Two: 
General Methods. 
4.4.1 Neuropsychometric Measures 
 The study reported here used 3 neuropsychometric measures: Conners’ 
Continuous Performance Test, Conners’ 3 Parent Rating Scale and the Conners’ 3 
Teacher Rating Scale.  The measures were conducted on two occasions, once 
during the initial meeting prior to any intervention, and 15 weeks later once the 
interventions had been completed. 
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4.4.1.1 Conners’ Continuous Performance Test (CPT) 
The Conners’ CPT is a computerised visual-motor task whereby 
participants hit the space bar when presented with any letter except for the letter 
“X”, therefore responding to both targets and non-targets (Conners, 2004).  Stimuli 
is presented every 2 or 4 seconds, is suitable for individuals over the age of 6 years 
old and takes 14 minutes to complete.  The CPT has a large database, consisting of 
2,686 clinical and non-clinical performances.  The Conners’ CPT measures a range 
of variables.  Please see Table 22 which identifies the variables and what they 
measure in relation to ADHD symptoms.    
Conners’ (1995), stated that when repeating the test, there is little practice 
effect, making it a useful tool to measure any possible benefit of interventions.   
Table 22. 
Conners’ Continuous Performance Test Variables 
 
Variable Description Measure 
Omission Failure to respond to target Inattention 
Commission Response to non-target Inattention and impulsivity 
Conners CPT Hit 
Response Time Average speed of correct responses 
Inattention and 
impulsivity 
Conners CPT Hit 
Response Time Std Error 
Response speed consistency.  High scores 
suggestive greater inconsistency. Inattention 
Conners CPT Variability Amount of variability across the various sections. Inattention 
Conners CPT 
Dectectability 
Ability to determine a target from a non-
target based on distribution score. Inattention 
Conners CPT Response 
Style 
Individuals response tendency.  Higher 
score suggests more cautious approach. 
 
Conners CPT 
Preservations 
Reaction time less than 100ms suggests 
individual anticipating stimulus rather than 
responding 
Impulsivity 
Conners CPT Response 
Time Block Change 
Measures change in reaction times across 
the test.  Higher scores show a slowing in 
reaction time. 
Vigilance and 
alertness 
Conners CPT Response 
Time Block Change Std 
Error 
Measures change in reaction consistency 
across the test.  Higher scores show a 
slowing in reaction time. 
Vigilance and 
alertness 
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4.4.1.2 Conners’ 3 Parent and Teacher Rating Scales 
The Conners’ 3 Parent Rating Scale is the most widely used scale among 
clinicians and researchers.  The Conners’ Rating Scale is designed to be brief, easy 
to score, and easy to administer.  Its primary aim is to screen for any 
psychopathology, to be a diagnostic aid as well as a measure of general treatment 
outcome.  Subscales include conduct disorder, anxiousness, restlessness, learning 
difficulties, psychosomatic, obsessive compulsive, anti-social and hyperactive 
behaviours.  It measures inattention, hyperactive/impulsivity, learning difficulties, 
executive function, defiance, and peer relations; each measure has several 
statements for the parents to answer.  These raw scores are combined to make a 
measure score which is then compared with a normative database of age and 
gender matched individuals.  The normative database contains data for 50 boys 
and 50 girls from each age group, from 6 to 18 years old.  Through the results, 
areas of difficulty can be identified. 
The online full version of the Conners’ 3 Parent and Teacher Rating Scales 
were used.  Both parents and teachers were emailed the online questionnaire to 
complete; the questionnaire comprised of 109 items for parents and 115 items for 
teachers, using a 4-point scale: not true at all, just a little true, pretty much true, 
and very much true.  The questionnaire was sent to the parent and teacher on the 
day that the initial meeting and last meeting took place with a covering email 
asking them to complete the questionnaire as soon as possible in one sitting.  If the 
questionnaire had not been completed within one week, parents and teacher were 
reminded by email and phone to complete the questionnaire.  
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4.5 Results 
 As the neuropsychometric measures were completed at 2 time points, pre-
measures before any intervention and post-measures after any intervention, the 
results have been presented in this way.
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4.5.1 Results of neuropsychometric performance pre-measures 
Table 23. 
MANOVA of diagnosis and gender on pre-measures  
a Significant after Bonferroni correction.  Calculation of 0.05/3=0.016 
 
A multivariate analysis of variance (MANOVA) was conducted to examine the overall effect of diagnosis and gender on the 
BIS/BAS scale.  A MANOVA is an extension of an ANOVA, examining the statistical differences of two or more dependent variables.  As 
Table 18 shows, there was no significant effect for gender on the Conners’ 3 Parent and Teacher Rating Scale or CPT, but there was a 
significant effect of clinical diagnosis on the Conners’ 3 Parent Rating Scale, which remained significant after Bonferroni correction.  
T-tests were conducted to assess further the significant difference between samples, Table 24. 
 
 
 
  Gender Clinical Diagnosis 
  Wilks Lambda f 
Hypothesis 
df 
Error 
df Sig. 
Wilks 
Lambda f 
Hypothesis 
df 
Error 
df Sig. 
Conners’ 3 Parent Rating Scale 0.91 1.46 5.00 75.00 0.21 0.78 4.36 5.00 75.00 0.001a 
Conners’ 3 Teacher Rating Scale 0.83 0.62 5.00 15.00 0.69 0.65 1.64 5.00 15.00 0.21 
CPT 0.89 0.81 11.00 70.00 0.63 0.85 1.09 11.00 70.00 0.39 
 130 
Table 24. 
Descriptive statistics and T-test results of pre-measure dependent variables on independent variable, diagnosis 
a Significant after Bonferroni correction.  Conners’ 3 Parent Rating Scale calculation of 0.05/5=0.01,  
b Significant after Bonferroni correction.  Conners’ 3 Teacher Rating Scale calculation of 0.05/5=0.01,  
c Significant after Bonferroni correction.  Conners’ CPT calculation of 0.05/10=0.005
    Typically Developed Sample ADHD Sample       
    N Mean SD  N Mean SD t  df  Sig. (2-tailed) 
Conners' 3 
Parent 
Rating Scale 
Learning Difficulties 38.00 9.20 5.84 45.00 11.60 6.23 1.81 81.00 0.07 
Executive Functions 38.00 10.64 5.52 45.00 14.26 5.48 2.98 81.00 0.01 a 
Defiance 38.00 3.46 3.84 45.00 7.60 6.77 3.48 81.00 0.01 a 
Inattention 38.00 11.86 7.44 45.00 18.94 6.50 4.57 81.00 0.01 a 
Hyperactive/Impulsive 38.00 11.86 9.57 45.00 22.26 12.51 4.28 81.00 0.01 a 
Conners' 3 
Teacher 
Rating Scale 
Learning Difficulties 15.00 3.13 3.81 9.00 8.00 6.36 2.35 22.00 0.02 
Executive Functions 15.00 7.00 4.70 9.00 11.37 4.20 2.19 21.00 0.03 
Defiance 15.00 3.60 5.51 9.00 5.00 5.91 0.58 22.00 0.56 
Inattention 15.00 8.00 7.32 9.00 16.25 7.38 2.56 21.00 0.01 b 
Hyperactive/Impulsive 15.00 9.26 11.18 9.00 7.12 6.89 -0.49 21.00 0.62 
Conners' 
CPT 
Omissions 36.00 15.31 17.08 48.00 20.05 20.43 1.16 82.00 0.25 
Commissions 36.00 22.15 7.81 48.00 24.05 7.91 1.10 82.00 0.27 
Hit Response Time 36.00 408.00 107.83 48.00 438.43 95.27 1.34 82.00 0.18 
Hit Response Time Std Error 36.00 10.99 7.50 48.00 14.45 9.22 1.89 82.00 0.06 
Variability 36.00 21.95 19.70 48.00 31.45 24.65 1.96 82.00 0.53 
Dectectability 36.00 0.36 0.37 48.00 0.31 0.40 -0.68 82.00 0.49 
Response Style 36.00 0.70 0.49 48.00 0.97 1.23 1.37 82.00 0.17 
Preservations 36.00 6.47 8.34 48.00 12.88 17.26 2.24 82.00 0.02 
Response Time Block Change 36.00 0.06 0.28 48.00 0.19 0.03 -0.76 82.00 0.44 
Block Change Std Error 36.00 0.11 0.29 48.00 0.09 0.10 -0.51 82.00 0.61 
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Table 24 shows means and statistical effects for all the dependent variables.  There was 
a significant main effect after Bonferroni correction of diagnosis on Conners’ 3 Parent 
Rating Scale subscales executive functions, defiance, inattention and 
hyperactive/impulsive as well as inattention subscales of the Conners’ 3 Teacher Rating 
Scale.  As expected, the ADHD sample were rated significantly higher in the 
aforementioned scales.   
A Pearson correlation coefficient was then computed to assess the relationship 
between the independent variables and age.  
Table 25. 
Pearson Product Moment correlations for dependent variables and age on the typically 
developed sample 
    N Pearson Correlation 
Strength of 
relationship Sig 
Conners' 
3 Parent 
Rating 
Scale 
Learning Difficulties 45.00 -0.23 Weak negative 0.11 
Executive Functions 45.00 0.13 Weak positive 0.36 
Defiance 45.00 -0.04 None 0.78 
Inattention 45.00 0.06 None -0.28 
Hyperactive/Impulsive 45.00 -0.41 Moderate negative 0.01 
Conners' 
3 
Teacher 
Rating 
Scale 
Learning Difficulties 15.00 0.03 None 0.91 
Executive Functions 15.00 0.14 Weak positive 0.59 
Defiance 15.00 -0.22 Weak negative 0.41 
Inattention 15.00 0.05 None 0.84 
Hyperactive/Impulsive 15.00 -0.44 Moderate negative 0.10 
Conners' 
CPT 
Omissions 48.00 -0.47 Moderate negative 0.01 
Commissions 48.00 -0.18 Weak negative 0.21 
Hit Response Time 48.00 -0.51 Moderate negative 0.01 
Hit Response Time Std Error 48.00 -0.59 Moderate negative 0.01 
Variability 48.00 -0.49 Moderate negative 0.01 
Dectectability 48.00 0.21 Weak positive 0.13 
Response Style 48.00 -0.16 Weak negative 0.25 
Preservations 48.00 -0.46 Moderate negative 0.01 
Response Time Block Change 48.00 -0.11 Weak negative 0.44 
Block Change Std Error 48.00 -0.21 Weak negative 0.16 
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Table 26. 
Pearson Product Moment correlations for dependent variables and age on the ADHD 
sample 
    N Pearson Correlation 
Strength of 
Relationship Sig 
Conners' 
3 Parent 
Rating 
Scale 
Learning Difficulties 38.00 -0.15 Weak negative 0.36 
Executive Functions 38.00 0.38 Moderate positive 0.01 
Defiance 38.00 -0.32 Moderate negative 0.04 
Inattention 38.00 -0.11 Weak negative 0.52 
Hyperactive/Impulsive 38.00 -0.47 Moderate negative 0.01 
Conners' 
3 
Teacher 
Rating 
Scale 
Learning Difficulties 8.00 -0.82 Strong negative 0.01 
Executive Functions 8.00 0.31 Moderate positive 0.45 
Defiance 8.00 0.12 Weak positive 0.75 
Inattention 8.00 0.03 None 0.92 
Hyperactive/Impulsive 8.00 -0.32 Moderate negative 0.43 
Conners' 
CPT 
Omissions 36.00 -0.42 Moderate negative 0.01 
Commissions 36.00 -0.21 Weak negative 0.19 
Hit Response Time 36.00 -0.62 Moderate negative 0.01 
Hit Response Time Std Error 36.00 0.84 Strong positive 0.01 
Variability 36.00 -0.43 Moderate negative 0.01 
Dectectability 36.00 0.15 Weak positive 0.41 
Response Style 36.00 0.09 None 0.59 
Preservations 36.00 -0.22 Weak negative 0.19 
Response Time Block Change 36.00 -0.21 Weak negative 0.21 
Block Change Std Error 36.00 -0.03 None 0.83 
As Table 25 and 26 show, age significantly correlated with Conners’ 3 Parent 
Rating Scale hyperactive/impulsive subscale, Conners’ CPT Omissions and Conners’ 
CPT Hit response time in both the typically developed and ADHD sample.  Also, age 
significantly correlated with Conners’ CPT Hit Response Time Standard Error in both 
samples, although in different directions.  Conners’ CPT variability and preservations 
were both significantly correlated with age in the typically developed sample where as 
Conners’ Teacher Learning Difficulties correlated with age in the ADHD sample.  
Consequently, age was included as a covariate in further analysis. 
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4.5.2 Results of neuropsychometric performance post-measures 
The results from the post-measures, which were completed after the 
interventions, will now be discussed. 
A MANOVA was conducted to assess how diagnosis and gender combined 
affect the overall post measures.  
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Table 27. 
MANOVA examining post measures across diagnosis and gender 
 
As Table 27 shows,  gender had a significant effect on the Conners’ Parent Rating Scale and diagnosis had a significant effect on three 
measures.  Therefore, the post measures were examined in more detail.  Due to the small sample in some of the conditions, it was not possible to 
conduct a post-hoc test. 
T-tests were then conducted to examine if there were any significant difference between the samples after interventions. 
 
 
 
 
 
  Gender Diagnosis  
Absolute 
Mean Change 
Score 
f Hypothesis 
df 
Error 
df 
Sig. Wilks 
Lambda 
Absolute 
Mean Change 
Score 
f Hypothesis 
df 
Error df Sig. 
Conners' 3 Parent Rating Scale -0.07 2.32 5.00 60.00 0.05 0.71 -0.07 4.91 5.00 60.00 0.01 
Conners' 3 Teacher Rating Scale -0.77 6.16 5.00 2.00 0.15 0.01 -0.84 33.91 5.00 2.00 0.03 
Conners' CPT -0.05 0.94 11.00 56.00 0.51 0.65 -0.21 2.71 11.00 56.00 0.01 
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Table 28. 
T-test results of post measure dependent variables on independent variable, diagnosis  
a Significant after Bonferroni correction.  Conners’ 3 Parent Rating Scale calculation of 0.05/5=0.01,  
b Significant after Bonferroni correction.  Conners’ 3 Teacher Rating Scale calculation of 0.05/5=0.01 
  Typically Developed Sample ADHD Sample    
  N Mean SD N Mean SD t df Sig. (2-tailed) 
Conners' 3 
Parent Rating 
Scale 
Learning Difficulties 38.00 8.31 5.35 30.00 10.43 5.28 1.62 66.00 0.11 
Executive Functions 38.00 9.84 4.66 30.00 12.16 5.21 1.93 66.00 0.05 
Defiance 38.00 2.84 3.22 30.00 5.93 6.29 2.62 66.00 0.01 a 
Inattention 38.00 9.05 5.69 30.00 15.40 6.11 4.41 66.00 0.01 a 
Hyperactive/Impulsive 38.00 9.42 7.67 30.00 18.86 8.40 4.83 66.00 0.01 a 
Conners' 3 
Teacher Rating 
Scale 
Learning Difficulties 7.00 3.00 3.05 5.00 10.20 4.49 3.32 10.00 0.01 b 
Executive Functions 7.00 5.71 2.69 5.00 12.80 4.86 3.25 10.00 0.01 b 
Defiance 7.00 3.42 5.88 5.00 8.80 11.45 10.07 10.00 0.31 
Inattention 7.00 4.71 6.10 5.00 18.20 9.09 3.09 10.00 0.01 
Hyperactive/Impulsive 7.00 4.33 7.44 4.00 20.25 24.06 1.55 8.00 0.15 
Conners' CPT 
Omissions 43.00 14.65 14.32 27.00 24.22 26.46 1.96 68.00 0.05 
Commissions 43.00 23.06 7.41 27.00 20.66 6.09 -1.41 68.00 0.16 
Hit Response Time 43.00 398.61 66.17 27.00 470.69 80.21 4.08 68.00 0.01 
Hit Response Time Std Error 43.00 10.68 6.51 27.00 15.67 10.01 2.56 68.00 0.01 
Variability 43.00 20.71 17.30 27.00 33.91 31.08 2.28 68.00 0.02 
Dectectability 43.00 0.29 0.29 27.00 0.41 0.25 1.80 68.00 0.07 
Response Style 43.00 0.65 0.38 27.00 0.75 0.44 1.04 68.00 0.29 
Preservations 43.00 7.97 946.00 27.00 15.11 20.75 1.95 68.00 0.05 
Response Time Block Change 43.00 0.01 0.03 27.00 0.01 0.03 -1.02 68.00 0.31 
Block Change Std Error 43.00 0.06 0.09 27.00 0.04 0.09 -0.93 68.00 9.35 
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As Table 28 shows, there was a significant main effect after Bonferroni 
correction of diagnosis on some of the Conners’ Parent subscales and some of the 
Conners’ Teacher subscales. 
Next, t-tests were conducted to examine if gender affected post-measure results 
(Table 29 and 30). 
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Table 29. 
T-tests of post dependent variables with gender on typically developed sample 
a Significant after Bonferroni correction.  Conners’ 3 Parent Rating Scale calculation of 0.05/5=0.01,  
b Significant after Bonferroni correction.  Conners’ 3 Teacher Rating Scale calculation of 0.05/5=0.01,  
c Significant after Bonferroni correction.  Conners’ CPT calculation of 0.05/10=0.005 
   Male Female       
    N Mean SD N Mean SD t  df  Sig.  
Conners' 3 
Parent Rating 
Scale 
Learning Difficulties 22.00 8.31 6.34 16.00 8.31 3.78 0.00 36.00 0.99 
Executive Functions 22.00 10.95 4.60 16.00 8.31 4.43 1.77 36.00 0.08 
Defiance 22.00 3.54 3.87 16.00 1.87 1.71 1.61 36.00 0.11 
Inattention 22.00 10.22 6.71 16.00 7.43 3.48 1.51 36.00 0.13 
Hyperactive/Impulsive 22.00 11.00 8.11 16.00 7.25 6.67 1.51 36.00 0.13 
Conners' 3 
Teacher Rating 
Scale 
Learning Difficulties 4.00 3.00 9.84 3.00 3.00 3.00 0.00 5.00 1.00 
Executive Functions 4.00 6.75 3.30 3.00 4.33 0.57 1.22 5.00 0.27 
Defiance 4.00 6.00 6.97 3.00 0.00 0.00 1.45 5.00 0.21 
Inattention 4.00 6.50 7.85 3.00 2.33 2.08 0.87 5.00 0.42 
Hyperactive/Impulsive 4.00 8.00 9.84 3.00 0.66 1.15 1.28 5.00 0.26 
Conners' CPT 
Omissions 27.00 14.25 14.39 16.00 15.31 14.65 -0.23 41.00 0.81 
Commissions 27.00 23.77 7.83 16.00 21.87 6.71 0.81 41.00 0.42 
Hit Response Time 27.00 394.88 62.31 16.00 404.89 73.91 -0.47 41.00 0.63 
Hit Response Time Std Error 27.00 10.62 6.01 16.00 10.78 7.51 -0.07 41.00 0.93 
Variability 27.00 19.71 14.88 16.00 22.39 21.19 -0.48 41.00 0.62 
Dectectability 27.00 0.30 0.30 16.00 0.28 0.29 0.18 41.00 0.85 
Response Style 27.00 0.61 0.30 16.00 0.70 0.49 -0.68 41.00 0.49 
Preservations 27.00 8.18 8.95 16.00 7.62 10.55 0.18 41.00 0.85 
Response Time Block Change 27.00 0.01 0.02 16.00 0.02 0.04 -0.77 41.00 0.44 
Block Change Std Error 27.00 0.06 0.09 16.00 0.07 0.11 -0.18 41.00 0.85 
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Table 30. 
T-tests of post dependent variables with gender for ADHD sample 
a Significant after Bonferroni correction.  Conners’ 3 Parent Rating Scale calculation of 0.05/5=0.01,  
b Significant after Bonferroni correction.  Conners’ 3 Teacher Rating Scale calculation of 0.05/5=0.01,  
c Significant after Bonferroni correction.  Conners’ CPT calculation of 0.05/10=0.005 
   Male Female       
    N Mean SD N Mean SD t  df  Sig. 
Conners' 3 
Parent Rating 
Scale 
Learning Difficulties 26.00 11.00 5.30 4.00 6.75 3.59 1.53 28.00 0.13 
Executive Functions 26.00 12.61 5.28 4.00 9.25 4.03 1.21 28.00 0.23 
Defiance 26.00 5.00 4.17 4.00 12.00 13.44 -2.21 29.00 0.03 
Inattention 26.00 16.15 6.21 4.00 10.50 1.73 1.78 28.00 0.08 
Hyperactive/Impulsive 26.00 20.34 7.77 4.00 9.25 6.02 2.71 298.00 0.01 
Conners' 3 
Teacher Rating 
Scale 
Learning Difficulties 5.00 10.20 4.49 - - - - - - 
Executive Functions 5.00 12.80 4.86 - - - - - - 
Defiance 5.00 8.80 11.45 - - - - - - 
Inattention 5.00 18.20 9.09 - - - - - - 
Hyperactive/Impulsive 5.00 29.25 24.06 - - - - - - 
Conners' CPT 
Omissions 24.00 26.87 26.89 3.00 3.00 5.19 1.51 25.00 0.14 
Commissions 24.00 21.37 5.72 3.00 15.00 7.21 1.77 25.00 0.08 
Hit Response Time 24.00 480.76 76.85 3.00 390.14 69.03 1.94 25.00 0.06 
Hit Response Time Std Error 24.00 16.78 9.95 3.00 6.72 5.41 1.70 25.00 0.10 
Variability 24.00 36.57 31.75 3.00 12.60 14.16 1.27 25.00 0.21 
Dectectability 24.00 0.40 0.26 3.00 0.52 0.17 -0.77 25.00 0.44 
Response Style 24.00 0.81 0.42 3.00 0.28 0.24 2.07 25.00 0.04 
Preservations 24.00 16.79 21.44 3.00 1.66 2.88 1.20 25.00 0.24 
Response Time Block Change 24.00 0.01 0.03 3.00 -0.01 0.02 0.97 25.00 0.34 
Block Change Std Error 24.00 0.05 0.08 3.00 -0.05 0.03 2.23 25.00 0.03 
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Analysis showed that gender had no significant effect on neuropsychological 
measures after Bonferroni correction. 
A Pearson correlation coefficient was then computed to assess the relationship 
between the independent variables and age at the post measures time point (Table 31 
and 32).  
Table 31. 
Pearson - product moment correlations for dependent variables and age on the 
typically developed sample for post measures 
    N Pearson Correlation Sig 
Conners' 3 
Parent Rating 
Scale 
Learning Difficulties 38.00 -0.17 0.29 
Executive Functions 38.00 0.00 0.98 
Defiance 38.00 -0.07 0.66 
Inattention 38.00 -0.20 0.22 
Hyperactive/Impulsive 38.00 -0.45 0.01 
Conners' 3 
Teacher 
Rating Scale 
Learning Difficulties 7.00 -0.61 0.13 
Executive Functions 7.00 -0.37 0.40 
Defiance 7.00 -0.23 0.61 
Inattention 7.00 -0.36 0.48 
Hyperactive/Impulsive 7.00 -0.35 0.48 
Conners' CPT 
Omissions 43.00 -0.43 0.01 
Commissions 43.00 -0.38 0.01 
Hit Response Time 43.00 -0.56 0.01 
Hit Response Time Std Error 43.00 -0.54 0.01 
Variability 43.00 -0.46 0.01 
Dectectability 43.00 0.39 0.02 
Response Style 43.00 0.00 0.15 
Preservations 43.00 0.00 0.01 
Response Time Block Change 43.00 -0.26 0.08 
Block Change Std Error 43.00 -0.20 0.19 
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Table 32. 
Pearson - product moment correlations for dependent variables and age on the ADHD 
sample for post measures 
    N Pearson Correlation Sig 
Conners' 3 
Parent Rating 
Scale 
Learning Difficulties 30.00 -0.14 0.44 
Executive Functions 30.00 0.41 0.02 
Defiance 30.00 -0.15 0.42 
Inattention 30.00 0.15 0.41 
Hyperactive/Impulsive 30.00 -0.12 0.51 
Conners' 3 
Teacher 
Rating Scale 
Learning Difficulties 5.00 -0.68 0.19 
Executive Functions 5.00 0.04 0.94 
Defiance 5.00 -0.11 0.86 
Inattention 5.00 -0.25 0.67 
Hyperactive/Impulsive 5.00 -0.14 0.85 
Conners' CPT 
Omissions 27.00 -0.31 0.11 
Commissions 27.00 -0.34 0.07 
Hit Response Time 27.00 -0.04 0.02 
Hit Response Time Std Error 27.00 -0.32 0.11 
Variability 27.00 -0.29 0.13 
Dectectability 27.00 0.19 0.33 
Response Style 27.00 -0.37 0.05 
Preservations 27.00 -0.27 0.17 
Response Time Block Change 27.00 -0.48 0.01 
Block Change Std Error 27.00 -0.08 0.66 
 
As Table 31 shows, age had a significant correlation of Conners’ 3 Parent 
Rating hyperactive subscale, and several of the Conners’ CPT subscales, within the 
typically developed sample.  Whereas Table 32 shows age had a significant correlation 
on Conners’ 3 Parent Rating executive functions subscale, and several of the Conners’ 
CPT subscales, within the ADHD sample.  In neither sample did age correlate with 
Conners’ 3 Parent Teacher Rating.
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4.5.3 Results Comparing Pre to Post of Neuropsychometric Performance Measures 
Table 33. 
Repeated MANOVA, pre-to post across typically developed and ADHD sample 
a Significant after Bonferroni correction.  Conners’ 3 Parent Rating Scale calculation of 0.05/5=0.01,  
b Significant after Bonferroni correction.  Conners’ 3 Teacher Rating Scale calculation of 0.05/5=0.01,  
c Significant after Bonferroni correction.  Conners’ CPT calculation of 0.05/10=0.005 
                       Pre to Post Gender     
  Mean f Sig. Mean f Sig. Mean f Sig. 
Conners' 
3 Parent 
Rating 
Scale 
Learning Difficulties 4.98 1.42 0.24 0.33 0.09 0.76 0.73 0.21 0.65 
Executive Functions 4.71 0.76 0.39 7.94 1.28 0.26 27.93 4.50 0.04 
Defiance 31.91 4.99 0.03 6.90 1.08 0.30 15.92 2.49 0.12 
Inattention 51.28 4.12 0.05 0.02 0.00 0.97 17.80 1.43 0.24 
Hyperactive/Impulsive 112.18 5.45 0.02 0.86 0.04 0.84 55.98 2.72 0.10 
Conners' 
3 
Teacher 
Rating 
Scale 
Learning Difficulties 0.01 0.01 0.93 5.54 5.29 0.07 0.35 0.34 0.59 
Executive Functions 0.56 0.21 0.68 1.15 0.41 0.55 7.34 2.55 0.17 
Defiance 0.22 0.02 0.88 39.18 4.23 0.09 0.41 0.04 0.84 
Inattention 0.67 0.29 0.61 0.00 0.00 0.97 3.71 1.63 0.26 
Hyperactive/Impulsive 1.57 0.03 0.86 183.96 3.98 0.11 0.35 0.01 0.93 
Conners' 
CPT 
Omissions 60.68 0.54 0.47 36.92 0.33 0.57 175.35 1.55 0.22 
Commissions 0.54 0.02 0.89 20.19 0.71 0.41 136.13 4.73 0.03 
Hit Response Time 1.82 0.00 0.98 1740.71 0.47 0.49 2893.58 0.78 0.38 
Hit Response Time Std Error 1.43 0.07 0.79 7.07 0.34 0.56 7.15 0.34 0.56 
Variability 10.96 0.06 0.81 7.67 0.04 0.84 81.13 0.42 0.52 
Dectectability 0.01 0.08 0.78 0.01 0.08 0.78 0.18 1.85 0.18 
Response Style 0.57 1.12 0.29 0.00 0.01 0.92 0.33 0.63 0.43 
Preservations 114.58 1.39 0.24 0.98 0.01 0.91 23.77 0.29 0.59 
Response Time Block Change 10.95 1.39 0.24 0.09 0.01 0.91 2.39 0.29 0.59 
Block Change Std Error 0.05 1.24 0.27 0.01 0.31 0.58 0.01 0.20 0.66 
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A paired t-test was then conducted to compare the independent variables from 
the first time point, pre measures, to after any intervention, post measures  
Table 34. 
Paired T-test results of pre-to post measure dependent variables  
a Significant after Bonferroni correction.  Conners’ 3 Parent Rating Scale calculation of 
0.05/5=0.01,  
b Significant after Bonferroni correction.  Conners’ 3 Teacher Rating Scale calculation 
of 0.05/5=0.01,  
c Significant after Bonferroni correction.  Conners’ CPT calculation of 0.05/10=0.005 
 
As Table 34 shows, there was a significant main effect of diagnosis on the 
dependent variables on all of the Conners’ Parent subscales. 
Furthermore, a repeated measures multivariate ANOVA with a Bonferroni 
correction was conducted to examine the significant difference between the 
neuropsychometric post measures and the study conditions.  No significant differences 
were found. 
    Mean SD t  df  
Sig. 
(2-
tailed) 
Conners' 3 Parent 
Rating Scale 
Learning Difficulties 0.98 2.61 3.05 65.00 0.01a 
Executive Functions 1.36 3.61 3.06 65.00 0.01a 
Defiance 1.51 3.67 3.34 65.00 0.01a 
Inattention 3.18 5.00 5.16 65.00 0.01a 
Hyperactive/Impulsive 3.50 6.61 4.30 65.00 0.01a 
Conners' 3 
Teacher Rating 
Scale 
Learning Difficulties 0.54 2.25 0.80 10.00 0.44 
Executive Functions -0.45 3.07 -0.49 10.00 0.63 
Defiance 0.90 4.80 0.62 10.00 0.54 
Inattention 1.45 2.94 1.63 10.00 0.13 
Hyperactive/Impulsive 0.66 11.50 0.17 8.00 0.86 
Conners' CPT 
Omissions -2.57 15.01 -1.41 67.00 0.16 
Commissions 0.19 7.68 -1.41 67.00 0.16 
Hit Response Time -5.64 85.34 -0.54 67.00 0.58 
Hit Response Time Std Error -0.48 6.34 -0.62 67.00 0.53 
Variability -0.70 19.35 -0.29 67.00 0.76 
Dectectability 0.03 0.43 0.54 67.00 0.58 
Response Style 0.12 1.01 0.98 67.00 0.32 
Preservations -2.70 12.64 -1.76 67.00 0.08 
Response Time Block Change 0.03 0.24 1.14 67.00 0.25 
Block Change Std Error 0.05 0.27 1.52 67.00 0.13 
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Table 35. 
Paired T-test results of pre-to post measure dependent variables on typically developed 
sample  
a Significant after Bonferroni correction.  Conners’ 3 Parent Rating Scale calculation of 
0.05/5=0.01,  
b Significant after Bonferroni correction.  Conners’ 3 Teacher Rating Scale calculation 
of 0.05/5=0.01,  
c Significant after Bonferroni correction.  Conners’ CPT calculation of 0.05/10=0.005 
 
 
 
 
 
 
 
    Mean SD t  df  
Sig. 
(2-
tailed) 
Conners' 3 
Parent Rating 
Scale 
Learning Difficulties 1.13 2.37 2.91 36.00 0.01a 
Executive Functions 0.62 2.89 1.31 36.00 0.19 
Defiance 0.70 2.81 1.51 36.00 0.13 
Inattention 2.45 4.83 3.09 36.00 0.01a 
Hyperactive/Impulsive 2.24 4.83 3.09 36.00 0.01a 
Conners' 3 
Teacher 
Rating Scale 
Learning Difficulties 0.00 2.64 0.00 6.00 1.00 
Executive Functions 0.42 2.99 0.37 6.00 0.71 
Defiance 1.71 5.28 0.89 6.00 0.42 
Inattention 2.00 2.58 0.85 6.00 0.08 
Hyperactive/Impulsive 3.49 12.78 0.67 6.00 0.53 
Conners' CPT 
Omissions -0.36 10.78 -0.23 40.00 0.81 
Commissions -1.37 7.51 -1.12 40.00 0.26 
Hit Response Time 3.96 93.57 0.27 40.00 0.78 
Hit Response Time Std Error 0.02 5.73 0.03 40.00 0.97 
Variability 0.74 17.14 0.27 40.00 0.78 
Dectectability 0.08 0.43 1.28 40.00 0.21 
Response Style 0.04 0.49 0.56 40.00 0.57 
Preservations -1.92 6.14 -2.01 40.00 0.05 
Response Time Block Change 0.04 0.31 0.99 40.00 0.32 
Block Change Std Error 0.05 0.33 1.11 40.00 0.27 
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Table 36. 
Paired T-test results of pre to post measure dependent variables on ADHD sample 
a Significant after Bonferroni correction Conners’ 3 Parent Rating Scale calculation of 
0.05/5=0.01,  
b Significant after Bonferroni correction  Conners’ 3 Teacher Rating Scale calculation of 
0.05/5=0.01 
 
As Table 35 and 36 show, both samples showed a significant main effect of 
change from pre-to-post measure on several of the Conners’ 3 Parent Rating Scale.  
There was no significant difference between pre-to post measures in either samples for 
the Conners’ Teacher Rating Scales. 
A Pearson correlation coefficient was then computed to assess the relationship 
between the pre and post measures and the independent variables (Table 37).   
 
 
    Mean SD t  df  
Sig. 
(2-
tailed) 
Conners' 3 
Parent Rating 
Scale 
Learning Difficulties 0.79 2.93 1.45 28.00 0.15 
Executive Functions 2.31 4.22 2.94 28.00 0.01a 
Defiance 2.55 4.38 3.13 28.00 0.01a 
Inattention 4.10 5.14 4.29 28.00 0.01a 
Hyperactive/Impulsive 1.51 7.78 3.52 28.00 0.01b 
Conners' 3 
Teacher 
Rating Scale 
Learning Difficulties 1.49 0.99 2.99 3.00 0.05 
Executive Functions -1.99 2.94 -1.35 3.00 0.26 
Defiance -0.49 4.12 -0.24 3.00 0.82 
Inattention 0.49 3.69 0.27 3.00 0.79 
Hyperactive/Impulsive -4.99 6.92 -1.25 3.00 0.33 
Conners' CPT 
Omissions -5.92 20.12 -1.53 26.00 0.13 
Commissions 2.48 7.51 1.71 26.00 0.09 
Hit Response Time -20.24 79.22 -1.49 26.00 0.14 
Hit Response Time Std Error -1.24 7.22 -0.86 26.00 0.37 
Variability -2.88 22.47 -0.66 26.00 0.51 
Dectectability -0.05 0.43 -0.71 26.00 0.47 
Response Style 0.23 1.49 0.92 26.00 0.41 
Preservations -3.88 18.75 -1.07 26.00 0.29 
Response Time Block Change 0.01 0.04 1.39 26.00 0.17 
Block Change Std Error 0.03 0.13 1.47 26.00 0.15 
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Table 37. 
Pearson correlation coefficient for pre to post measures of age on dependent variable of 
diagnosis  
    Pearson Correlation Sig. 
Strength of 
relationship 
Conners' 3 
Parent Rating 
Scale 
Learning Difficulties 0.90 0.01 Strong positive 
Executive Functions 0.78 0.01 Strong positive 
Defiance 0.79 0.01 Strong positive 
Inattention 0.78 0.01 Strong positive 
Hyperactive/Impulsive 0.84 0.01 Strong positive 
Conners' 3 
Teacher 
Rating Scale 
Learning Difficulties 0.95 0.01 Strong positive 
Executive Functions 0.14 0.71 Very weak positive 
Defiance 0.92 0.01 Strong positive 
Inattention 0.79 0.01 Strong positive 
Hyperactive/Impulsive 0.70 0.01 Strong positive 
Conners' CPT 
Omissions 0.68 0.01 Strong positive 
Commissions 0.49 0.01 Moderate positive 
Hit Response Time 0.55 0.01 Moderate positive 
Hit Response Time Std Error 0.70 0.01 Strong positive 
Variability 0.68 0.01 Strong positive 
Dectectability 0.25 0.03 Weak positive 
Response Style 0.69 0.57 Strong positive 
Preservations 0.59 0.01 Moderate positive 
Response Time Block Change -0.03 0.80 None 
Block Change Std Error 0.01 0.91 None 
 
 As Table 37 shows, age had a significant correlation on all but 4 subscales when 
comparing pre to post results across all samples.
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Table 38. 
Descriptive statistics Absolute change mean scores from pre to post measures 
 
    
T-test of gender 
  
  
T-test of diagnosis Typically developed 
sample 
ADHD sample Pearson Product 
correlation of age 
    Typically 
developed 
sample 
ADHD 
sample 
Male Female Male Female Typically 
developed 
sample 
ADHD 
sample 
Conners' 3 
Parent Rating 
Scale 
Learning Difficulties -0.89 -1.17 -0.89 -0.87 -0.87 -12.41 0.06 0.01 
Executive Functions -0.81 -2.11 -0.56 -0.75 -1.64 -5.08 -0.126 0.03 
Defiance -0.62 -1.67 -0.56 -0.44 -1.93 0.84 -0.03 0.17 
Inattention -2.81 -3.54 -3.33 -1.38 -2.72 -8.83 -0.261 0.256 
Hyperactive/Impulsive -2.44 -3.41 -1.93 -2.68 -3.25 -5.916 40.55 0.35 
Conners' 3 
Teacher Rating 
Scale 
Learning Difficulties -0.13 2.21 -0.51 0.61 2.21 - -0.64 0.14 
Executive Functions -1.29 1.43 -1.35 -0.47 1.43 - -0.51 -0.27 
Defiance -0.18 3.81 2.51 -3.81 3.81 - 21.77 -0.23 
Inattention -3.29 1.95 -2.4 -3.87 1.95 - -0.41 -0.28 
Hyperactive/Impulsive -4.93 13.13 -0.9 -1899.3 22.13 - 0.09 0.18 
Conners' CPT Omissions -5.41 8.91 -1.59 1.06 6.78 -21.00 0.04 0.11 
Commissions -0.99 -1.49 0.91 1.19 -2.69 -9.00 -0.2 -0.13 
Hit Response Time -39.82 62.69 -9.08 -10.96 44.93 -58.21 -0.05 0.58 
Hit Response Time Std Error -3.77 4.68 -0.39 -0.16 2.14 -6.52 0.05 -1.16 
Variability -10.74 11.96 -1.81 -0.44 4.39 -14.31 0.03 0.14 
Dectectability -0.02 0.05 -0.04 -0.14 0.064 0.41 0.18 0.04 
Response Style -0.32 0.05 -0.05 -0.078 -0.16 -0.73 0.16 -0.46 
Preservations -4.91 8.64 1.00 2.56 2.83 -4.54 0.46 -0.05 
Response Time Block Change -0.18 -0.05 -0.06 0.01 -0.002 -0.03 -0.15 -0.27 
Block Change Std Error -0.03 -0.07 -0.07 -0.01 -0.04 -0.11 0.004 -0.05 
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Paired t-tests were then conducted on each condition, comparing pre-to post measures on all the dependent variables (Table 39 to Table 
45).  This examined the main effect of intervention on the dependent variables.  
Table 39. 
Repeated measures T-test from pre-to post measure dependent variables on typically developed neurofeedback condition 
    Neurofeedback 
    Mean SD t d Sig. (2-tailed) 
Cohen's 
d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Conners' 3 
Parent 
Rating 
Scale 
Learning Difficulties 1.73 2.83 2.02 10.00 0.07 0.61 -0.17 3.62 
Executive Functions 1.55 2.66 1.93 10.00 0.08 0.58 -0.24 3.33 
Defiance 1.64 4.25 1.28 10.00 0.23 0.39 -1.21 4.49 
Inattention 4.18 7.11 1.95 10.00 0.08 0.59 -0.59 8.95 
Hyperactive/Impulsive 4.36 6.98 2.07 10.00 0.06 0.62 -0.32 9.04 
Conners' 3 
Teacher 
Rating 
Scale 
Learning Difficulties -4.33 7.51 -1.00 2.00 0.42 -0.58   
Executive Functions 0.33 0.58 1.00 2.00 0.42 0.57 -5.85 6.85 
Defiance -1.67 3.79 -0.76 2.00 0.53 -0.44   
Inattention -2.00 3.46 -1.00 2.00 0.42 -0.58 -6.85 5.85 
Hyperactive/Impulsive -2.38 12.68 -0.68 2.00 0.51 -0.19   
Conners' 
CPT 
Omissions -2.38 9.22 -0.93 12.00 0.37 -0.26 -11.37 3.04 
Commissions -33.95 147.93 -0.83 12.00 0.42 -0.23 -25.66 9.19 
Hit Response Time -2.36 7.31 -1.16 12.00 0.27 -0.32 -135.25 60.36 
Hit Response Time Std Error -4.79 18.82 -0.92 12.00 0.38 -0.25 -7.55 1.85 
Variability 0.03 0.42 0.30 12.00 0.77 0.07 -18.32 5.02 
Dectectability -0.13 0.35 -0.36 12.00 0.20 -0.37 -0.24 0.31 
Response Style -1.38 4.63 -1.08 12.00 0.30 -0.30 -0.35 0.11 
Preservations -0.43 1.43 -1.08 12.00 0.30 -0.30 -4.66 1.32 
Response Time Block Change 0.16 0.56 1.02 12.00 0.33 0.29 -0.21 0.54 
Block Change Std Error 0.18 0.57 1.15 12.00 0.27 0.32 0.17 0.55 
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Table 40. 
Repeated measures T-test from pre-to post measure dependent variables on typically developed control condition 
    Control 
    
Mean SD t d 
Sig. 
(2-
tailed) 
Cohen's 
d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Conners' 3 
Parent 
Rating 
Scale 
Learning Difficulties 0.80 1.78 14.00 0.10 0.45 1.00 -0.18 1.78 
Executive Functions -0.60 2.72 -0.85 14.00 0.42 -0.22 -2.10 0.91 
Defiance 0.00 1.85 0.00 14.00 1.00 0.00 -1.02 1.02 
Inattention 0.47 3.25 0.56 14.00 0.59 0.14 -1.33 2.26 
Hyperactive/Impulsive 0.00 3.51 0.00 14.00 1.00 0.00 -1.94 1.94 
Conners' 3 
Teacher 
Rating 
Scale 
Learning Difficulties 5.25 16.13 0.65 3.00 0.56 0.33 -5.31 3.31 
Executive Functions -1.00 2.71 -0.74 3.00 0.51 -0.37 -4.43 2.43 
Defiance -1.00 2.16 -0.93 3.00 0.42 -0.46 -9.32 13.82 
Inattention 2.25 7.27 0.62 3.00 0.58 0.31 0.71 3.29 
Hyperactive/Impulsive 1.60 8.42 0.74 14.00 0.47 0.19 -20.42 30.92 
Conners' 
CPT 
Omissions -0.33 6.29 -0.21 14.00 0.84 -0.05 -3.06 6.36 
Commissions 12.25 39.27 1.21 14.00 0.25 0.31 -10.33 8.65 
Hit Response Time 1.09 4.06 1.04 14.00 0.31 0.27 -9.51 33.99 
Hit Response Time Std Error 2.20 14.07 0.60 14.00 0.56 0.16 -1.15 3.34 
Variability 0.13 0.46 1.12 14.00 0.28 0.28 -5.59 9.98 
Dectectability 0.14 0.46 1.15 14.00 0.27 0.30 -0.12 0.38 
Response Style -1.60 6.49 -0.95 14.00 0.36 -0.25 -0.11 0.39 
Preservations -0.49 2.01 -0.95 14.00 0.36 -0.24 -5.19 1.99 
Response Time Block Change 0.00 0.04 -0.18 4.00 0.86 0.00 -0.02 0.02 
Block Change Std Error 0.00 0.12 -0.11 14.00 0.91 0.00 -0.06 0.06 
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Table 41. 
Repeated measures T-test from pre-to post measure dependent variables on typically developed active control condition 
    Active Control 
    
Mean SD t d 
Sig. 
(2-
tailed) 
Cohen's 
d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Conners' 3 
Parent 
Rating 
Scale 
Learning Difficulties 1.00 2.68 1.24 10.00 0.24 0.37 -0.80 2.80 
Executive Functions 1.36 298.00 1.52 10.00 0.16 0.46 -0.63 3.36 
Defiance 0.73 2.00 1.20 10.00 0.26 0.37 -0.61 2.07 
Inattention 3.45 2.91 3.94 10.00 0.01 1.19 1.49 5.41 
Hyperactive/Impulsive 3.16 4.64 2.27 10.00 0.05 0.69 0.06 6.30 
Conners' 3 
Teacher 
Rating 
Scale 
Learning Difficulties - - - - - - - - 
Executive Functions - - - - - - - - 
Defiance - - - - - - - - 
Inattention - - - - - - - - 
Hyperactive/Impulsive - - - - - - - - 
Conners' 
CPT 
Omissions -1.00 7.24 -0.52 13.00 0.61 -0.14 -5.21 6.78 
Commissions 30.60 52.97 2.16 13.00 0.05 0.58 -15.07 8.72 
Hit Response Time 1.35 5.12 0.99 13.00 0.34 0.26 0.00 61.17 
Hit Response Time Std Error 5.52 18.11 1.14 13.00 0.27 0.30 -1.60 4.31 
Variability 0.08 0.42 0.70 13.00 0.50 0.19 -4.93 15.97 
Dectectability 0.09 0.62 0.53 13.00 0.61 0.15 -0.16 0.32 
Response Style -2.50 7.18 -1.30 13.00 0.22 -0.35 -0.26 0.44 
Preservations -0.77 2.22 -1.30 13.00 0.22 -0.35 -6.64 1.64 
Response Time Block Change 0.01 0.03 0.81 13.00 0.43 0.33 -0.01 0.02 
Block Change Std Error 0.02 0.10 0.77 13.00 0.46 0.20 -0.03 0.08 
None of the interventions had a large effect size on CPRS, CTRS or CPT. 
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Table 42. 
Repeated measures T-test from pre-to post measure dependent variables on ADHD medication condition 
 
  Medication   
    
Mean SD t d Sig. (2-tailed) Cohen's d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Conners' 3 
Parent 
Rating Scale 
Executive Functions 3.00 4.27 2.81 15.00 0.01 0.70 0.72 5.27 
Defiance 2.88 4.38 2.63 15.00 0.02 0.66 0.54 5.21 
Inattention 5.44 4.86 4.48 15.00 0.01 1.12 2.84 8.02 
Hyperactive/Impulsive 6.38 8.12 3.14 15.00 0.00 0.79 2.04 10.70 
Conners' 3 
Teacher 
Rating Scale 
Learning Difficulties 1.67 1.15 2.50 2.00 0.13 1.45 -1.20 4.53 
Executive Functions -0.67 1.53 -0.76 2.00 0.53 -0.44 -4.46 3.12 
Defiance 1.33 2.31 1.00 2.00 0.42 0.58 -4.40 7.07 
Conners' 
CPT 
Omissions -6.13 22.95 -1.04 14.00 0.32 -0.27 -18.84 6.57 
Commissions 0.30 8.07 0.10 14.00 0.92 0.02 -11.83 13.04 
Hit Response Time -27.15 82.22 -1.28 14.00 0.22 -0.33 -72.68 18.38 
Hit Response Time Std Error -2.00 7.43 -1.04 14.00 0.31 -0.27 -6.11 2.11 
Variability -0.45 19.05 -0.09 14.00 0.93 -0.02 -12.44 28.91 
Dectectability 0.09 0.47 0.75 14.00 0.47 0.19 -0.16 0.35 
Response Style 0.27 1.95 0.54 14.00 0.69 0.14 -0.81 1.35 
Preservations -6.47 10.70 -2.34 14.00 0.03 -0.60 2.76 -12.39 
Response Time Block Change 0.01 0.03 1.53 14.00 0.15 0.33 -0.01 0.03 
Block Change Std Error 0.05 0.12 1.50 14.00 0.15 0.42 -0.01 0.11 
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Table 43. 
Repeated measures T-test from pre-to post measure dependent variables on ADHD medication and neurofeedback home training condition 
  Medication and Neurofeedback Home Training   
    
Mean SD t d Sig. (2-tailed) Cohen's d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Conners' 3 
Parent 
Rating 
Scale 
Executive Functions 2.00 4.73 1.04 5.00 0.35 0.42 -2.96 6.96 
Defiance 2.17 4.26 1.25 5.00 0.26 0.51 -2.31 6.63 
Inattention 3.83 5.34 1.76 5.00 0.14 0.72 -1.77 9.44 
Hyperactive/Impulsive 3.50 6.35 1.35 5.00 0.23 0.55 -3.16 10.16 
Conners' 3 
Teacher 
Rating 
Scale 
Learning Difficulties - - - - - - - - 
Executive Functions - - - - - - - - 
Defiance - - - - - - - - 
Conners' 
CPT 
Omissions 1.50 10.95 0.34 5.00 0.75 0.14 -9.99 12.99 
Commissions 5.83 7.68 1.86 5.00 0.12 0.70 -6.17 38.58 
Hit Response Time 12.93 4.66 0.73 5.00 0.50 0.30 -32.82 58.67 
Hit Response Time Std Error 3.53 6.87 1.30 5.00 0.24 0.53 -3.57 10.84 
Variability 8.25 19.79 1.02 5.00 0.35 0.42 -12.44 28.91 
Dectectability -0.24 0.34 -1.71 5.00 0.15 -0.71 -0.60 0.12 
Response Style 0.04 0.71 0.13 5.00 0.90 0.06 -0.71 0.78 
Preservations 0.33 20.74 1.11 5.00 0.32 0.45 -12.43 31.10 
Response Time Block Change 0.01 0.03 0.68 5.00 0.53 0.33 -0.02 0.03 
Block Change Std Error -0.03 0.17 -0.39 5.00 0.71 -0.18 -0.20 0.14 
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Table 44. 
Repeated measures T-test from pre-to post measure dependent variables on ADHD medication and neurofeedback in clinic condition 
 
  Medication and Neurofeedback Clinic Training   
    
Mean SD t d Sig. (2-tailed) Cohen's d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Conners' 3 
Parent 
Rating 
Scale 
Executive Functions 2.50 4.65 1.07 3.00 0.36 0.54 -4.91 9.91 
Defiance 3.00 6.06 0.99 3.00 0.39 0.50 -6.63 12.63 
Inattention 3.40 5.92 1.18 3.00 0.32 0.59 -5.91 12.91 
Hyperactive/Impulsive 5.75 10.53 1.09 3.00 0.35 0.55 -11.01 22/.508 
Conners' 3 
Teacher 
Rating 
Scale 
Learning Difficulties - - - - - - - - 
Executive Functions - - - - - - - - 
Defiance - - - - - - - - 
Conners' 
CPT 
Omissions -20.75 14.97 -2.77 3.00 0.07 -1.39 -44.57 3.07 
Commissions 3.75 4.03 1.86 3.00 0.16 0.93 -7.39 28.22 
Hit Response Time -27.73 48.23 1.15 3.00 0.33 -0.57 -104.48 49.01 
Hit Response Time Std Error -5.40 471.00 -2.29 3.00 0.11 -1.15 -12.89 2.09 
Variability -26.56 24.43 -2.17 3.00 0.12 -1.09 -65.42 12.31 
Dectectability -0.22 0.20 -2.15 3.00 0.12 -1.10 -0.54 0.11 
Response Style 0.57 0.73 1.57 3.00 0.21 0.78 -0.58 1.72 
Preservations -4.75 27.97 -0.34 3.00 0.76 -0.17 -49.25 39.75 
Response Time Block Change -0.02 0.07 -0.45 3.00 0.68 -0.29 -0.12 0.09 
Block Change Std Error 0.05 0.16 0.62 3.00 0.58 0.31 -206.00 0.31 
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Table 45. 
Repeated measures T-test from pre-to post measure dependent variables on ADHD neurofeedback in clinic condition 
  Neurofeedback Clinic Training   
    
Mean SD t d Sig. (2-tailed) Cohen's d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Conners' 3 
Parent 
Rating 
Scale 
Executive Functions -1.00 2.00 -0.87 2.00 0.48 -0.50 -5.96 3.96 
Defiance 1.00 4.36 0.40 2.00 0.73 0.23 -9.82 11.82 
Inattention -1.67 2.08 -1.39 2.00 0.30 -0.80 -6.83 3.50 
Hyperactive/Impulsive 0.67 6.03 0.19 2.00 0.87 0.11 -14.04 15.64 
Conners' 3 
Teacher 
Rating 
Scale 
Learning Difficulties - - - - - - - - 
Executive Functions - - - - - - - - 
Defiance  - - - - - - - 
Conners' 
CPT 
Omissions - - - - - - - - 
Commissions - - - - - - - - 
Hit Response Time - - - - - - - - 
Hit Response Time Std Error - - - - - - - - 
Variability - - - - - - - - 
Dectectability - - - - - - - - 
Response Style - - - - - - - - 
Preservations - - - - - - - - 
Response Time Block Change - - - - - - - - 
Block Change Std Error - - - - - - - - 
 
 154 
Table 46. 
Descriptive statistical and absolute change scores of dependent variables on typically developed sample conditions 
 
  
Neurofeedback Control Active Control 
  
 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Conners' 
3 Parent 
Rating 
Scale 
Learning Difficulties 10.33 9.00 -1.33 7.87 7.07 -0.80 10.25 9.25 -1.00 
Executive Functions 12.53 11.36 -1.17 8.27 8.87 0.60 11.83 9.67 -2.17 
Defiance 4.60 3.36 -1.24 3.07 3.07 0.00 3.08 2.08 -1.00 
Inattention 15.47 11.00 -4.47 8.53 8.07 -0.47 12.67 8.50 -4.17 
Hyperactive/Impulsive 13.80 10.36 -3.44 8.73 8.73 0.00 12.92 9.42 -3.50 
Conners' 
3 
Teacher 
Rating 
Scale 
Learning Difficulties 5.60 6.33 0.73 1.80 3.25 1.45 4.25 - - 
Executive Functions 6.60 8.67 2.07 4.80 5.75 0.95 10.75 - - 
Defiance 1.40 2.67 1.27 3.40 2.00 -1.40 6.75 - - 
Inattention 8.40 10.33 1.93 4.60 3.00 -1.60 16.50 - - 
Hyperactive/Impulsive 2.60 7.67 5.07 10.00 6.00 -4.00 19.50 - - 
Conners' 
CPT 
Omissions 14.67 18.43 3.76 15.47 13.87 -1.60 12.21 12.73 0.52 
Commissions 21.53 23.14 1.61 22.80 23.13 0.33 21.79 22.60 0.81 
Hit Response Time 379.62 411.73 32.11 410.79 398.55 -12.25 427.99 398.76 -29.23 
Hit Response Time Std Error 9.29 11.57 2.28 11.98 10.89 -1.09 11.31 10.06 -1.24 
Variability 19.09 23.73 4.64 24.37 22.17 -2.20 21.96 17.07 -4.89 
Dectectability 0.37 0.34 -0.02 0.39 0.25 -0.13 0.37 0.30 -0.06 
Response Style 0.57 0.75 0.18 0.69 0.55 -0.14 0.75 0.68 -0.07 
Preservations 4.00 5.57 1.57 7.20 8.80 1.60 6.71 8.93 2.22 
Response Time Block Change 0.14 0.01 -0.13 0.03 0.03 0.00 0.01 0.00 -0.01 
Block Change Std Error 0.19 0.05 -0.14 0.11 0.11 0.00 0.05 0.04 -0.01 
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When examining the effect size of the interventions in the ADHD sample, 
medication has a large effect size on CPRS executive function, hyperactive/impulsive.  
Medication and neurofeedback home training has a large effect size on CPRS 
inattention, and CPT commissions.  Medication and neurofeedback in clinic has a large 
effect size on CPT response style and a very large effect size on CPT commissions.  
 The neurofeedback condition saw an increase, worsening of results, in absolute 
change on many of the Conners’ Teachers Rating Scale and Conners’ CPT scales.  
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Table 47. 
Descriptive statistics and absolute change mean scores of dependent variables on ADHD sample conditions 
    Medication Medication and 
Neurofeedback Home 
Training 
Medication and 
Neurofeedback Clinic 
Neurofeedback Home 
Training 
  
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score     
Conners' 3 
Parent 
Rating Scale 
Learning Difficulties 10.83 9.53 -1.30 11.43 9.83 -1.60 14.50 14.75 0.25 10.00 11.00 1.00 
Executive Functions 14.50 11.65 -2.85 12.43 10.00 -2.43 14.25 11.75 -2.50 19.00 20.00 1.00 
Defiance 7.11 4.35 -2.76 11.43 10.17 -1.26 9.00 6.00 -3.00 7.33 6.33 -1.00 
Inattention 19.00 14.29 -4.71 17.57 12.67 -4.90 20.75 17.25 -3.50 23.00 24.67 1.67 
Hyperactive/Impulsive 22.78 16.88 -5.90 24.00 20.33 -3.67 24.00 18.25 -5.75 28.67 28.00 
 
Conners' 3 
Teacher 
Rating Scale 
Learning Difficulties 7.33 7.67 0.33 - - - - - - - 28.00 - 
Executive Functions 10.80 9.67 -1.13 - - - - - - - 54.00 - 
Defiance 5.83 2.67 -3.17 - - - - - - - 12.00 - 
Inattention 14.00 12.00 -2.00 - - - - - - - 16.00 - 
Hyperactive/Impulsive 8.80 3.00 -5.80 - - - - - - 
 
28.00 - 
Conners' 
CPT 
Omissions 13.53 19.33 5.80 26.57 13.17 -13.40 28.50 49.25 20.75 27.00 61.00 - 
Commissions 21.24 20.13 -1.10 25.00 20.00 -5.00 28.25 24.50 -3.75 32.00 20.00 - 
Hit Response Time 424.61 454.21 29.60 480.53 441.93 -38.61 488.49 516.22 27.73 366.70 595.55 - 
Hit Response Time Std Error 11.62 13.66 2.04 17.35 10.14 -7.21 19.99 25.39 5.40 19.88 38.97 - 
Variability 24.73 25.61 0.88 36.99 20.90 -16.09 39.05 65.61 26.56 51.34 113.32 - 
Dectectability 0.44 0.40 -0.04 0.26 0.47 0.22 0.05 0.27 0.22 0.00 0.85 - 
Response Style 0.97 0.71 -0.26 0.82 0.75 -0.07 1.44 0.87 -0.57 1.07 0.75 - 
Preservations 5.18 11.27 6.09 17.00 4.33 -12.67 27.00 31.75 4.75 43.67 85.00 - 
Response Time Block Change 0.02 0.00 -0.02 0.01 0.01 0.00 0.03 0.04 0.02 0.05 -0.01 - 
Block Change Std Error 0.11 0.05 -0.05 0.03 0.07 0.04 0.09 0.04 -0.05 0.15 -0.05 - 
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4.6 Discussion 
The present study investigated the differences of neuropsychological profiles 
between typically developed children and children with a diagnosis of ADHD.  
Comparisons took place pre and post interventions to understand the effect of 
neurofeedback home training on concentration and impulsive behaviours.  The main 
findings from prior and post interventions in turn, in relation to previous research, will 
now be discussed. 
4.6.1 Discussion Regarding Pre Measures 
In line with previous literature, it was hypothesised that there would be a 
significant difference between the ADHD and typically developed sample on the 
Conners’ 3 Parent Rating Scale (Snyder et al., 2008), with the ADHD sample showing 
significantly impaired results on the Conners’ 3 Parent and Teacher Rating Scales. 
The research presented in this thesis replicated this finding; the ADHD sample 
were significantly different from the typically developed sample, with the ADHD 
sample showing higher impairment on the executive functions, defiance, inattention, 
hyperactive/impulsive Conners’ 3 Parent Rating Subscales and learning difficulties, 
executive functions, inattention and hyperactive/impulsive Conners’ 3 Teacher Rating 
Subscales.  This finding replicates previous research on the different presentation 
between typically developed individuals and individuals with a diagnosis of ADHD, as 
rated by parents and teachers (Conners, 2008; Snyder et al., 2008; Tripp et al., 2006).  
Additionally, no effect was found for gender which supports previous research 
(Gianarris et al., 2001).   
It is interesting that both executive functions, inattention and 
hyperactive/impulsive subscales on the Conners’ 3 Parent and Teacher Rating Scales 
were significantly different in the ADHD sample compared to the typically developed 
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sample.  Difficulties in inattention are part of executive function, requiring activation, 
focus and effort (Brown, 2006).  Similarly, impulsivity requires executive function 
input by being able to inhibit a response (Barkley, 1997).  This evidence supports 
Barkley and Brown’s theories of ADHD, that the condition consists of impairments in 
executive functions, which overlap with inattention and impulsivity (Barkley, 2003).   
Based upon previous research, it was hypothesised that the ADHD sample 
would have higher scores, specifically commission and omission errors, on the CPT 
than the typically developed sample (Preston et al., 2000; McGee et al., 2000; Epstein 
et al., 2003; Advokat et al., 2007).  This research found a significant difference 
between the ADHD and typically developed sample on the preservations subscale, 
although this was not significant after Bonferroni correction.  Although this was not the 
omission and commissions subscales as expected, the ADHD sample did show more 
impairment on these scales, but not significantly.  This provides very limited support 
for previous literature that the CPTs are able to identify individuals with ADHD traits 
because only one of the 10 CPT items showed a statistically significant difference 
(Preston et al., 2005, McGee et al., 2000; Epstein et al., 2003; Advokat et al., 2007).  
Furthermore, this finding links other variables of CPT to the theories of ADHD.  
Although commission and omission errors are typically referred to (McGee et al., 
2000; Epstein et al., 2003; Advokat et al., 2007), the research in this thesis suggests 
that other CPT measures, such as preservations, is an indicator of inattention.  As both 
Barkley (1997) and Brown (2006) state, ADHD is caused by deficits in executive 
function, which includes the ability to sustain and shift attention. 
The reason for the lack of significant difference on the commission and 
omission errors could be due to the self-selecting nature of participants.  Specifically, 
based upon the researcher’s clinical experience, it is suggested that the ADHD 
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population may not have been a typical sample due to recruitment taking place from a 
private clinic setting.  The clinic was based in a wealthy area and participants had to 
pay to access the Centre, consequently being in a financial position to afford 
assessment.  Furthermore, individuals accessing the Centre were typically previously 
turned away from the National Health Service due to not meeting their criteria level.  
This may account for there not being a significant difference between the two samples 
as expected.    
McGee et al. (2000) found that Conners’ CPT was not correlated with age, 
showing appropriate age relative norms.  This was not a finding that was replicated in 
our study.  Instead, age had an effect on CPT performance, specifically a moderate 
negative relationship with CPT results, across both the ADHD and typically developed 
samples.  This would suggest that older children attend better or understand the task to 
complete it more effectively.  In practice, two seven-year-old children in the ADHD 
sample were unable to complete the task due to finding it difficult and older children 
persevering to complete it.    
In regard to gender, McGee et al. (2000) found that males with a diagnosis of 
ADHD made more commission errors, although this was not a robust finding.  Hasson 
et al. (2012) also found males with ADHD made more commission errors than 
omission errors and replicated this in a typically developed sample.  This finding was 
not produced in our study.  As mentioned previously, this could be due to the self-
selecting nature of participants and consequently skewed the data. 
4.6.2 Discussion Regarding Post Measures 
Based upon previous research, it was hypothesised that the typically developed 
sample who received neurofeedback home training would show greater improvement 
on neuropsychometric scales compared to the other conditions in that sample.  Previous 
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research has shown that neurofeedback can reduce CPT scores in typically developed 
adults (Vernon et al., 2003; Egner & Gruzelier, 2001).  As hypothesized, results in our 
study showed that the typically developed sample neurofeedback home training 
condition saw the most amount of absolute change mean scores across the typically 
developed sample, although not a statistically significant change.  Specifically, all of 
the Conners’ 3 Parent Rating subscales reduced, with the largest decreases across 
conditions in learning difficulties, defiance, inattention and hyperactive/impulsivity 
subscales.   
Vernon et al. (2003) examined adults completing neurofeedback, with a theta 
enhancing condition and a SMR enhancing condition.  Results showed SMR 
neurofeedback to improve CPT results, specifically attention.  Results in the present 
study showed neurofeedback created a worsening on CPT but an improvement on 
parent rating.  This evidence therefore conflicts with Vernon et al. (2003) findings.  
Previous research has shown potential negative side effects of neurofeedback, 
including inducing seizures (Vernon et al., 2004), irritability and moodiness (Monastra 
et al., 2002) with the present study showing neurofeedback home training potentially 
worsening concentration.  This could support Cortese et al. (2016) where evidence 
failed to support the use of neurofeedback as a treatment for ADHD in addition to 
Sonuga-Barke et al. (2013) where significant treatment effects of neurofeedback were 
non-existent when participants were blinded to intervention. 
However, many of the Conners’ 3 Teacher Rating subscales and CPT subscales 
in the neurofeedback home training condition in the typically developed sample 
increased, showing a worsening of concentration.  Specifically, an increase on 
executive function, defiance, inattention, and hyperactive/impulsive subscales of the 
Conners’3 Teacher Rating Scale, and an increase in CPT omissions, commissions, hit 
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response time, hit response time standard error and response style.  This supports 
Kaner (2011) and McGee et al. (2000) who found poor agreement on difficulties 
between rater’s responses.  Every individual will interpret behaviours differently 
depending on rater’s familiarity with the behaviour and situation of the observed 
behaviour (De Log Reyes & Kazdin, 2005).  The worsening of inattention as rated by 
teachers and CPT but improvement when rated by parents supports Snyder et al. (2008) 
who found that rating scales had an accuracy rate of 47-58% in identifying ADHD, 
likely to be due to informant bias.  The findings of positive outcome from parent’s 
report but not teacher report suggests possible parental bias due to subconscious bias 
by parents based on cognitive dissonance.  As parents have invested time and energy 
into participating in the research, they may be more likely to expect, and hope for, a 
positive outcome.  This supports Cortese et al. (2016) and Sonuga-Barke et al. (2013) 
where it was also found significant effects of nonpharmacological treatments when 
rated by individuals not blinded to the intervention, compared to blinded raters who 
showed non-significant effects.  This therefore highlights that the CPRS is a very 
subjective scale (Gianarris, Golden, & Greene, 2001) which is a weakness of this tool, 
and highlights the importance of other measures, such as a teacher rating scale or EEG.  
Additionally, it fails to support the use of neurofeedback as a treatment for ADHD as 
measured by parent, teacher and CPT. 
Unexpectedly, the active control condition in the typically developed sample 
saw a significant effect from pre to post measures in the CPRS subscales of inattention, 
hyperactive/impulsive and CPT commission subscales.  This was an unexpected 
finding as it was hypothesized that there would be no differences on Conners’ CPT 
omission and commission subscales, as well as Conners’ Parent/Teacher Rating Scales 
in the typically developed sample control and active control conditions.  However, 
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literature shows that video gaming can alter brainwave activity as well as attention 
skills.  Specifically, a more complex video game that is played, the faster brainwaves 
are produced to aid in extra concentration to successfully complete the game 
(Bakaoukas, Coada, & Liarokapis, 2015).  The evidence in this research supports this, 
with significant improvement in attention, as rated by parents, and on a less subjective 
measure, the CPT.   
 As expected, the ADHD sample saw larger absolute change mean scores in the 
CPRS and CTRS compared to the typically developed sample.  Specifically, in the 
ADHD sample, most absolute change mean scores on CPT were seen in the medication 
and neurofeedback home training condition, followed by the medication and 
neurofeedback in clinic condition.  When examining neurofeedback and stimulant 
medication independently in an ADHD sample, it is well established that stimulant 
medication is an effective treatment, having a positive effect in approximately 65% to 
77% of children (Barkley, 1997; Johnston et al., 2015) and improves CPT performance 
(Pearson et al., 2004).  Additionally, it is known that neurofeedback, when completed 
within a clinic, improves clinical outcomes with a large effect size on inattention and 
impulsivity (Arns et al., 2012).  As stated by Arns et al. (2009) further research is 
required to understand the impact of medication of neurofeedback.  In an ADHD 
sample, there were more and larger absolute change mean scores when medication was 
combined with neurofeedback in clinic than medication in isolation.  This suggests that 
for the best outcome for medication, it could be combined with neurofeedback, either 
in clinic or home training.  Unfortunately, due to the small sample size, the study was 
unable to assess the use of neurofeedback home training only and therefore it is not 
possible to make comparisons to the other conditions.  The lack of significant findings 
could be Type II error due to small sample sizes.  Additionally, as the present study is a 
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feasibility study with small samples, findings are treated as tentative for implications, 
and need to be replicated in a larger sample. 
Fuchs et al. (2003) conducted enhancing SMR neurofeedback on ADHD 
children for 36 sessions.  A reduction on Conners’ Behaviour Rating Scale, as 
completed by parents and teacher, as well as a moderate effect size was found.  In our 
study, when neurofeedback home training in an ADHD sample was completed, no 
moderate effect sizes were found.  However, when neurofeedback home training was 
combined with stimulant medication, a moderate effect size was found on CPRS 
subscales including defiance, inattention, and hyperactive/impulsive.  Similarly, when 
neurofeedback in clinic was combined with stimulant medication, a moderate effect 
size was found on all CPRS subscales.  However, there was not a significant difference 
from pre-to-post measures or between conditions.  Unfortunately, the finding was not 
replicated in teachers due to the small sample size.  Consequently, future research 
could replicate this research with a larger sample to examine if the improvements seen 
by parents is transferred to a school setting.  The findings in the present research show 
that neurofeedback in clinic or home training does not statistically significantly affect 
concentration.  Therefore, neurofeedback as a treatment for ADHD may not be as 
beneficial in the treatment of ADHD as previously thought, as suggested by a recent 
meta-analysis (Cortese et al., 2016).   
The present research is evidence to support the use of stimulant medication, 
with only this condition in the ADHD sample finding significant effects from pre to 
post measures.  Specifically, stimulant medication found a significant effect on 
Conners’ 3 Parent Rating Scale executive functions, defiance, inattention, and 
hyperactive/impulsive subscales.  This replicates findings from the meta-analysis, 
which found improvements on hyperactive/impulsive behaviours as rated by parents, 
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when long acting methylphenidate was used (Punja et al., 2013).  Additionally, the 
significant finding of stimulant medication improving executive functions, defiance, 
inattention, and hyperactive/impulsive subscales, supports the theories and causes of 
ADHD.  It is understood that ADHD is caused by deficits in executive functions 
(Barkley, 1997; Brown, 2006) as well as the role of dopamine (Tripp & Wickens, 
2009) with our finding suggesting that stimulant medication directly effects these 
deficits.  The lack of significant findings could be Type II error due to small sample 
sizes.  Additionally, as the present study is a feasibility study with small samples, 
findings are treated as tentative for implications, and need to be replicated in a larger 
sample.  Alternatively, neurofeedback may not be as effective as a treatment for 
ADHD, supporting Cortese et al. (2016). 
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5 Study Three: Effect of Neurofeedback on Electroencephalograms  
5.1 Introduction 
As previously discussed, neurofeedback has been shown to improve 
concentration and impulsivity in an ADHD sample (Lubar & Shouse, 1976; Arns et al., 
2014; Arns et al., 2009; Carmody et al., 2001; Fuchs et al., 2003; Kaiser & Othmer, 
2000; Rossiter, 2004; Rossiter & La Vaque, 1995).  Neurofeedback works by an 
individual learning to regulate levels of cortical arousal in the brain via visual and/or 
auditory reinforcement (Monastra, 2005), specifically via operant conditioning 
(Skinner, 1938).  However, the extent to which neurofeedback manipulates EEG is 
unclear with limited studies examining this (Lansbergen, Arns, Dongen-Boomsma, 
Spronk, & Buitelaar, 2011).   
Electroencephalograms (EEGs) collect electrical data from the cerebral cortex, 
specifically the electrical activity of neurons and information sent between areas of the 
brain, created by the central nervous system (Demos, 2004).  Postsynaptic changes are 
reflected in EEGs, tracking rapid changes in brain functioning. EEGs are digitally 
recorded and quantitatively analysed to inspect specific frequency and amplitude of 
electrical brain activity.  Brainwaves progress from the slow wave of delta, theta, alpha 
and SMR, to the fast wave of beta and gamma, each associated with varying 
behaviours (Demos, 2004). 
5.1.1 EEG Development 
Throughout childhood, as humans physically develop, our brain develops, and 
EEG patterns change.  During our first year of life, EEG patterns evolve through 
interactions with physical items in our surroundings.  Specifically, there is an increase 
in slow theta waves, 3-4 Hz at 3 months to 5Hz at 5 months, increasing further to 6-
7Hz at 12 months of age.  The pace of EEG development slows during the second year 
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of childhood, with theta rhythms developing while delta becomes more prominent.  At 
approximately 3-4 years old, EEG patterns are established in the alpha range, 
continuing to evolve when eyes are closed; while theta is becoming more noticeable.  
During the ages of 4 to 6 years old, a large brain growth occurs, increasing coherence 
in the frontal regions and left frontal-occipital coupling (Barry, Clarke, McCarthy, & 
Selikowitz, 2002).  A further EEG growth spurt occurs during 8 to 10 years old which 
involves increasing fronto-temporal connections in the right hemisphere.  A final 
growth spurt occurs at 11 to 14 years old, during which time synapses within the brain 
are either being formed or eliminated, a process known as synaptic pruning (Barry et 
al., 2002).  The first age-related resting state EEG study was conducted by Matousek 
and Petersen (1973), showing slow wave activity, namely delta and theta, were 
dominant up to the age of 4.  After this time, delta and theta decrease with an increase 
in age, with the rate of higher frequency waves, namely alpha and beta, increasing.  
In summary, in typically developed children, brain activity changes and 
develops with age; a process known as maturation.  Specifically, as a child gets older, 
there is a decrease in slow wave theta levels and an increase in beta levels (Bresnahan 
& Barry, 2002).   
With regards to EEG development and gender differences, findings show a 
maturational lag in males (Matousek & Petersen, 1973).  However, this gender 
difference disappears during adolescents.  Matousek and Petersen (1973) suggested 
that EEG differences showed early maturation in girls.  In 1980, Matthis, Scheffner, 
Benninger, Lipinski, and Stolzis sampled 285 healthy individuals aged 4 to 11 years 
old.  A 12 channel eyes closed resting state EEG was conducted.  Findings showed that 
girls, compared to boys, have higher levels of relative theta power and lower levels of 
fast alpha frequencies at the age of 6.  However, by age 11, girls have surpassed boys 
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in alpha in occipital regions, but girls have lower levels of alpha in frontal regions 
compared to boys. 
In a study of 40 healthy adults aged between 20 and 26, an 18 channel EEG 
with eyes closed resting state showed females to have a higher EEG amplitude.  
Specifically, females had significantly higher amplitude of theta, alpha and beta bands 
at 16 electrode locations: FP1, FP2, F7, F8, F3, Fz, F4, C3, C4, P3, Pz, P4, T5, T6, O1 
and O2.  The underlying reason for the male female EEG difference is not known, 
although thought that menstrual phase, smaller average women head size and skull 
thickness does not have an impact.  Consequently, age and gender matching is 
important when comparing samples (Wada, Takizawa, Zheng-Yan, & Yamaguchi, 
1994). 
Many neurodevelopmental conditions have been linked to differences in EEG 
patterns (Chabot, Michele, & Prichep, 2005; Cantor & Chabot, 2009).  Specific 
brainwaves associated with concentration and impulsivity difficulties will now be 
discussed.  
5.1.2 EEG and ADHD 
There is a large body of research that examines evidence of EEG patterns in 
individuals with Attention Deficit Hyperactivity Disorder (Monastra, 2008; Chabot et 
al., 2005; Chabot & Serfontein, 1996; Barry, Johnstone, & Clarke, 2003; Fonseca et al., 
2008; Cantor & Chabot, 2009; Bresnahan & Barry, 2002; Clarke, Barry, McCarthy, & 
Selikowitz,1998).  As research demonstrates, EEGs have a high rate of specificity and 
sensitivity in identifying individuals with ADHD (Fonseca et al., 2008; Chabot & 
Serfontein, 1996).  In a sample of 30 children with ADHD and 30 controls, aged 8 to 
11 years old, an eyes closed resting state EEG was recorded from 21 electrodes.  EEG 
had a rate of 83.3% sensitivity and specificity in correctly identifying ADHD (Fonseca 
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et al., 2008).  Another study showed quantitative EEGs to be 93.7% sensitive and had 
88% specificity to distinguish healthy children from children with a diagnosis with 
ADHD.  This was concluded from a study of 439 children with ADHD and 310 healthy 
children, aged between 6 and 17 years old who underwent an EEG eyes closed 
procedure for 20 minutes with 19 electrodes.  The specific EEG markers found in an 
ADHD population included theta/alpha excess with normal alpha mean frequency in 
frontal regions, and a second marker of theta/alpha excess in addition to decreased 
alpha mean frequency (Chabot & Serfontein, 1996).     
5.1.2.1 EEG and ADHD in Children 
Chabot et al. (2005) conducted a meta-analysis of EEG data of children and 
adolescents with ADHD.  With the development of technology and more EEG 
recording locations across the scalp, EEG activity in resting eyes closed conditions of 
children with ADHD are characterised by increased delta and theta and decreased 
alpha, specifically in the occipital region.     
The main EEG pattern in children with ADHD is an excess of theta waves in 
approximately 84 – 94% of individuals.  One study with such findings was conducted 
by Chabot and Serfontein (1996), whereby 439 children with ADHD and 310 healthy 
children, aged between 6 and 17 years old, underwent an eyes closed resting state EEG.  
Findings showed the ADHD population to have theta/alpha excess in the frontal 
regions with normal alpha mean frequency, or theta/alpha excess across the posterior 
and/or midline regions with decreased alpha mean frequency.  Furthermore, Fonseca et 
al. (2008) compared 30 children with ADHD to a healthy control sample during a 
resting EEG with eyes open.  Results showed ADHD participants had more absolute 
theta power, and diffuse increase in delta power across all but occipital regions, 
compared to healthy children.  Another example is by Chabot and Serfontein (1996).  
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A sample of 310 healthy children and 407 clinical children, 40% ADD, 43% ADHD, 
aged 6-12 years old, underwent a resting state eyes closed EEG using 19 electrodes.  
Children with ADHD had increased theta with decreased alpha mean frequency in 
frontal regions.   
Absolute and relative power provide reliable measures of quantifiable changes 
in EEG.  Absolute power refers to averaging the amplitude of every wave in a given 
bandwidth whereas relative power refers to dividing the absolute amplitude of one 
frequency by the sum of the absolute amplitudes of all the calculated frequency bands 
(Barry et al., 2003). 
As discussed in the previous section, power levels have been shown to be 
abnormal in individuals with ADHD (Chabot & Serfontein, 1996; Lubar, 1995).  
Usually their EEG profiles are characterised by increased theta, both absolute and 
relative power, in the frontal lobe with slight increase in alpha relative power (Chabot 
& Serfontein, 1996).  Lubar (1995) found that the power of theta compared to beta was 
different among children with ADHD, with the greatest difference being at the 10-20 
electrode locations of Cz and frontal regions, F3 and F4.  Absolute and relative power 
has been shown to be the most reliable EEG measures to demonstrate differences 
between ADHD and healthy controls, with many clinicians using this information to 
aid diagnosis due to its overall classification accuracy of 83.1% (Magee, Clarke, Barry, 
McCarthy, & Selikowitz, 2005).  The overall pattern in absolute and relative power 
research shows that individuals with ADHD exhibit increased slow wave activity in the 
frontal lobe, with an increase in absolute theta and relative theta, a pattern which has 
been replicated in males and females (Clarke, Barry, Bond, McCarthy, & Selikowitz, 
2002).     
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Another EEG measurement is coherence.  Coherence focuses on a particular 
bandwidth and measures the cross-spectral power between two electrodes (John, 
Prichep, & Easton, 1987) providing information regarding coupling of the brain 
activity across two electrodes (Barry et al., 2003).   Coherence provides information 
regarding the degree of connectivity between structures underlying a pair of electrodes 
(Dupuy, Clarke, Barry, McCarthy, & Selikowitz, 2008).   
There is some evidence to suggest abnormal coherence levels in individuals 
with ADHD, as demonstrated in the following literature.  Looking specifically at 
interhemispheric coherence, Montagu (1975) found that hyperactive children had 
higher levels of intrahemispheric coherence in 2Hz, 4Hz, 6Hz, and 8Hz compared to 
control groups.   
Barry et al. (2002) found increased intrahemispheric coherences at short-
medium inter-electrode distances but found reduced intrahemispheric coherences at 
longer electrode distances.  The sample consisted of 40 female children diagnosed with 
ADHD combined subtype, 40 ADHD inattentive subtype, and 40 control, all of which 
were aged 8 to 12 years old and completed a resting state eyes closed EEG.  Dupuy et 
al. (2010) demonstrated elevated frontal interhemispheric coherences in the theta band 
and that individuals with combined ADHD were reported to have increased laterality 
over short-medium interhemispheric distances.  This sample consisted of males aged 
between 8 to 12 years old diagnosed with ADHD and a control group, completing an 
EEG resting eyes closed measure.  The evidence of children with ADHD having 
elevated interhemispheric coherence suggests underdeveloped long axonal connections 
compared to control groups. 
Ratio is an EEG feature which refers to the relationship between brain 
frequencies compared to normal controls.  Initial findings showed that individuals with 
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ADHD had an increased theta and increased beta activity, therefore creating an 
abnormal theta/beta ratio compared to healthy peers (Lubar, 1991).  
Clarke et al. (2002) conducted eyes closed resting state EEG in 20 participants 
with ADHD and 20 healthy individuals, aged 8 to 12 years old.  Here it was found that 
individuals with ADHD had higher theta/alpha ratio compared to the control group.  
Arns et al. (2012) conducted a meta-analysis on theta/beta data during eyes open EEG.  
EEG recordings took place at Cz, with a sample of 1253 children with and 517 without 
ADHD, aged 6 to 18 years old.  Analysis found a decrease in theta/beta ratio across the 
years in the ADHD sample, whereas an increase in theta/beta ratio was seen in the 
healthy children.  It was concluded that excessive theta/beta ratio was not a reliable 
measure of ADHD.   
5.1.2.2 EEG and ADHD in Adults 
Bresnahan and Barry (2002) conducted research in adults with ADHD.  The 
sample consisted of 50 adults diagnosed with ADHD, 50 adults with ADHD symptoms 
but not diagnosed, and 50 controls.  EEG was completed in a resting state while eyes 
where fixated on a screen, using a 17 electrode cap.  Findings showed the ADHD 
group to have higher levels of absolute delta than the other two conditions, as well as 
more absolute and relative theta power, particularly at Cz.   
Straub et al. (2015) conducted a similar study, examining 33 adults with ADHD 
compared to 35 matched controls in an eyes closed resting state.  Analysis showed that 
the ADHD participants had significantly lower levels of arousal and less EEG 
vigilance as measured by EEG and the vigilance algorithm, compared to the controls.  
This was seen as a predictor of ADHD, as hyperactivity and sensation seeking is due to 
an unstable regulation of brain arousal. 
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The typical EEG pattern seen in ADHD is an excess of slow theta wave activity 
in the frontal regions of the brain (Monastra, 2008; Chabot et al., 2005; Chabot & 
Serfontein, 1996; Barry et al., 2003; Fonseca et al., 2008; Cantor & Chabot, 2009; 
Bresnahan & Barry, 2002; Clarke et al., 1998).  In typically developed children, brain 
activity changes and develops with age; a process known as maturation.  Specifically, 
as a child gets older, there is a decrease in slow wave theta levels and an increase in 
beta levels (Bresnahan & Barry, 2002).  The pattern seen in individuals with ADHD is 
similar to that seen in a child during development, indicating possible developmental 
delay in the maturation process in an individual with ADHD.  The research in adults 
with ADHD discussed here (Bresnahan & Barry, 2002; Struab et al., 2015) suggests 
that brain activity in ADHD populations do change with age, however they do not 
catch up with their counterparts.   
5.1.3 ADHD Subtypes and EEG Findings 
As previously discussed, according to the current DSM-5, there are three 
diagnostic subtypes of ADHD: ADHD inattentive, ADHD hyperactive impulsive and 
ADHD combined subtype (APA, 2013).   
 Research has found subtle differences in EEG abnormalities across the different 
ADHD subtypes.  Studies focusing on ADHD inattentive subtype concluded that their 
EEGs are characterised by generalised high levels of theta, particularly high in frontal 
regions, and generalised low levels of beta across the brain (Chabot et al., 2005).   
Barry et al. (2003) agreed with such findings, with a meta-analysis of EEG and ADHD 
research showing an increase in absolute and relative theta in the frontal regions in 
children with ADHD inattentive subtype.  Dupuy, Clarke, Barry, McCarthy, and 
Selikowitz (2010) found increased intrahemispheric beta coherence; higher levels of 
beta connection between structures underlying the pair of recording electrodes within 
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one hemisphere, specific to the combined subtype of ADHD.  This sample consisted of 
males aged between 8 to 12 years old diagnosed with ADHD and a control group, 
completing an EEG resting eyes closed measure.  
However, findings by Clarke et al. (1998) disagreed with this.  Clarke et al. 
(1998) conducted EEG in a resting eyes closed state using 21 electrodes with 60 
children aged 8 to 12 years old.  Twenty participants were diagnosed ADHD combined 
subtype, 20 were ADHD inattentive subtype and 20 were a control.  ADHD combined 
participants had greater levels of absolute and relative theta over all regions.  This was 
also the case in the ADHD inattentive subtype sample but less severe than ADHD 
combined subtype.  Barry et al. (2002) found similar results.  EEG was conducted in an 
eyes closed resting state on children aged 8 to 12 years old, 40 diagnosed ADHD 
combined subtype, 40 diagnosed ADHD inattentive subtype and 40 controls.  Findings 
showed individuals with ADHD inattentive and combined subtypes had the same 
abnormalities as each other, specifically high levels of interhemispheric coherences for 
delta and theta bands, but with the inattentive subtype being less deviant.  
5.1.4 EEG and Neurofeedback in ADHD 
Evidence suggests that using neurofeedback as a strategy for individuals 
diagnosed with ADHD can normalise EEG patterns as well as reduce inattentive and 
impulsive symptoms as a long-term strategy (Vernon et al., 2004).  However, there are 
very few studies that have looked at changes in EEG oscillations after neurofeedback 
training (Lansbergen, Arns, Dongen-Boomsma, Spronk, & Buitelaar, 2011).  Monastra 
et al. (2002) examined EEG changes after neurofeedback in an ADHD population.  
Here, 100 children aged 6 to 19 years old with a diagnosis of ADHD, underwent 
neuropsychological and EEG measures.  EEG was completed while participants 
underwent a performance task, such as reading, listening, drawing and recorded 
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activity between 4 to 8Hz and 13 to 21Hz.  Fifty participants received EEG 
neurofeedback downtraining theta and uptraining beta at Cz and Fz, with an average of 
43 sessions. Measures were completed a year after the initial measures.  Results 
showed a significant reduction in cortical slowing, which was only found in 
participants who received neurofeedback. 
A neurofeedback RCT study has been conducted examining the effects of 
neurofeedback and methylphenidate.  One hundred and twelve children with a 
diagnosis of ADHD ranging in age from 7 to 13 were involved.  The three conditions 
consisted of neurofeedback, 30 sessions of theta/beta training at Cz for 10 weeks, 
physical activity semi-active control group, and methylphenidate.  Pre to post EEG 
findings showed similar reduction in theta activity for individuals who received 
neurofeedback and methylphenidate.  However, individuals who received 
neurofeedback, with a theta/beta training protocol, showed greater overall reductions in 
ADHD symptoms as measured by rating scales.  Despite this success, improvement 
was not generalised to classroom behaviours (Janssen et al., 2016). 
 Although there is evidence on neuropsychological measures that neurofeedback 
improves ADHD symptoms (Carmody et al., 2001; Fuchs et al., 2003; Kaiser & 
Othmer, 2000; Rossiter, 2004; Rossiter & La Vaque, 1995), very little is known as to 
how EEG is affected.  Further research is required to understand the full affect 
neurofeedback has on underlying EEG in an ADHD population.  This is a vast area that 
needs to be examined further, an issue that aims to be addressed in this research by 
conducting EEGs prior and post neurofeedback treatment.   
5.1.5 EEG and Stimulant Medication 
There are several studies that have examined the effect of stimulant medication, 
in the treatment of ADHD, has on EEG.  Clarke et al. (2002) completed pre and post 
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eyes closed resting state EEG of 20 males with ADHD inattentive subtype and 20 
controls, aged 8 to 13 years old.  An EEG recording was conducted following a 6-
month stimulant medication trial.  Findings showed that medication produced changes 
in EEG towards normalization, with reduction in absolute and relative theta, 
theta/alpha and theta/beta ratios and increase in relative alpha and beta.  Similarly, 
Chabot, Orgil, Crawford, Harris, and Serfontein (1999) conducted an eyes closed 
resting EEG during an initial assessment, and repeated 10 months later following 
stimulant medication treatment which the child had taken on the day of repeat testing.  
This was conducted in a sample of 130 ADHD diagnosed children, aged 6 to 16 years 
old.  Results showed that 56.9% of the children had normalized EEG at the repeat 
testing, 33.8% were unchanged, and 9.3% had an increase in EEG abnormality. 
Clarke et al. (2005) completed an eyes closed resting state EEG, on 40 males 
aged 8 to 13 years old, 20 diagnosed with ADHD combined subtype.  The EEG was 
repeated after a 6-month medication trial and 1 hour after medication had been taken, 
but failed to identify any changes in coherence due to stimulant medication.  Dupuy et 
al. (2008) conducted a similar study in females, 20 females diagnosed ADHD 
combined subtype, 20 females diagnosed ADHD inattentive subtype and 20 control, all 
aged between 7 and 12 years old.  EEG eyes closed resting state was recorded pre and 
post a medication trial.  Again, there was no significant difference on coherence 
between the two EEGs in the ADHD conditions.   
As recently discussed, although there is little research, it is shown that 
neurofeedback can normalise EEG in ADHD (Vernon et al., 2004), and that stimulant 
medication in isolation can also normalise EEG in ADHD.  However, it is not known 
what effect neurofeedback and stimulant medication have in combination on EEG in 
ADHD.  Information regarding this interaction on the brain may aid in understanding 
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the root cause of ADHD, as well as the best combination of treatments to normalise 
abnormal brainwaves seen in ADHD.  This is an area that the research presented in this 
thesis aims to examine. 
5.2 Aims of the Study 
The present study firstly aims to examine EEG differences between an ADHD 
and typically developed sample.   
Secondly, the study aims to examine the effect of neurofeedback home training 
on EEG, in both an ADHD and typically developed sample.  This is an area that has 
not been previously investigated (Vernon et al., 2004; Rutterford et al., 2008).  As seen 
in the literature review, although there have been studies which have examined the 
effect of neurofeedback on ADHD symptoms (Lubar & Shouse, 1976; Arns et al., 
2014; Arns et al., 2009; Carmody et al., 2001; Fuchs et al., 2003; Kaiser & Othmer, 
2000; Rossiter, 2004), there are few studies which have examined the effect on 
brainwaves (Vernon et al., 2004; Lansbergen et al., 2011, Monastra et al., 2002).   
Thirdly, the study aims to examine the effect of stimulant medication in 
combination with neurofeedback home training on EEG.  It has been shown that 
neurofeedback can normalise EEG in ADHD (Vernon et al., 2004), and that stimulant 
medication in isolation can also normalise EEG in ADHD (Clarke et al., 2002; Chabot 
et al., 1999).  However, it is not known what effect neurofeedback and stimulant 
medication have in combination on EEG in ADHD.  Information regarding this 
interaction on the brain may aid an understanding of the root cause of ADHD, as well 
as the best combination of treatments to normalise abnormal brainwaves seen in 
ADHD.   
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5.3 Hypothesis 
Based on the previous research and the aims of the present study, the hypotheses 
for the pre-measures are as follows: 
• The ADHD sample will show more slow brain waves, specifically theta, SMR 
and alpha, across C3, Cz, and C4 than the typically developed sample. 
Based upon the previous research and the aims of the present study, the hypotheses 
for the post-measures are as follows: 
• The ADHD sample neurofeedback home training and medication condition 
will show the greatest increase in theta, alpha and SMR activity, across the 
two samples. 
• Across the typically developed sample, the neurofeedback home training 
condition will see the greatest change in theta, alpha and SMR activity.   
• No change will be seen in theta, SMR or alpha waves in the control or active 
control conditions in the typically developed sample. 
5.4 Methods 
 The present study followed the general methods previously set out in this thesis.  
For details regarding participants and interventions, see Chapter Two: General Methods. 
5.4.1 EEG Measures 
The EEG was acquired with a sampling rate of 500Hz and amplified before 
being converted into a digital format, using the Deymed TruScan system including 
TruScan Acquisition software.  The EEG was recorded from 19 electrode sites (FP1, 
FP2, F3, F4, C3, C4, P3, P4, O1, O2, F7, F8, T3, T4, T5, T6, Fz, Cz, Pz) in line with 
the International 10-20 System using an electrode cap and fixed in place by an elastic 
strap around the participant’s chest.  The prefrontal electrodes, namely FP1 and FP2, 
were additionally secured with disposable sponge disks.  Approximately 30 minutes 
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was spent fitting the electrodes with gel (which conducts electricity from the scalp to 
the electrode) being injected through the electrodes with a blunt syringe.  The EEG 
referenced to linked ears, using an additional electrode on the left and right mastoid.  
Impedance readings were kept below 5 kΩ.   
The EEG was recorded in two resting conditions: eyes open and eyes closed.  
Each condition was replicated 5 times in an alternating way, each of them lasting 1 
minute.   The EEG recording was completed while resting as it is a reliable measure 
that differentiates between ADHD and typically developed individuals as well as 
sensitive to any changes (Barry et al., 2003). 
This process was completed on 2 occasions with all participants, once at the 
beginning prior to any intervention, and again 15 weeks later after an intervention had 
taken place.  
5.5 Analysis 
 Power EEG data from the eyes closed resting condition was analysed using 
Brain Vision Analyser.  Unfortunately, data collection did not include the use of 
electrooculogram (EOG), electrical noise generated by eye movement.  Due to this, 
analysis was unable to remove EOG artefact from the eyes open data, and therefore 
was unable to analyse this data.  This was overcome by using eyes closed data.   
To convert the oscillatory activity in the EEG into a measured form, data was 
segmented into 300000ms bins.  Artefact correction took place, then a Fast Fourier 
Transform (FFT) was conducted to transform the data from time to frequency domain 
to express the frequency of each brainwave.  
5.6 Results 
 The EEG recording was completed at 2 time points, pre-measures before any 
intervention and post-measures after intervention, and specific bandwidths were 
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examined, alpha, SMR and theta.  Results are presented looking at each bandwidth in 
turn, firstly at pre-measures, secondly at post-measures, and finally comparing pre and 
post measures. 
5.6.1 Results from Alpha Bandwidths (8-12 Hz) 
5.6.1.1 Alpha Pre Measures 
 Firstly, descriptive statistics are provided for the data obtained on alpha in both 
samples.  The ADHD sample had a higher mean amplitude of alpha at Cz and C4 
compared to the typically developed sample, and the typically developed sample had a 
higher mean amplitude of alpha at Cz than the ADHD sample. 
Table 48. 
Descriptive statistics of alpha pre-measures 
  N Mean Std. 
Deviation 
Std. 
Error 
Mean 
Alpha C3 ADHD sample 39 6.65 6.82 1.09 
Typically developed sample 47 8.97 12.63 1.84 
Alpha Cz ADHD sample 39 7.37 7.92 1.27 
Typically developed sample 47 6.38 4.05 0.59 
Alpha C4 ADHD sample 39 7.01 7.02 1.12 
Typically developed sample 47 6.33 3.53 0.52 
 
 Next, a multivariate ANOVA was conducted to examine any effect of diagnosis 
and gender of total alpha scores. However, neither gender F (3, 80) =0.0.3, p<0.82; 
Wilk’s = 0.98, or diagnosis, F (3, 80) =0.85, p<0.46; Wilk’s = 0.96, had a significant 
effect on alpha.   
 Then, a t-test was conducted to examine any significant difference of 
alpha between the two samples: ADHD and typically developed, but again differences 
were not significant; alpha C3 (ADHD (M = 6.64, SD = 6.82) and typically developed 
(M = 8.97, SD = 12.62) samples; t(84) = -1.03, p = 0.306), alpha Cz (ADHD (M =7 .38, 
SD = 7.91) and typically developed (M = 6.38, SD = 4.04) samples; t(84) = 0.74, p = 
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0.45), and C4 (ADHD (M = 7.008, SD = 7.02) and typically developed (M = 6.33, SD = 
3.53) samples; t(84) = 0.57, p = 0.56). 
5.6.1.2 Alpha Post Measures  
Descriptive statistics are provided for the data obtained on alpha in both samples 
at the second data collection, post measures.  The means were very similar across all 
electrode locations in both samples. 
Table 49. 
Descriptive statistics of alpha post-measures 
  N Mean Std. 
Deviation 
Std. 
Error 
Mean 
Alpha C3 ADHD sample 32.00 6.19 2.14 0.38 
Typically developed sample 40.00 6.38 3.86 0.61 
Alpha Cz ADHD sample 32.00 6.75 3.42 0.61 
Typically developed sample 40.00 6.47 5.31 0.84 
Alpha C4 ADHD sample 32.00 6.79 3.07 0.54 
Typically developed sample 40.00 6.57 3.75 0.59 
 
Next, a multivariate ANOVA was conducted to examine any effect of diagnosis 
and gender of total alpha scores, but neither gender, F (3, 66) = 0.42, p<0.98; Wilk’s = 
0.99, or diagnosis, F (3, 66) = 0.19, p<0.89; Wilk’s = 0.99, had a significant effect on 
alpha. 
Then, a t-test was conducted to examine any significant difference of alpha 
between the two samples: ADHD and typically developed.  Alpha at C3 showed no 
significant difference between the ADHD (M = 6.19, SD = 2.14) and typically 
developed (M = 6.38, SD = 3.86) samples; t(70) = -0.24, p = 0.09, there was no 
significant difference at electrode Cz (ADHD (M = 6.74, SD = 3.42) and typically 
developed (M = 6.46, SD = 5.31) samples; t(70) = 0.25, p = 0.38, and C4 (ADHD (M = 
6.79, SD = 3.07) and typically developed (M = 6.57, SD = 3.74) samples; t(70) = 0.26, 
p = 0.28). 
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5.6.1.3 Alpha Comparison Pre to Post Measures 
 A paired t-test was conducted to examine any significant difference of alpha 
from pre to post measures across samples, but again differences were not significant 
(Alpha C3 pre (M = 8.57, SD = 11.409) and post (M = 6.27, SD = 3.22) measures; t(69) 
= 1.604, p = 0.11; alpha Cz pre (M = 7.24, SD = 6.66) and post (M = 6.59, SD = 5.82) 
measures; t(69) = 0.77, p = 0.43; alpha C4 pre (M = 7.02, SD = 5.82) and post (M = 
6.67, SD = 3.49) measures; t(69) = 0.46, p = 0.64). 
An absolute change score was calculated on mean scores across conditions in 
both samples, to see the extent on any change.   
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Table 50. 
Absolute change scores for alpha on typically developed sample conditions  
 
 In the typically developed sample, the largest absolute mean change was seen at alpha C3 in the control condition with a reduction in 
amplitude  
Table 51. 
Absolute change scores for alpha on ADHD sample conditions 
                          
   Medication Medication and Neurofeedback Home Training Medication and Neurofeedback Clinic Neurofeedback Home Training 
 
  Pre Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% 
Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% 
Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% 
Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% 
Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Alpha 
C3 7.403 5.51 -1.893 0.2 -2.63 6.408 5.64 7.37 1.73 -0.61 -3.96 1.03 7.41 8.02 0.62 -0.12 -8.56 7.33 5.04 3.52 -1.52 - - - 
Alpha 
Cz 7.46 5.92 -1.54 0.18 -2.51 5.58 5.99 9.504 3.514 0.84 -8.52 0.92 13.83 6.91 -6.92 0.41 -20.26 34.08 5.11 3.15 -1.96 - - - 
Alpha 
C4 7.903 5.87 -2.033 0.21 -2.69   6.43 9.49 3.06 -0.55 -9.83 3.07 8.19 7.44 -0.75 -0.15 -7.05 8.54 4.49 3.32 -1.17 - - - 
                         
                          
  Neurofeedback Control Active Control 
  Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% Lower 
Confidence 
Interval 
95%Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Alpha C3 6.14 6.4 0.29 0.06 -3.408 3.74 9.71 5.15 -4.56 0.32 -6.23 17.51 7.96 7.35 -0.61 0.11 -1.89 2.84 
Alpha Cz 6.04 6.2 0.15 0.06 -3.44 3.56 5.12 4.85 -0.27 0.76 -2.17 2.89 8.54 8.06 -0.48 0.05 -2.84 3.35 
Alpha C4 5.89 6.9 0.97 -0.11 -4.73 3.109 5.31 5.28 -0.03 0.82 -1.98 2.45 8.201 7.43 -0.7707 0.18 -1.34 2.58 
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In the ADHD sample, the largest absolute mean change after intervention was 
seen at alpha Cz in the medication and neurofeedback in clinic condition with a 
reduction in alpha amplitude compared to the other ADHD conditions.  The medication 
condition and neurofeedback home training condition saw a reduction in absolute mean 
change in alpha at all electrode locations, whereas the medication and neurofeedback 
home training condition saw an increase in absolute mean change in alpha at all 
electrode locations.  
5.6.2 Results from Theta Bandwidths (4-7 Hz) 
5.6.2.1 Theta Pre Measures 
Firstly, descriptive statistics are provided for the data obtained on theta in both 
samples.  The ADHD sample had a higher mean amplitude of theta at Cz and C4 
compared to the typically developed sample, and the typically developed sample had a 
higher mean amplitude of alpha at Cz than the ADHD sample. 
Table 52. 
Descriptive statistics of theta pre-measures 
  N Mean Std. 
Deviation 
Std. 
Error 
Mean 
Theta C3 ADHD sample 40.00 8.47 15.22 2.41 
Typically developed sample 47.00 9.49 12.82 1.87 
Theta Cz ADHD sample 40.00 9.02 13.89 2.20 
Typically developed sample 47.00 8.00 8.75 1.28 
Theta C4 ADHD sample 40.00 8.74 15.01 2.37 
Typically developed sample 47.00 7.63 7.45 1.09 
 
Next, a multivariate ANOVA was conducted to examine any effect of diagnosis 
and gender of total theta scores.  Neither gender F (3, 81) = 0.16, p<0.91; Wilk’s = 0.99, 
or diagnosis F (3, 81) = 0.69, p<0.5; Wilk’s = 0.97, had a significant effect on theta.   
Then, a t-test was conducted to examine any significant difference of theta 
between the two samples: ADHD and typically developed.   
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There was no significant difference of theta pre-measures between the ADHD 
and typically developed sample (theta C3 ADHD (M = 8.46, SD = 15.21) and typically 
developed (M = 9.49, SD = 12.82) samples; t(85) = -0.34, p = 0.73; theta Cz ADHD (M 
= 9.02, SD = 13.88) and typically developed (M = 7.99, SD = 8.75) samples; t(85) = 
0.41, p = 0.67; and theta C4 ADHD (M = 8.73, SD = 15.01) and typically developed (M 
= 7.63, SD = 7.44) samples; t(85) = 0.44, p = 0.65).  
5.6.2.2 Theta Post Measures 
Descriptive statistics are provided for the data obtained on theta in both samples.  
The ADHD sample had a higher mean amplitude of theta at C4 than the typically 
developed sample, and the typically developed sample had a higher mean amplitude of 
theta at C3 and Cz than the ADHD sample. 
Table 53. 
Descriptive statistics of theta post-measures 
 
Next, a multivariate ANOVA was conducted to examine any effect of diagnosis 
and gender of total theta scores.  Neither gender F (3, 66) = 2.22, p<0.88; Wilk’s = 0.99, 
or diagnosis F (3, 66) = 0.407, p<0.74; Wilk’s = 0.98, had a significant effect on theta. 
 Then, a t-test was conducted to examine any significant difference of theta 
between the two samples: ADHD and typically developed.   
There was no significant difference of theta post-measures between the ADHD 
and typically developed sample on any of the electrodes; theta C3 ADHD (M = 6.64, 
  N Mean Std. 
Deviation 
Std. 
Error 
Mean 
Theta 
C3 
ADHD sample 32.00 6.64 2.66 0.47 
Typically developed sample 40.00 6.84 3.91 0.62 
Theta Cz ADHD sample 32.00 7.72 4.78 0.84 
Typically developed sample 40.00 8.09 7.65 1.21 
Theta 
C4 
ADHD sample 32.00 7.19 4.56 0.81 
Typically developed sample 40.00 6.74 3.96 0.63 
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SD = 2.65) and typically developed (M = 6.83, SD = 3.91) samples; t(70) = -0.23, p = 
0.81; theta Cz ADHD (M = 7.72, SD = 4.77) and typically developed (M = 8.09, SD = 
7.65) samples; t(70) = -0.23, p = 0.81; and theta C4 ADHD (M = 7.18, SD = 4.56) and 
typically developed (M = 6.74, SD = 3.96) samples; t(70) = 0.44, p = 0.66). 
5.6.2.3 Theta Comparison Pre to Post Measures 
There was no significant difference of theta from pre to post measures (theta C3 
pre (M = 9.97, SD = 15.33) and post (M = 6.76, SD = 3.42) measures; t(69) = 1.69, p = 
0.09; theta Cz pre (M = 9.28, SD = 12.504) and post (M = 7.97, SD = 6.56) measures; 
t(69) = 0.75, p = 0.45; theta C4 pre (M = 8.88, SD = 12.69) and post (M = 6.95, SD = 
4.26) measures; t(69) = 1.207, p = 0.23). 
Next, a between subjects repeated multivariate ANOVA was conducted to 
examine any effect of diagnosis and gender of total theta scores across samples.  Neither 
gender F (2, 65) = 0.22, p<0.79; Wilk’s = 0.99, or diagnosis, F (2, 65) = 0.04, p<0.95; 
Wilk’s = 0.99, had a significant effect on theta. 
 An absolute change score was calculated on mean scores across conditions in 
both samples, to see the extent on any change.  
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Table 54. 
Absolute change scores for theta on typically developed sample conditions 
  Neurofeedback Control Active Control 
  Pre Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Theta C3 8.24 8.12 -0.12 0.11 -6.61 8.91 5.65 6.43 0.78 -0.15 -3.13 1.91 11.55 6.15 -5.4 0.37 -2.93 13.47 
Theta Cz 8.26 9.98 1.72 -0.05 -11.6 9.85 5.62 6.29 0.67 -0.15 -2.77 1.71 11.42 8.23 -3.19 0.17 -6.91 12.63 
Theta C4 8.24 7.81 -0.43 0.11 -6.62 9.19 5.28 6.09 0.81 -0.17 -3.11 1.81 10.66 6.43 -4.23 0.37 -2.38 10.58 
 
In the typically developed sample, the largest absolute mean change was seen at theta in the active control condition with a reduction in 
amplitude at C3, Cz and C4.  On the other hand, the control condition saw an increase of theta at all three electrode locations.    
Table 55. 
Absolute change scores for theta on ADHD sample conditions 
 
  Medication Medication and Neurofeedback Home Training Medication and Neurofeedback Clinic Neurofeedback Home Training 
  Pre Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% Lower 
Confidence 
Interval 
95% 
Upper 
Confide
nce 
Interval 
Pre 
Mean 
Post 
Mean 
Abso
lute 
Chan
ge 
Score 
Cohen’s 
d 
95% 
Lower 
Confidenc
e Interval 
95% 
Uppe
r 
Confi
dence 
Inter
val 
Pre 
Mean 
Post 
Mean 
Absolut
e 
Change 
Score 
Cohe
n’s d 
95% 
Lower 
Confide
nce 
Interval 
95% 
Upper 
Confi
dence 
Interv
al 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen
’s d 
95% 
Lower 
Confide
nce 
Interval 
95% 
Upp
er 
Con
fide
nce 
Inter
val 
Theta C3 5.42 6.29 0.87 -0.41 -1.89 0.14 6.44 7.82 1.38 -0.61 -2.81 0.73 32.8 6.98 -25.8 0.58 -45.5 97.2 5.33 3.48 -1.85 - - - 
Theta Cz 5.71 7.11 1.39 -0.6 -2.49 -0.28 6.73 10.7 3.95 -0.55 -12.11 3.82 36.5 6.71 -29.8 0.81 -28.5 88.1 6.23 2.92 -3.31 - - - 
Theta C4 5.83 6.39 0.56 -0.21 -1.79 0.68 7.51 9.66 2.16 -0.31 -9.78 5.42 32.3 7.49 -24.8 0.54 -47.8 97.4 5.32 3.47 -1.85 - - - 
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In the ADHD sample, the largest absolute mean change was seen at theta in the 
medication and neurofeedback clinic condition.   
5.6.3 Results from SMR Bandwidths (12-15 Hz) 
5.6.3.1 SMR Pre Measures 
Descriptive statistics are provided for the data obtained on SMR in both 
samples.  The typically developed sample had a higher amplitude of SMR at all three 
electrode locations. 
Table 56. 
Descriptive statistics of SMR pre-measures 
  N Mean 
Std. 
Deviation 
Std. Error 
Mean 
SMR C3 ADHD sample 40 2.49 4.29 0.68 
Typically developed sample 47 3.62 4.93 0.72 
SMR Cz ADHD sample 40 2.19 2.84 0.45 
Typically developed sample 47 3.08 4.02 0.59 
SMR C4 ADHD sample 40 2.43 4.33 0.68 
Typically developed sample 47 2.82 3.25 0.47 
 
 Next, a multivariate ANOVA was conducted to examine any effect of diagnosis 
and gender of total SMR scores.  Neither gender F (3, 81) = 0.49, p<0.68; Wilk’s = 
0.98, or diagnosis F (3, 81) = 1.24, p<0.31; Wilk’s = 0.95, had a significant effect on 
SMR.   
 Then, a t-test was conducted to examine any significant difference of SMR 
between the two samples: ADHD and typically developed.  There was no significant 
difference of SMR pre-measures between the ADHD and typically developed sample 
(SMR C3 ADHD (M = 2.49, SD = 4.29) and typically developed (M = 3.62, SD = 4.92) 
samples; t(85) = -1.13, p = 0.26; SMR Cz ADHD (M = 2.18, SD = 2.83) and typically 
developed (M = 3.08, SD = 4.02) samples; t(85) = -1.17, p = 0.24; SMR C4 ADHD (M 
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= 2.43, SD = 4.32) and typically developed (M = 2.82, SD = 3.25) samples; t(85) = -
0.47, p = 0.63). 
5.6.3.2 SMR Post Measures 
Descriptive statistics are provided for the data obtained on SMR in both 
samples.  The typically developed sample had a higher amplitude of SMR at all three 
electrode locations. 
Table 57. 
Descriptive statistics of SMR post-measures 
 
 Next, a multivariate ANOVA was conducted to examine any effect of diagnosis 
and gender of total SMR scores.  Neither gender F (3, 66) = 0.24, p<0.86; Wilk’s = 
0.98, or diagnosis F (3, 66) = 0.53, p<0.66; Wilk’s = 0.97, had a significant effect on 
SMR. 
 Then, a t-test was conducted to examine any significant difference of SMR 
between the two samples: ADHD and typically developed.  There was no significant 
difference of SMR post-measures between the ADHD and typically developed sample 
(SMR C3 ADHD (M = 1,96, SD = 0.76) and typically developed (M = 2.02, SD = 
1.207) samples; t(70) = -0.26, p = 0.79; SMR Cz ADHD (M = 2.003, SD = 1.01) and 
typically developed (M = 2.23, SD = 1.93) samples; t(70) = -0,62, p = 0.53; SMR C4 
ADHD (M = 2.05, SD = 1.31) and typically developed (M = 2.23, SD = 1.14) samples; 
t(70) = -0.62, p = 0.53). 
  N Mean Std. 
Deviation 
Std. 
Error 
Mean 
SMR C3 ADHD sample 32 1.960 0.797 0.141 
Typically developed sample 40 2.03 1.21 0.19 
SMR Cz ADHD sample 32 2.00 1.02 0.18 
Typically developed sample 40 2.24 1.93 0.31 
SMR C4 ADHD sample 32 2.05 1.31 0.23 
Typically developed sample 40 2.23 1.15 0.18 
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5.6.3.3 SMR Comparison Pre to Post Measures 
There was a significant difference of SMR from pre to post measures on SMR 
C3 (SMR C3 pre (M = 3.37, SD = 5.15) and post (M = 2.02, SD = 1.04) measures; t(69) 
= 2.16, p = 0.03) although this was not significant after Bonferroni correction 
(calculation of 0.05/3 = p value of 0.016).  Consequently, this was replicated in the 
separate samples to see where the significance lay. 
The typically developed showed significant change in SMR at electrode C3 from 
pre to post measures (SMR C3 pre (M = 3.93, SD = 5.36) and post (M = 2.05, SD = 
1.209) measures; t(38) = 2.13, p = 0.04) although this was not significant after 
Bonferroni correction (calculation of 0.05/3 = p value of 0.016).  . 
Next, a between subjects repeated multivariate ANOVA was conducted to 
examine any effect of diagnosis and gender of total SMR scores across samples.   
Neither gender F (2, 65) = 0.503, p<0.607; Wilk’s = 0.98, or diagnosis, F (2, 65) =0 .88, 
p<0.42; Wilk’s = 0.97, had a significant effect on SMR. 
 An absolute change score was calculated on mean scores across conditions in 
both samples, to see the extent on any change.   
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Table 58. 
Absolute change scores for SMR on typically developed sample conditions 
 
 
In the typically developed sample, the largest absolute mean change was seen at SMR Cz and C4 in the active control condition with a 
reduction in amplitude.   
Table 59. 
Absolute change scores for SMR on ADHD sample conditions 
In the ADHD sample, the largest absolute mean change was seen at SMR C3 and C4 in the medication condition with a reduction in 
amplitude, and SMR Cz in the medication and neurofeedback in clinic condition.
  Neurofeedback Control Active Control 
  Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
SMR C3 2.72 2.27 -0.45 0.27 -0.68 1.73 3.38 1.54 -1.84 0.37 -1.55 5.89 3.91 2.22 -1.69 0.29 -1.59 4.78 
SMR Cz 2.56 2.33 -0.23 0.07 -1.04 1.39 2.005 1.72 -0.285 0.22 -0.602 1.24 5.22 2.64 -2.58 0.42 -0.93 5.87 
SMR C4 2.69 2.59 -0.1 0.05 -1.09 1.37 1.97 1.98 -0.01 0.01 -0.77 0.809 4.19 2.19 -2.00 0.34 -1.33 5.18 
  Medication Medication and Neurofeedback Home Training Medication and Neurofeedback Clinic Neurofeedback Home Training 
  Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% 
Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% 
Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% 
Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
Pre 
Mean 
Post 
Mean 
Absolute 
Change 
Score 
Cohen’s 
d 
95% 
Lower 
Confidence 
Interval 
95% Upper 
Confidence 
Interval 
SMR C3 3.09 1.6 -1.46 0.24 -1.49 4.406 1.6 2.4 0.79 -0.88 -2.23 0.19 2.41 2.4 0.01 0 -3.53 3.52 1.9 1.23 -0.7 - - - 
SMR Cz 2.29 1.7 -0.62 0.18 -1.04 2.28 1.5 2.76 1.22 -1.43 -2.49 -0.38 3.59 1.8 -1.8 0.36 -6.02 9.57 1.6 1.01 -0.6 - - - 
SMR C4 3.04 1.6 -1.47 0.23 -1.54 4.501 1.8 3.19 1.42 -0.87 -3.78 0.34 2.47 2.1 -0.4 0.18 -3.24 4.08 1.4 0.97 -0.4 - - - 
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5.7 Discussion 
The present study investigated the difference in EEG profiles, specifically alpha, 
theta and SMR activity over the central motor strip at C3, C4 and Cz, between typically 
developed children and children with a diagnosis of ADHD.  Comparisons between the 
two samples took place pre and post interventions.  We shall look at the main findings 
from both prior and post interventions in turn. 
5.7.1 Discussion Regarding Pre Measures 
Based upon previous research, it was hypothesised that there would be a greater 
amount of alpha, theta and SMR waves, across C3, Cz and C4 in the ADHD sample 
(Barry et al., 2003; Fonseca et al., 2008).  Findings from this research showed no 
significant difference between alpha, theta or SMR across these electrodes between the 
typically developed and ADHD sample, before interventions took place.   
Unfortunately, due to a design flaw, the present study was unable to use eyes 
open data as EOG data were not collected and therefore eye blinks were unable to be 
screened for.   
The research presented in this thesis did not find an effect of gender in either 
sample or EEG bandwidths.  This was contrary to Matthis et al. (1980), who found 
healthy girls had higher levels of relative theta power and lower levels of fast alpha 
frequencies at the age of 6, compared to boys.  However, by age 11, girls had surpassed 
boys in alpha in occipital regions but deficiencies in alpha frontal regions.  The reason 
for lack of evidence in this research could be due to the small sample size, particularly a 
small sample of females in the ADHD sample (typically developed sample were 68% 
male, 32% female, whereas the ADHD sample were 85% male and 15% female). 
One possible reason for the lack of significant difference on the EEG measures 
could be due to the self-selecting nature of participants.  Specifically, based upon the 
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researcher’s clinical experience, it is suggested that the ADHD population may not 
have been a typical sample due to recruitment taking place from a private clinic setting.  
The clinic was based in a wealthy area and participants had to pay to access the Centre, 
consequently being in a financial position to afford assessment.  Furthermore, 
individuals accessing the Centre were typically previously turned away from the 
National Health Service due to not meeting their criteria level.  This may account for 
there not being a significant difference between the two samples as expected.    
5.7.2 Discussion Regarding Post Measures 
Based upon previous research regarding the use of neurofeedback, it was 
hypothesised that the ADHD sample would show the greatest differences on EEG 
results, particularly across the C3, Cz, and C4 electrodes, compared to the typically 
developed sample (Egner & Gruzelier, 2001; Vernon et al., 2003; Vernon, 2005; Fritson 
et al., 2007; Carmody et al., 2001; Fuchs et al., 2003; Kaiser & Othmer, 2000; Rossiter, 
2004; Rossiter & La Vaque, 1995).  It was unexpected to find that there were no 
significant difference on alpha, theta and SMR bandwidths between the two samples 
after completion of the interventions.  
A possible reason for the lack of significant difference is that in the ADHD 
conditions, there was a small sample per condition that may have skewed the results.  
The small sample size was due to recruitment difficulties, specifically in the 
neurofeedback conditions.  With regard to the neurofeedback home training conditions, 
the research had limited access to neurofeedback equipment only enabling 3 
neurofeedback participants at any one time.  Participation in the research was a long 
process with each participant completing the intervention at home for almost 4 months.  
These two difficulties combined meant that, particularly for the neurofeedback home 
training conditions, recruitment was limited.  Additionally, recruitment for the 
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neurofeedback in clinic condition was poor as individuals needed to live in close 
proximity to the Centre to access neurofeedback. This limited the target population.   
Alternatively, it may be that the interventions, specifically neurofeedback, did 
not have the impact on the brainwaves as was expected (Egner & Gruzelier, 2001; 
Vernon et al., 2003).   
The typically developed sample saw the largest amount of absolute change mean 
scores in the SMR bandwidth when comparing pre to post measures.  This was 
expected, as the typically developed sample received SMR uptraining in the 
neurofeedback home training condition.  However, the largest absolute change mean 
scores were in the active control condition, not the neurofeedback home training 
condition. Furthermore, the active control group saw the largest amount of absolute 
change scores across alpha, theta and SMR.  Specifically, the active control condition 
saw a decrease in all theta readings as well as alpha at Cz, SMR at Cz and C4.  This 
suggests that sitting and focusing on a computer-based programme can alter 
brainwaves, specifically reduce slow brainwave activity.  Computer use is a growing 
area due to the vast development of technology and its use in our everyday lives.  
Literature shows that video gaming can alter brainwave activity as well as attention 
skills.  Specifically, a more complex video game that is played, the faster brainwaves 
are produced to aid in extra concentration to successfully complete the game 
(Bakaoukas et al., 2015).  It has been suggested that video gaming can alter neural 
plasticity because video games require an individual to process complex events in a 
specific sequence as well as to respond quickly and rapidly (Gong et al., 2016).  The 
findings in this research supports the ever-changing neural plasticity of children and 
how brain activity can be altered by participating in a computer-based activity.  Future 
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research involving gaming should include some form of brain activity measures, to 
understand the impact it is having on the brain.   
In regard to the ADHD sample, most absolute mean change scores on EEG 
measures were seen in the medication and neurofeedback in clinic condition, although 
this was not statistically significant.  As an outcome of the combined interventions, 
alpha at Cz and SMR at Cz were within the same range as the typically developed 
sample.  This trend suggests that neurofeedback may alter brainwave activity.  
However, this was only achieved when neurofeedback took place in clinic and in 
conjunction with stimulant medication, suggesting the role of the clinician in the 
neurofeedback process may impact on the success of the intervention.  The role of the 
clinician in neurofeedback has not been previously considered and is an area that 
requires further investigation (Vernon et al., 2004; Rutterford et al., 2008).  On the other 
end of the scale, the condition with the least amount of changes was the neurofeedback 
home training condition.  Again, this supports that the role of the clinician is important 
in administering neurofeedback but also the possibility that the home may not be a very 
controlled environment to conduct such treatment. 
Previous research of neurofeedback in an ADHD child population showed a 
reduction in cortical slowing following downtraining theta and increasing beta at Cz and 
Fz (Monastra et al., 2002).  The present study found similar results, with the 
neurofeedback home training condition showing the largest trend of reduction in theta 
compared to neurofeedback home training and medication.   
When considering the effect of medication on the brain, Clarke et al. (2002) 
found that medication produced changes in EEG towards normalization, with reduction 
in absolute and relative theta.  The present results did not support this, with the 
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stimulant medication only condition showing an increase in theta and a decrease in 
alpha.  
Furthermore, when examining neurofeedback compared to medication, previous 
EEG findings showed similar reduction in theta activity for both conditions, with the 
neurofeedback condition showing greater overall reductions in ADHD symptoms as 
measured by rating scales.  However, the present study was unable to replicate these 
findings.  Specifically, medication saw an increase in theta, and neurofeedback home 
training having a decrease in theta, with the latter finding similar to that of Janssen et al. 
(2016).  
Both of these findings are unexpected.  The reasons for these results are unclear, 
whether it is due to small sample size or the nature of the samples.  As previously 
discussed, the typically developed sample may not have been a true typical sample due 
to self-selecting participation.  Although a lack of diagnosis was screened for, possible 
undiagnosed difficulties were not.  Similarly, the ADHD sample were recruited from a 
private Centre.  The Centre was based in a wealthy area and participants had to pay to 
access the Centre, consequently being in a financial position to afford assessment.  
Furthermore, individuals accessing the Centre were typically previously turned away 
from the National Health Service due to not meeting their criteria level.  This may 
account for there not being a significant difference between the two samples as 
expected.  Furthermore, the lack of significant findings could be Type II error due to 
small sample sizes.  Additionally, as the present study is a feasibility study with small 
samples, findings are treated as tentative for implications, and need to be replicated in a 
larger sample. 
In summary, the results from the electroencephalogram and neurofeedback home 
training study revealed no significant effect in either ADHD or typically developed 
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sample.  The ADHD neurofeedback home training condition saw the least EEG changes 
and the medication only and medication combined with neurofeedback in clinic saw the 
largest improvements in EEG. 
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6 General Discussion 
This thesis examined the effectiveness of neurofeedback home training on 
concentration and impulsivity difficulties in children.  Data were collected from a 
typical and ADHD child population. Analysis examined differences between the two 
populations as well as the effect of neurofeedback home training on EEG measures, 
personality, concentration, and impulsivity as measured by neuropsychological 
measures.  
The main findings were: 
Pre measures: 
• The ADHD sample were significantly affected on all Conners’ 3 Parent 
Rating subscales compared to the typically developed sample. 
• The ADHD sample were significantly more impaired on CPT 
preservations than the typically developed sample, although not 
significant after Bonferroni correction. 
• There were no significant differences on personality or EEG measures 
between the 2 samples. 
Post measures: 
• Within the typically developed sample, the active control condition had 
the most amount of absolute mean change, with an increase in SMR at 
C4 and C3, alpha at Cz and theta at Cz, C3 and C4, as well as an increase 
in BIS, BAS fun and BAS reward but was not statistically significant.   
• The typically developed neurofeedback home training condition saw the 
most improvement in the Conners’ 3 Parent Rating Scale with a 
reduction in symptoms, specifically on learning difficulties, defiance, 
inattention and hyperactive/impulsivity, but teachers saw an increase in 
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difficulties, specifically executive functions, defiance, inattention and 
hyperactive/impulsive but was not statistically significant. 
• Within the ADHD sample, the medication condition had a statistically 
significant improvement in the executive function, defiance, inattention 
and hyperactive/impulsive subscales of the Conners’ 3 Parent Rating 
Scale. 
• The ADHD medication and neurofeedback in clinic condition saw the 
most improvement on EEG measures, including theta at Cz, C3 and C4, 
alpha at Cz and SMR at Cz but was not statistically significant.   
• In the ADHD sample, the neurofeedback home training condition had the 
largest change on personality, with an increase in BIS and decrease in 
BAS drive but was not statistically significant. 
• The ADHD neurofeedback home training and medication condition saw 
the most change with an improvement on CPT, including commission, 
hit response time, and preservations but was not statistically significant.   
These findings are discussed below.  This chapter considers the findings in 
relation to theories of ADHD.  Finally, the implications of this research for clinical 
applications and future research are outlined. 
6.1 Summary of Experimental Findings  
6.1.1 Summary of experimental findings comparing ADHD and typically developed 
samples 
Prior to interventions being conducted, comparisons took place between the two 
populations and the way they present on neuropsychological, personality and brainwave 
measures.   
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 The present study found that the ADHD sample were significantly affected on 
all Conners’ 3 Parent Rating subscales, 4 of the Conners’ 3 Teacher Rating subscales, as 
well as more impaired on CPT hit response time standard error and preservations, 
compared to the typically developed sample.  Significant impairment on parental and 
teacher ratings replicates previous research, including Biedermann et al., 2001; Snyder 
et al., 2008; Conners, 2008; Tripp et al., 2006.  This research also found a significant 
difference, although not significant after Bonferroni correction, between the ADHD and 
typically developed sample on the CPT preservations scores, showing impulsivity.  
Although significant difference on omission and commissions subscales was not found 
as expected (Gianarris et al., 2001; Epstein et al., 2003; Epstein et al., 2010; Advokat et 
al., 2007), the ADHD sample did show more impairment on these scales and showed 
inattention and impulsive abnormalities on other scales.  Combining the results from the 
parental and teacher rating scales, and from the CPT, gives results that support previous 
theories of ADHD.  Executive functions, inattention, hyperactivity and impulsivity were 
significantly different in the ADHD sample compared to the typically developed sample 
when rated by parents, teachers and on CPT subscales.  This supports Barkley’s 
Behavioural Response Inhibition Theory, where ADHD is explained as a deficit in a 
specific area of executive function, namely inhibition response, which overlaps with 
inattention and impulsivity (Barkley, 1997).  All of these areas, namely executive 
functions, inattention and impulsivity, were significantly different between ADHD and 
typically developed sample when rated by parents, teachers and CPT subscales, in this 
research.  Similarly, the evidence in this thesis supports Brown’s ADD syndrome 
model, whereby ADD is explained by deficits in all 6 areas of executive functions, 
which includes focus and effort (Brown, 2006).   
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 Contrary to the parental and teacher results which showed significant 
differences, the personality and EEG measures between the two samples showed 
differences, but they were not significant.  This was a surprising result, with previous 
literature showing that individuals with ADHD have higher levels of slow brainwave 
activity, specifically theta (Chabot & Serfontein, 1996; Fonseca et al., 2008; Bresnahan 
& Barry, 2002) and an overactive BAS, consequently seeking rewards and positive 
emotions, with low BIS showing an impaired inhibition to punishment (Barkley et al., 
1990; Hundt et al., 2008; Gomez & Corr, 2010).   
 Carver and White (1994) explained the Behavioural Activation System uses 
dopaminergic pathways within the brain, particularly within the basal ganglia.  As the 
current study and previous literature has shown, individuals with ADHD have increased 
BAS (Barkley et al., 1990; Hundt et al., 2008).  ADHD is linked to abnormal levels of 
dopamine in the brain’s neurotransmitters (Fuchs et al., 2003).  Specifically, there is 
evidence that individuals with ADHD have a variation in the dopamine transporter 
gene, causing deficits in the dopamine cell response (Tripp & Wickens, 2009).  
Consequently, the present study supports Carver and White (1994) that individuals with 
ADHD have higher levels of BAS, and therefore suggests that dopamine contributes to 
the cause of ADHD.  Furthermore, this suggests that dopamine pathways not only cause 
ADHD, but also effects our personality.   
 As discussed in previous chapters, one theory of ADHD is the developmental 
deviation model.  Typical development of the Central Nervous System includes 
synapses within the brain either being formed or eliminated (Barry et al., 2002), 
changes which are measured by EEG (Demos, 2004).  The developmental deviation 
model would suggest that the ADHD brain is unlikely to mature to the expected level.  
In this research, prior to any interventions taking place, there was no significant 
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difference on EEG measures between the two samples.  Consequently, this does not 
support the developmental deviation model of ADHD or Burke and Edge (2013) who 
found evidence of abnormal EEG patterns at all ages.  The reason for this is not clear, 
but could be due to the self-selecting nature of the participants.  This is discussed 
further in the methodological issues and technical limitations section of this thesis.  
Alternatively, EEG measures in an ADHD and typically developed population may not 
be as different as previously expected.   
6.1.2 Summary of experimental findings of the typically developed sample 
Neurofeedback has been shown to have a positive effect on typically developed children 
(Egner & Gruzelier, 2001; Vernon et al., 2003; Vernon, 2005; Fritson et al., 2007).  
However, much of the evidence came from a clinical setting and overlooked the use of 
neurofeedback being conducted in the family home under the remote guidance of a 
therapist (Vernon et al., 2004; Rutterford et al., 2008). 
 Across all 3 studies within this research, attempts were made to establish 
whether neurofeedback home training has a positive effect on improving concentration 
and impulsivity in a typically developed sample.  Specifically, study one examined the 
effect on personality, study two examined the effect on neuropsychological measures, 
specifically attention and impulsivity, and study three examined the effect on 
brainwaves.   
 The research did not find a statistically significant effect of neurofeedback home 
training or clinic training on concentration, impulsivity, personality or EEG.  The 
neurofeedback home training condition saw an increase in symptoms when rated by 
teachers.  Snyder et al., (2008) found that there was an informant bias and low 
agreement between parent and teacher ratings.  As Snyder et al. (2008) suggests and this 
research confirms, rating scales are useful within a clinical setting to help determine if 
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ADHD is present or not, but needs to involve other elements of assessment.  
Furthermore, interpreting observer results via rating scales needs to be done with 
caution.  Every individual will interpret behaviours differently depending on rater’s 
familiarity with the behaviour and situation of the observed behaviour.  For example, in 
a less restrictive and demanding environment such as at home, symptoms may not be as 
evident or troublesome (Barkley, 2003).  This concept is supported by Cortese et al. 
(2016) and Sonuga-Barke et al. (2013) where significant effects of nonpharmacological 
treatments when rated by individuals not blinded to intervention, compared to blinded 
raters who showed non-significant effects.  Specifically, possible parental bias due to 
subconscious bias by parents based on cognitive dissonance.  The use of such subjective 
measures then become questionable in its use of assessment and monitoring progress, 
and therefore suggest the possibility of an independent observer who does not know the 
individual, may be more reliable.  
 This research found the active control group had the largest change on EEG, 
specifically increased SMR at C3 and C4, alpha at Cz and theta at Cz, C3 and C4, as 
well as the largest mean absolute change scores, although not statistically significant, on 
personality, with an increase in BIS, BAS fun and BAS reward.  Research by Gong et 
al. (2015) shows that video gaming can alter brainwaves via neural plasticity due to 
gaming requiring the ability to process complex events in a specific sequence as well as 
to respond quickly and rapidly.  The research presented here has produced a unique 
finding, comparing neurofeedback home training to a computer-based activity, with the 
trend in results suggesting that sitting and focusing on a computer-based programme 
can influence our personality, specifically seeking reward and positive feelings (Carver 
& White, 1994).  Furthermore, completing a computer-based programme can alter 
brainwaves.  Literature shows that video gaming can alter brainwave activity as well as 
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attention skills.  Specifically, a more complex video game that is played, the faster 
brainwaves are produced to aid in extra concentration to successfully complete the game 
(Bakaoukas et al., 2015).  Within today’s society and the ever-growing use of modern 
technology, a computer-based treatment would be very beneficial and accessible to 
many individuals.  Computer based treatment in the treatment of neurodevelopmental 
conditions is an area which needs greater understanding.   
6.1.3 Summary of Experimental Findings of the ADHD Sample 
Neurofeedback has been shown to have a positive effect on individuals with a 
diagnosis of ADHD, improving impulsivity and attention (Carmody et al., 2001; Fuchs 
et al., 2003; Kaiser & Othmer, 2000; Rossiter, 2004; Rossiter & La Vaque, 1995).  
However, much of the evidence took place in a clinical setting and overlooked the use 
of neurofeedback being conducted in the family home under the remote guidance of a 
therapist (Vernon et al., 2004; Rutterford et al., 2008).  Similarly, medication is an 
established intervention in the treatment of ADHD (Barkley, 1997; Whalen et al., 1990; 
Schachar et al., 1997; Punja et al., 2013; Storebo et al., 2015; Pearson et al., 2004) but 
there are few studies examining the combination of neurofeedback and stimulant 
medication in the treatment of ADHD (Monastra et al., 2002; Monastra et al., 2004; 
Duric et al., 2012). 
 Across all 3 of the studies, attempts were made to establish whether 
neurofeedback home training has a positive effect on improving concentration and 
impulsivity.  Specifically, study one examined the effect on personality, study two 
examined the effect on neuropsychological measures, specifically attention and 
impulsivity, and study three examined the effect on brainwaves. 
 Neurofeedback produced no statistically significant effects on personality, 
concentration and impulsivity, or EEG.  The lack of significant findings could be Type 
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II error due to small sample sizes.  Additionally, as the present study is a feasibility 
study with small samples, findings are treated as tentative for implications, and need to 
be replicated in a larger sample.  Although there were few significant results within the 
present research, null results are important findings.  Null findings can inform 
researchers of what should be examined differently in future research.  Furthermore, the 
null results can inform policy and practice for implementing strategies (Miller-
Halegoua, 2017).  For example, the null results within this research would suggest that 
neurofeedback home training is not an effective strategy for treating childhood ADHD.   
Previous research has shown potential negative side effects to neurofeedback, 
including inducing seizures (Vernon et al., 2004), irritability and moodiness (Monastra 
et al., 2002) with the present study showing neurofeedback home training potentially 
worsening concentration.  This could support Cortese et al. (2016) where evidence 
failed to support the use of neurofeedback as a treatment for ADHD in addition to 
Sonuga-Barke et al. (2013) where significant treatment effects of neurofeedback were 
non-existent when participants were blinded to intervention. 
6.2 Methodological Issues and Technical Limitations 
The research in this thesis underwent many ethical reviews which ensured a very 
robust design; however, several methodological and technical limitations were 
experienced.  
Neurofeedback home training is an up and coming technology, with, to the 
researcher’s knowledge, this being the first study to examine its effect.  Consequently, 
the technology is yet to be developed and refined to be sufficiently user friendly for 
someone who is not experienced in conducting neurofeedback.  Because of this, 
problems were experienced by participants setting up and completing neurofeedback at 
home, creating a dropout rate of 10%.  Difficulties included the software not being 
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compatible with Mac computers, electrodes not being applied correctly and 
consequently not giving a clear signal, and batteries not lasting.  However, in many 
situations, these difficulties were overcome, through the loan of laptops and provision 
of new equipment and advice for the participants.  It is hoped that with the development 
of technology and as the use of neurofeedback grows, the equipment will become more 
robust and user friendly for individuals who are not experienced in the field. 
The research was initially comprised through ill advice regarding the collection 
of electrooculography (EOG) data, the omission of which only became evident at the 
analysis stage.  In particular, this made eyes open data unusable as eye blinks and 
twitches could not be screened for.  However, this was overcome by using eyes closed 
data only.  For future research, it is recommended that the EEG is conducted with an 
EOG measure in place and eyes open data collected and analysed, then compared to 
eyes closed data.   
 During the final data collection phase of the research, the Centre from where 
ADHD participants were being recruited, closed its main Centre in Horsham with 
resultant redundancy of staff, including the researcher of this thesis; instead, patients 
were seen in the London and Manchester Centres.  This made data collection for the 
final phase difficult despite permission being granted for remote access to the patient 
records after redundancy.  Furthermore, data collection for the neurofeedback in clinic 
condition was no longer possible as there was no clinic for this to take place.  Therefore, 
the data collection phase was ended sooner than anticipated, this being part of the 
reason why a larger sample size was not achieved.    
 The small ADHD sample size was due to recruitment difficulties.  For the 
neurofeedback home training conditions, the research had limited access to 
neurofeedback equipment only enabling 3 neurofeedback home training participants at 
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any one time.  Participation in the research was a long process with each participant 
completing the intervention at home for almost 4 months.  Access to 3 home training 
kits and long participation meant that, particularly for the neurofeedback home training 
conditions, recruitment was limited.  Additionally, recruitment for the neurofeedback in 
clinic condition was poor as individuals needed to live in close proximity to the Centre 
to access neurofeedback. This limited the target population and the number of 
appropriate participants.   
As previously discussed, the typically developed sample may not have been a 
true typical sample due to self-selecting participation.  Although a lack of diagnosis was 
screened for, possible undiagnosed difficulties were not.  Similarly, the ADHD 
population may not have been a typical sample due to recruitment taking place from a 
private clinic setting in an affluent area with participants being in a financial position to 
pay to access the Centre.  Furthermore, individuals accessing the Centre were typically 
previously turned away from the National Health Service due to not meeting their 
criteria threshold.  This may have contributed to there not being a significant difference 
between the two samples as had been expected.    
6.3  Implications for Future Research  
It is acknowledged that some of the work in this thesis should be viewed with 
consideration of several limitations; it is hoped that future research would be able to 
address the highlighted issues.   
 Firstly, regarding the small sample size, particularly in the ADHD neurofeedback 
conditions; with an effect size of 0.50 and the usual recommended power of 0.80, the 
ideal sample size needed would have been 64 participants per condition.  Unfortunately, 
after 3 years of data collection, the sample size was not achieved due to limited access to 
neurofeedback equipment, difficulties with the neurofeedback equipment and proximity 
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of participants to the Centre.  Future research would need to address these difficulties to 
achieve a larger sample and provide more robust statistical data.  
 With regard to the typically developed sample; it is possible that the sample had 
not developed as typically as expected, either academically or socially.  The present study 
did not examine this but assumed typical development based upon a lack of formal 
diagnosis.  A recommendation for future studies would be to include a measure of 
intelligence to control the sample. 
 A further suggestion for future research is that a personality scale which is more 
child friendly, be used.  For example, the wording of the BIS question “criticism or 
scolding hurts me quite a bit” may not be understood by seven-year olds.  The fact that 
there was a significant effect of age on the BIS/BAS scale may be explained by the fact 
that the older children understood the questions and answered appropriately.  
The present study was conducted as a feasibility study, with the aim to examine 
if successful implementation of neurofeedback home training is possible.  
Consequently, the present study showed that neurofeedback home training can be 
conducted within the home after participants have been provided with a demonstration 
and visual information.  Furthermore, recruitment, although sample sizes, was possible 
through a private Centre.  Therefore, to valid the findings of the present research, it 
would be beneficial to complete within a larger sample.   
6.4 Conclusion 
 In conclusion, the work within this thesis expands on literature in regard to 
neurofeedback, specifically within the ADHD field, and investigates the effect of 
neurofeedback being conducted at home; to the researcher’s knowledge, this is the first 
study to examine neurofeedback home training.  The research presented within this thesis 
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has been an extension of an existing body of research focused on concentration and 
impulsivity in typical individuals and individuals with a diagnosis of ADHD. 
The main results were that: (i) ADHD sample were significantly different to 
typically developed peers when rated by parents and on CPT, differences were found as 
expected on personality and EEG measures, but these were not significant, (ii) stimulant 
medication significantly improves executive function, defiance, inattention, hyperactive 
and impulsive traits when rated by parents in an ADHD population, (iii) neurofeedback 
in clinic and home training does not significantly effect concentration, impulsivity, 
personality or EEG in a ADHD or typically developed sample. In order to fully 
understand the use of neurofeedback home training, further research would benefit from 
replication of this model on a larger scale with the research’s identified limitations being 
addressed. 
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Appendix A: Ethical process 
17th January 
2012 
Application submitted to and reviewed by NRES Committee South East Coast 
Research Ethics Committee 
31st January 
2012 
Received unfavourable opinion outcome letter.   
The committee asked for the following information/alterations: 
• An explanation of what type of clinic the study would be taking place 
in.  
• A definition of Neurofeedback.  
• Clarification of how the recruitment process will be randomised.  
• Clarification as to whether the NICE guidelines would be followed.  
• Separate consent forms for over 12 years old.  
• Details on the dosage of the treatment.  
• Clarification on the sample size of the study.  
• The word ‘expected’ in the second paragraph on the debrief sheet 
should be changed to ‘may’. 
• Changes to the recruitment structure.  It was considered that the 
randomised method needed to be changed, as the randomisation 
method proposed may be seen as biased. 
• Clarification of what Neurofeedback is in the participant information 
sheet. 
• The paediatricians involved in the study should be named and their 
involvement made more prominent. 
5th April 2012 The following changes were made and application resubmitted and reviewed 
by NRS Committee South East Coast Research and Ethics Committee. 
• The recruitment structure was changed so that the intervention 
strategies would be randomly allocated to participants, rather than self 
selection.   
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• Definition of neurofeedback was inserted in the Participant 
Information Sheet. 
• The involvement of Specialist Consultant Paediatrician was explained 
in more detail on the Participant Information Sheet. 
• The 2008 NICE guidelines were discussed in more detail and an 
explanation is given as to how diagnosis and management of 
individuals with ADHD is conducted at the Centre in line with these 
guidelines. 
• A more detailed description of the Learning Assessment and 
Neurocare Centre was provided. 
• A separate Research Participant Consent Form for 12 to 17 years old 
participants was included. 
• Information was inserted in the Participant Information Sheet to clarify 
what forms part of the patients assessment at the Centre, what 
information from the assessment would be used for research and what 
additional information would be collected for research purpose. 
• Information was inserted in the Participant Information Sheet 
regarding the risks and disadvantages of taking part. 
12th April 2012 Received unfavourable opinion outcome letter. 
The committee asked for further information/alterations and made the 
following comments: 
• Clarity required on why an external independent peer review had not 
been sought for the study.  
• Concerned that the control group of participants would not be offered 
any treatment for 15 weeks if they agreed to take part.  
• Members commented that the paediatrician would not have the 
expertise to make a full assessment especially in mental health terms.  
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• Concern that the submission indicated that the study drugs would not 
cause any harm and did not have any long-term effects, however, 
members did not agree with this.  
• Clarity on whether participants who were distressed or upset for any 
reason as a result of taking part would be referred back to their GPs.  
• Members commented that there was a small chance that the completed 
questionnaires may reveal problems that had not been picked up earlier 
which members felt needed to be addressed.  
• Information sheets were still quite difficult to understand especially for 
the target population.  
• It was pointed out that information sheets and consent forms for 
parents and teachers to take part in the study in their own right was 
also required in addition to the information sheet submitted. 
• Consent forms required for older children, assent forms for young 
children and consent forms for parent/guarding. 
• Members queried whether there was any particular reason why the 
study was not being registered on a national database (A50 of the REC 
form).  
• Queried whether the neurofeedback sessions would be done at home, 
and wanted to know, if there was outcome measure for this 
intervention.  
• Members queried whether the private patients had to pay for their 
treatment for 26 weeks. 
17th April 2012 Meeting with UEA University’s Research, Enterprise and Engagement office 
stating NHS ethical approval was no longer required. 
June 2012
  
The following changes were made in response to the NHS ethics latest 
comments and application submitted to UEA FMH Ethics Committee. 
• External independent peer review completed. 
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• The NICE guidelines do not recommend neurofeedback as a form of 
treatment for ADHD.  However, there is a wealth of evidence that 
neurofeedback is an effect treatment for ADHD.   
• It was clarified that a complete assessment is completed at the 
Learning Assessment and Neurocare Centre by Consultant 
Paediatrician who adheres to the DSM-IV and NICE guidelines.  The 
doctor is qualified and experienced to diagnosis and manage ADHD 
and other neurodevelopmental conditions.   
• A discussion on the long-term effects of stimulant medication was 
added to the Participant Information Sheet. 
• Information has been inserted in the Information Sheet to point out that 
there is the possibility that the participant and/or family will 
experience distress due to the sensitive issues that are being discussed 
in the questionnaire. 
• Responses to additional questionnaires conducted specifically for this 
research, after completing the initial assessment at the Learning 
Assessment and Neurocare Centre would be passed to the Specialist 
Consultant Paediatrician.  This will ensure that if any further concerns 
are discovered, the correct specialist would be aware and able to take 
appropriate action.  
• Child/participants will be provided with a written information sheet 
and assent form to complete.  Parents will also have an information 
sheet and consent form to complete.  A teachers consent form was 
devised. 
• The child/participant will be provided with their own information sheet 
and assent form to understand and complete.   
• The research will be registered on a national database via journals. 
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• The outcome measure for neurofeedback home training would be the 
post measures QEEG, Conners’ rating scales for parents and teachers 
and the CPT. 
• The conflict of interests would be overcome by a second supervisor on 
the supervisor team who is completely independent of the Learning 
Assessment and Neurocare Centre. 
• Participants would be required to pay the cost of their treatment at the 
Learning Assessment and Neurocare.  They would not be paying any 
additional fees to take part in this research. 
27th September 
2012 
Reviewed by UEA Faculty Research Ethics Committee 
October 2012 Received unfavourable outcome letters. 
Issues included: 
• Concern regarding the fourth, control condition.  The committee felt 
that the condition should be dropped. 
• Concern regarding the information sheets.  Nature of neurofeedback 
and exactly what participants are consenting to needs to be clear. 
• Need clear consent from the owners of the clinic. 
• The ethics committee stated that ideally NRES approval could be 
gained. 
• Altering the design of the project. 
12th December 
2012 
Following changes were made and application resubmitted to UEA FMH 
Ethics Committee (however, the review was delayed due to administrative 
reasons). 
• The control arm of the study was removed. 
• The information sheets were re-written.  Diagrams were inserted to 
help illustrate the procedure. 
• UEA advised that NRES approval was not required. 
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• Participants would only be asked to take part if both treatments 
involved in this study, neurofeedback and stimulant medication, were 
offered to them as part of their standard treatment as deemed 
appropriate by Consultant Paediatrician at the Learning Assessment 
and Neurocare Centre.  If a participant decided to take part, they would 
randomly allocated by the researcher to a treatment condition. 
• Two further conditions have been added to the project; neurofeedback 
clinic training and neurofeedback clinic training with stimulant 
medication.  This would result in the project having 5 conditions; 1 
neurofeedback home training, 2 neurofeedback home training and 
stimulant medication, 3 stimulant medication, 4 neurofeedback clinic 
training, 5 neurofeedback clinic training and stimulant medication.  
September 
2013  
The researcher transferred to City University London 
1st October 
2013 
Reviewed by City University Senate Research Ethics Committee 
14th October 
2013 
Received unfavourable outcome letter 
10th December 
2013  
Reviewed by City University Senate Research Ethics Committee 
18th December 
2013 
Received outcome letter, unable to reach a decision.   
Issues included: 
• Unclear why UEA ethics approval was not granted. 
• Committee wanted further information regarding why the NRES 
approval was not necessary. 
• The study should be registered as a clinical trial. 
• Allocation of groups was not randomised. 
• There needs to be a statistical review to clarify what effect size the 
study is looking at. 
• The intervention will be provided for 30 sessions, below sub-optimal 
level of 43 sessions. 
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• Issue of side effects, risk of seizure unattended at home. 
• A full trail should not proceed until results of the current (sample one) 
study is available. 
 
January 2014 Application submitted and reviewed by the Learning Assessment and 
Neurocare Centre Ethical Committee and received a favourable opinion 
January 2014 The following changes and clarifications were made and application 
resubmitted to City University Senate Research Ethics Committee.   
• It would be the parent’s decision to approach the Centre, and this 
would not be a formal referral; they could do this independently of 
their NHS GP. The Centre would provide the GP with patient 
information (with their consent) as a courtesy, and not as an official 
report. Therefore, as these were private, and not NHS patients, NRES 
approval was not needed. This was the decision of the ethics 
committee of the Faculty of Medicine and Health Sciences. 
• This is not a formal clinical trial; it is an initial experimental feasibility 
study. It is in no way intended to provide data of direct clinical 
significance. Rather it is intended to provide scientific knowledge of 
an experimental nature that could then be used to inform early-stage 
clinical trials. Such a study is entirely appropriate for a PhD project.  
• Allocation to groups is randomised, and only patients willing to 
participate in the study would be eligible. The Consultant will only be 
deciding from a medical perspective if appropriate for the patient to 
receive neurofeedback and/or stimulant medication.   
• The main statistical information to be derived from this study is 
estimation of the effect size of the different treatments. The nature of 
this study is thus exploratory and these important statistical matters 
will form a crucial part of the thesis.  As this research is part of a PhD 
there are necessary resource limitations as regards the number of 
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sessions and number of participants; however, the data would be novel 
and would be the first of their kind and, as such, will represent new, 
and perhaps important, information.  
• There has only been one previous research study that has referred to 
the possibility of neurofeedback inducing a seizure (Vernon et al., 
2004), and there is very little evidence for this. There have been no 
incidences of seizures when neurofeedback is conducted in the clinic.  
• The first study, titled “Examining the effect of neurofeedback home 
training on typical individuals’ concentration abilities” does have some 
early findings available. A paired t-test assessed the difference 
between pre and post measures of concentration and impulsivity across 
the conditions.  Parents’ rating on concentration and impulsivity were 
improved in the neurofeedback home training condition (t = 3.00, df = 
3, p = 0.058) compared to no change in the control conditions (t = 
0.555, df = 8, p = 0.594). The measures and interventions that would 
be collected for this study are already in use at the Learning 
Assessment and Neurocare Centre.  This includes the use of 
quantitative EEGs, Conners CPT, neurofeedback home training, in 
clinic training and in combination with stimulant medication. This 
research would not be looking into the effect of a new treatment but of 
a treatment that is already established and in use.  The research would 
be collecting the data that is already being produced and using it in a 
research perspective.  It is, therefore, known that the procedures 
outlined in this research study are effective.   
February 2014 Email received from Research Ethics Committee asking for clarification on 
following issues: 
• What is the involvement of the Centre and consultant paediatrician 
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• The approval letter from the Centre mentions that many of the 
procedures intended to be used in the study are already being 
conducted at the Centre. The Committee would like to know explicitly 
which procedures are in use already, and which ones are not and how 
these will be supported. 
• Proposed alterations to wording in Information Sheet. 
February 2014 Following changes were made and application resubmitted to City University 
Senate Research Ethics Committee.   
• The Centre undertakes a quantitative EEG and Conners CPT on all 
child patients as part of their initial diagnostic paediatric assessments.  
The Centre provides a range of management options for patients 
including all conditions which will be involved in this study; namely, 
patients receiving neurofeedback at home with remote supervision, 
patients receiving neurofeedback at home with remote supervision 
with stimulant medication monitored by the consultant paediatrician, 
patients receiving medication only supervised by the consultant 
paediatrician, patients receiving neurofeedback in the clinic, patients 
receiving neurofeedback in the clinic with stimulant medication 
supervised by consultant paediatrician.   
• The research should not have been submitted to the NRES in the first 
place, so this was probably the result of a misunderstanding of the 
NRES on the part of the University of East Anglia (UEA). They 
returned it to UEA.  We believe that what changed was UEA’s 
understanding of these rules, which in an event did not involve private 
patients. This set of events may have reflected UEA’s over-caution of 
this proposal because it involved children. 
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• The title of the study was changed to “A feasibility study to investigate 
the effect of neurofeedback and stimulant medication on children with 
Attention Deficit Hyperactivity Disorder (ADHD)” 
March 2014 Received a favourable outcome 
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Appendix L: BIS/BAS questionnaire 
Please indicate if you agree or disagree with the following statements.  For each 
question, indicate your answer by using the 4-point scale below the question.  There are 
no right or wrong answers to these questions, simple provide your level of agreement or 
disagreement. 
 
1.  A person’s family is the most important thing in life. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
2. Even if something bad is about to happen to me, I rarely experience fear or 
nervousness. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
3. I go out of my way to get things I want. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
4. When I’m doing well at something I love to keep at it. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
5. I’m always willing to try somethinG new if I think it will be fun. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
6. How I dress is important to me. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
7. When I get something I want, I feel excited and energised. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
8. Criticism or scolding hurts me quite a bit. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
9. When I want something I usually go all-out to get it. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
 
10. I will often do things for no other reason than that they might be fun. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
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11. It’s hard for me to find the time to do things such as a get a haircut. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
12. If I see a chance to get something I want I move on it right away. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
13. I feel pretty worried or upset when I think or know somebody is angry at me. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
14. When I see an opportunity for something I like I get excited right away. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
15. I often act on the spur of the moment. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
16. If I think something unpleasant is going to happen I usually get pretty “worked 
up.” 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
17. I often wonder why people act the way they do. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
18. When good things happen to me, it affects me strongly. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
19. I feel worried when I think I have done poorly at something important. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
20. I crave excitement and new sensations. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
21. When I go after something I use a “no holds barred” approach. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
22. I have very few fears compared to my friends. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
23. It would excite me to win a contest. 
1 2 3 4 
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Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
24. I worry about making mistakes. 
1 2 3 4 
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree 
 
 
Thank you very much for completing this questionnaire. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
269 
Appendix M: Conners’ 3 Parent Rating Scale 
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Appendix N: Conners’ 3 Teacher Rating Scale 
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Appendix O: Typically developed sample neurofeedback home training 
guidelines 
This would be personalised for the ADHD sample. 
 
Neurofeedback Home Training Guidelines 
 
 
I have agreed that ..................................................(participants name) will complete 
neurofeedback sessions on ....................................(day)  at ............................(time)  and 
..........................................(day) at ......................(time) at home with the supervision of 
...................................................(parent/guardian). 
 
After every 2 sessions, the researcher will provide the participant will some written 
feedback via email about their completed sessions.   
 
Pre-Training Software Guidelines 
 
1. Insert the purple dongle. 
2. Double click on the appropriate design icon on the desktop for the training 
session 
C3 Pacman 
Cz Boxes 
C4 Video 
 
Pre-Training Hardware Guidelines 
 
1. Switch PET on. Check light is on. 
2. Plug PET USB silver dongle into the computer. You MUST always use the same 
USB port as identified at identified by your neurofeedback therapist. 
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Attaching Electrode at C3  
 
1. Clip a disposable electrode onto the black and yellow leads.  
2. Strap the PET around the right upper-arm with the electrode leads at the top. 
Ensure it is Velcro tightly.  
3. Clean the skin at the position of the mastoids (see diagram) by rubbing some 
Nuprep on the skin. 
4. Wipe the residual Nuprep off with a tissue. 
5. Remove the plastic film and stick the black and yellow electrodes at the 
position of the mastoids (see diagram) 
6. Clip a disposable electrode onto the blue lead.  
7. Remove the plastic film and put some Ten20 paste onto this electrode. Spread 
a thin film of the paste all over the electrode and leave a pea sized amount in 
the centre of the electrode. 
8. Using the diagram below locate the desired electrode location.  
9. Clean the desired electrode location by rubbing some Nuprep on the scalp. 
10. Position the blue electrode at the identified location. If necessary put a little 3 X 
3 cm piece of kitchen towel paper on top and around the electrode to ensure 
that it remains in its position. 
 
 
 
 
Software Guidelines 
 
1. You need to have the ‘Instruments 1’ window open, so if necessary click on 
‘Window’, and click on ‘Instruments 1’. 
2. Click on ‘Play’ and check for good signal. 
3. Click on ‘Record’. 
4. Save the file including the date and electrode location e.g.......C3Pacman 
5. Click Save. 
6. Click OK in the ‘Session Info’ box. 
7. Click on ‘Window’, and select ‘Instruments 2’. 
8. The client can now do the session. 
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9. At the end of the session, close down Bioexplorer and select the next 
appropriate design icon on the desktop for the next session. 
 
Attaching Electrode at Cz 
 
1. Replenish Ten20 paste onto the blue electrode if necessary.  
2. Using the diagram below locate the desired electrode location.  
3. Clean the desired electrode location by rubbing some Nuprep on the scalp. 
4. Position the blue electrode at the identified location. If necessary put a little 3 X 
3 cm piece of kitchen towel paper on top and around the electrode to ensure 
that it remains in its position. 
 
 
 
 
 
Software Guidelines 
 
1. You need to have the ‘Instruments 1’ window open, so if necessary click on 
‘Window’, and click on ‘Instruments 1’. 
2. Click on ‘Play’ and check for good signal. 
3. Click on ‘Record’. 
4. Save the file including the date and electrode location e.g.......CzBoxes 
5. Click Save. 
6. Click OK in the ‘Session Info’ box. 
7. Click on ‘Window’, and select ‘Instruments 2’. 
8. The client can now do the session. 
9. At the end of the session, close down Bioexplorer and select the next 
appropriate design icon on the desktop for the next session. 
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Attaching Electrode at C4 
 
1. Replenish Ten20 paste onto the blue electrode if necessary.  
2. Using the diagram below locate the desired electrode location.  
3. Clean the desired electrode location by rubbing some Nuprep on the scalp. 
4. Position the blue electrode at the identified location. If necessary put a little 3 X 
3 cm piece of kitchen towel paper on top and around the electrode to ensure 
that it remains in its position. 
 
 
 
 
 
Software Guidelines 
 
1. As you are intending to do a session with video feedback you may want to 
change the videos. To do this click on ‘Window’, and click on ‘Signal Diagram’. 
2. You may need to scroll to the right. Right-click on the ‘Video-Player 1’ box. 
3. Click ‘Properties’. Click ‘Remove’ to remove any videos you do not want, and 
click ‘Add’ to select those you do. The ‘Video’ folder is on the desktop, from 
which the video files can be selected. 
4. You need to have the ‘Instruments 1’ window open, so if necessary click on 
‘Window’, and click on ‘Instruments 1’. 
5. Click on ‘Play’ and check for good signal. 
6. Click on ‘Record’. 
7. Save the file including the date and electrode location e.g.......C4Video 
8. Click Save. 
9. Click OK in the ‘Session Info’ box. 
10. Click on ‘Window’, and select ‘Instruments 2’. 
11. The client can now do the session. 
12. At the end of the session, close down Bioexplorer and select the next 
appropriate design icon on the desktop for the next session. 
 
 
 
 280 
 
 
Post-Training Software Guidelines 
1. If the session is the final one for the day, close Bioexplorer. 
2. Send all saved sessions to hannah.wachnianin@lanc.uk.com   
 
Post-Training Hardware Guidelines 
1. At end of session take electrodes off scalp and mastoids. 
2. Dispose of electrodes. 
3. Unplug the PET USB dongle from the computer. 
4. Turn off PET.  
5. Unplug the purple dongle. 
6. Place all hardware in packaging. 
 
Battery Charging (This can be done at anytime) 
1. Remove battery from PET. 
2. Insert the battery into the battery charger. 
3. Plug the battery charger in to a wall socket. 
4. Once charged insert the battery into the PET. 
5. Place the battery charger back in the packaging. 
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Appendix P: Typically developed sample active control group guidelines 
Computer Game Training Guidelines 
 
 
I have agreed that ..................................................(participants name) will complete 
computer game training sessions on ....................................(day) at 
............................(time)  and ..........................................(day) at ......................(time) at 
home with the supervision of ...................................................(parent/guardian). 
 
Before starting the games, set a timer for 30 minutes.  You can use the following online 
timer.  Simply write the website into your browser http://timer.onlineclock.net/, click on 
the little drop down arrow and select 30 minutes.  Ensure the sound on your computer is 
on.  The timer will start straight aware.   
 
Depending on the child’s age, please select the most appropriate website below: 
 
Children aged between 7 and 10 - http://www.bbc.co.uk/bitesize/ks2/ 
 
Children aged between 11 and 14 - http://www.bbc.co.uk/schools/ks3bitesize/  
 
Children aged between 15 and 17 - http://www.bbc.co.uk/schools/gcsebitesize/  
 
The child can choose which activities they complete on that website.  Please write down 
which activities are completed, and if a score is given, please write down the score 
gained.  When one activity is completed, the child can choose another until they have 
completed 30 minutes worth of activities.   
 
After 30 minutes, the online timer will start to beep. Once this has sounded, please close 
down the website with the timer and the website with the games – the session has 
ended. 
 
Now email the researcher on  letting her know that  
the session has been completed and which activities your child completed.   
 
 
 
 
 
 
 
 282 
Appendix Q: Typically developed sample child debrief 
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Appendix R: ADHD sample child debrief 
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Appendix S: Typically developed sample parent debrief 
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Appendix T: ADHD sample parent debrief 
 
 
